0001144204-16-131382.txt : 20161103 0001144204-16-131382.hdr.sgml : 20161103 20161103160655 ACCESSION NUMBER: 0001144204-16-131382 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 65 CONFORMED PERIOD OF REPORT: 20160930 FILED AS OF DATE: 20161103 DATE AS OF CHANGE: 20161103 FILER: COMPANY DATA: COMPANY CONFORMED NAME: STAAR SURGICAL CO CENTRAL INDEX KEY: 0000718937 STANDARD INDUSTRIAL CLASSIFICATION: OPHTHALMIC GOODS [3851] IRS NUMBER: 953797439 STATE OF INCORPORATION: DE FISCAL YEAR END: 1228 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-11634 FILM NUMBER: 161971608 BUSINESS ADDRESS: STREET 1: 1911 WALKER AVE CITY: MONROVIA STATE: CA ZIP: 91016 BUSINESS PHONE: 6263037902 MAIL ADDRESS: STREET 1: 1911 WALKER AVE CITY: MONROVIA STATE: CA ZIP: 91016 FORMER COMPANY: FORMER CONFORMED NAME: STAAR SURGICAL COMPANY DATE OF NAME CHANGE: 19920703 10-Q 1 v451100_10q.htm FORM 10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 10-Q

(Mark One)

þ	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
	For the quarterly period ended: September 30, 2016
	Or
¨	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
	For the transition period from to

Commission file number: 0-11634

STAAR SURGICAL COMPANY

(Exact name of registrant as specified in its charter)

Delaware

95-3797439

(State or other jurisdiction of

incorporation or organization)

(I.R.S. Employer

Identification No.)

1911 Walker Avenue

Monrovia, California 91016

(Address of principal executive offices)

(626) 303-7902

(Registrant’s telephone number, including area code))

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes þ No ¨

Indicate by check mark whether the Registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the Registrant was required to submit and post such files). Yes þ No ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

¨ Large accelerated filer

þ Accelerated filer

¨ Non-accelerated filer

(Do not check if a smaller reporting company)

¨ Smaller reporting company

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ¨ No þ

The registrant has 40,609,093 shares of common stock, par value $0.01 per share, issued and outstanding as of October 24, 2016.

STAAR SURGICAL COMPANY

INDEX

		PAGE
		NUMBER

PART I – FINANCIAL INFORMATION

Item 1.	Financial Statements.	1

Item 2.	Management's Discussion and Analysis of Financial Condition and Results of Operations.	14

Item 3.	Quantitative and Qualitative Disclosures About Market Risk.	20

Item 4.	Controls and Procedures.	20

PART II – OTHER INFORMATION

Item 1.	Legal Proceedings.	20

Item 1A.	Risk Factors.	21

Item 4.	Mine Safety Disclosures.	21

Item 5.	Other Information.	21

Item 6.	Exhibits.	21

PART 1 – FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS

STAAR SURGICAL COMPANY

CONDENSED CONSOLIDATED BALANCE SHEETS

(In thousands, except par value amounts)

(Unaudited)

	September 30, 2016			January 1, 2016
ASSETS

Current assets:
Cash and cash equivalents	$	14,284		$	13,402
Accounts receivable trade, net of allowance for doubtful accounts of $2,039 and $1,877, respectively		14,372			15,675
Inventories, net		15,895			15,921
Prepayments, deposits and other current assets		4,649			3,636
Deferred income taxes		518			439
Total current assets		49,718			49,073
Property, plant and equipment, net		11,718			10,095
Intangible assets, net		607			666
Goodwill		1,786			1,786
Deferred income taxes		1,670			717
Other assets		835			617
Total assets	$	66,334		$	62,954

LIABILITIES AND STOCKHOLDERS’ EQUITY

Current liabilities:
Line of credit	$	4,941		$	4,159
Accounts payable		7,973			6,691
Deferred income taxes		370			370
Obligations under capital leases		398			362
Other current liabilities		7,568			6,305
Total current liabilities		21,250			17,887
Obligations under capital leases		1,676			204
Deferred income taxes		1,005			1,888
Asset retirement obligations		225			156
Deferred rent		68			87
Pension liability		4,380			3,886
Total liabilities		28,604			24,108

Commitments and contingencies (Note 12)


Stockholders’ equity:
Common stock, $0.01 par value; 60,000 shares authorized; 40,607 and 39,887 shares issued and outstanding at September 30, 2016 and January 1, 2016, respectively		406			399
Additional paid-in capital		196,411			187,007
Accumulated other comprehensive loss		(145	)		(1,580	)
Accumulated deficit		(158,942	)		(146,980	)
Total stockholders’ equity		37,730			38,846
Total liabilities and stockholders’ equity	$	66,334		$	62,954

See accompanying notes to the condensed consolidated financial statements.

STAAR SURGICAL COMPANY

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(In thousands, except per share amounts)

(Unaudited)

	Three Months Ended						Nine Months Ended
	September 30, 2016			October 2, 2015			September 30, 2016			October 2, 2015

Net sales	$	20,052		$	18,750		$	60,295		$	56,264
Cost of sales		5,180			5,951			17,804			18,206

Gross profit		14,872			12,799			42,491			38,058

General and administrative		4,985			4,853			18,378			14,748
Marketing and selling		7,149			6,284			22,006			17,784
Research and development		4,453			3,684			16,018			10,800
Total selling, general and administrative expenses		16,587			14,821			56,402			43,332

Operating loss		(1,715	)		(2,022	)		(13,911	)		(5,274	)

Other income (expense):
Interest income		‒			1			1			50
Interest expense		(29	)		(29	)		(86	)		(97	)
Gain (loss) on foreign currency transactions		(29	)		20			13			(692	)
Royalty income		134			224			507			375
Other income, net		(68	)		43			(150	)		62
Other income (expense), net		8			259			285			(302	)

Loss before provision for income taxes		(1,707	)		(1,763	)		(13,626	)		(5,576	)
Provision (benefit) for income taxes		71			(11	)		(1,664	)		114
Net loss	$	(1,778	)	$	(1,752	)	$	(11,962	)	$	(5,690	)

Net loss per share – basic and diluted	$	(0.04	)	$	(0.04	)	$	(0.30	)	$	(0.14	)

Weighted average shares outstanding – basic and diluted		40,486			39,727			40,227			39,409

See accompanying notes to the condensed consolidated financial statements.

STAAR SURGICAL COMPANY

CONDENSED CONSOLIDATED STATEMENTS

OF COMPREHENSIVE LOSS

(In thousands)

(Unaudited)

	Three Months Ended						Nine Months Ended
	September 30, 2016			October 2, 2015			September 30, 2016			October 2, 2015
Net loss	$	(1,778	)	$	(1,752	)	$	(11,962	)	$	(5,690	)
Other comprehensive income (loss):
Defined benefit pension plans:
Net change in plan assets		(11	)		(9	)		(34	)		(27	)
Reclassification into earnings		27			14			80			44
Foreign currency translation gain		232			288			2,000			54
Tax effect		(67	)		(99	)		(611	)		(18	)
Other comprehensive income, net of tax		181			194			1,435			53
Comprehensive loss	$	(1,597	)	$	(1,558	)	$	(10,527	)	$	(5,637	)

See accompanying notes to the condensed consolidated financial statements.

STAAR SURGICAL COMPANY

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands)

(Unaudited)

	Nine Months Ended
	September 30, 2016			October 2, 2015
Cash flows from operating activities:

Net loss	$	(11,962	)	$	(5,690	)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Depreciation of property, plant and equipment		1,933			1,563
Amortization of intangibles		171			154
Deferred income taxes		(1,806	)		(148	)
Change in net pension liability		390			136
Stock-based compensation expense		8,143			2,747
Provision for sales returns and bad debts		99			331
Changes in working capital:
Accounts receivable		1,707			(2,040	)
Inventories, net		1,601			1,497
Prepayments, deposits and other current assets		(1,118	)		737
Accounts payable		594			(991	)
Other current liabilities		1,104			1,387
Net cash provided by (used in) operating activities		856			(317	)

Cash flows from investing activities:
Acquisition of property, plant and equipment		(2,709	)		(1,283	)
Cash proceeds from sale of property, plant and equipment		65			2
Net cash used in investing activities		(2,644	)		(1,281	)

Cash flows from financing activities:
Repayment of capital lease obligations		(302	)		(306	)
Proceeds from sale-leaseback transactions		1,154			—
Repurchase of employee common stock for taxes withheld		(611	)		—
Proceeds from exercise of stock options		1,652			2,149
Proceeds from exercise of warrants		—			2,800
Net cash provided by financing activities		1,893			4,643

Effect of exchange rate changes on cash and cash equivalents		777			23

Increase in cash and cash equivalents		882			3,068
Cash and cash equivalents, at beginning of the period		13,402			13,013
Cash and cash equivalents, at end of the period	$	14,284		$	16,081

See accompanying notes to the condensed consolidated financial statements.

STAAR SURGICAL COMPANY

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

Note 1 — Basis of Presentation and Significant Accounting Policies

The condensed consolidated financial statements of the Company present the financial position, results of operations, and cash flows of STAAR Surgical Company and its wholly owned subsidiaries. All significant intercompany accounts and transactions have been eliminated. The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X of the Securities Exchange Commission. In accordance with those rules and regulations certain information and footnote disclosures normally included in comprehensive financial statements have been condensed or omitted pursuant to such rules and regulations. The consolidated balance sheet as of January 1, 2016 was derived from the audited financial statements at that date, but does not include all the information and footnotes required by GAAP. These financial statements should be read in conjunction with the audited financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended January 1, 2016.

The accompanying interim condensed consolidated financial statements, in the opinion of management, include all adjustments, consisting only of normal recurring adjustments, necessary for a fair presentation of the Company’s financial condition and results of operations. The condensed consolidated results of operations are not necessarily indicative of the results to be expected for any other interim period or for the entire year.

Each of the Company's reporting periods ends on the Friday nearest to the quarter ending date and generally consists of 13 weeks. Unless the context indicates otherwise “we,” “us,” the “Company,” and “STAAR” refer to STAAR Surgical Company and its consolidated subsidiaries.

Recent Accounting Pronouncements

In August of 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2016-15, “Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments” (“ASU 2016-15”), which clarifies how companies present and classify certain cash receipts and cash payments in the statement of cash flows. ASU 2016-15 is effective for fiscal years beginning after December 15, 2017 and early adoption is permitted. The Company is currently evaluating the impact ASU 2016-15 will have on its consolidated financial statements.

In May 2016, the FASB issued ASU 2016-12, “Revenue from Contracts with Customers (Topic 606): Narrow-Scope Improvements and Practical Expedients” (“ASU 2016-12”). The amendments in ASU 2016-12 provide clarifying guidance in certain narrow areas and add some practical expedients. Specifically, the amendments in this update (1) clarify the objective of the collectability criterion in step 1, and provides additional clarification for when to recognize revenue for a contract that fails step 1, (2) permit an entity, as an accounting policy election, to exclude amounts collected from customers for all sales (and other similar) taxes from the transaction price, (3) specify that the measurement date for noncash consideration is contract inception, and clarifies that the variable consideration guidance applies only to variability resulting from reasons other than the form of the consideration, (4) provide a practical expedient that permits an entity to reflect the aggregate effect of all modifications that occur before the beginning of the earliest period presented when identifying the satisfied and unsatisfied performance obligations, determining the transaction price, and allocating the transaction price to the satisfied and unsatisfied performance obligations, and (5) clarifies that a completed contract for purposes of transition is a contract for which all (or substantially all) of the revenue was recognized under legacy GAAP before the date of initial application. Further, accounting for elements of a contract that do not affect revenue under legacy GAAP are irrelevant to the assessment of whether a contract is complete. In addition, the amendments permit an entity to apply the modified retrospective transition method either to all contracts or only to contracts that are not completed contracts, and clarifies that an entity that retrospectively applies the guidance in Topic 606 to each prior reporting period is not required to disclose the effect of the accounting change for the period of adoption. However, an entity is still required to disclose the effect of the changes on any prior periods retrospectively adjusted. The effective date and transition requirements for the amendments are the same as the effective date and transition requirements in Topic 606. The guidance is effective for the Company beginning January 1, 2018, although early adoption is permitted beginning January 1, 2017. The Company is currently evaluating the effects of ASU 2016-12 on its consolidated financial statements.

In April 2016, the FASB issued ASU 2016-10, “Revenue from Contracts with Customers (Topic 606): Identifying Performance Obligations and Licensing.” The amendments clarify two aspects of Topic 606: (a) identifying performance obligations; and (b) the licensing implementation guidance. The update is effective for annual periods beginning after December 15, 2017 including interim reporting periods therein. The Company is currently evaluating the impact the adoption of ASU 2016-10 will have on its consolidated financial statements.

STAAR SURGICAL COMPANY

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

In March 2016, the FASB issued ASU 2016-09, “Compensation—Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting”, which simplifies several aspects of the accounting for share-based payment transactions, including the income tax consequences, forfeitures, classification of awards as either equity or liabilities, and classification of awards on the statement of cash flows. The update is effective for fiscal years beginning after December 15, 2016. The Company is currently evaluating the impact of the adoption of ASU 2016-09 will have on its consolidated financial statements.

In February 2016, the FASB issued ASU 2016-02, “Leases (Topic 842)”, which requires lessees to recognize assets and liabilities for leases with lease terms greater than twelve months in the statement of financial position. Leases will be classified as either finance or operating, with classification affecting the pattern of expense recognition in the income statement. ASU 2016-02 also requires improved disclosures to help users of financial statements better understand the amount, timing and uncertainty of cash flows arising from leases. The update is effective for fiscal years beginning after December 15, 2018, including interim reporting periods within that reporting period. Early adoption is permitted. The Company is currently evaluating the impact the adoption of ASU 2016-02 will have on its consolidated financial statements.

In November 2015, the FASB issued ASU 2015-17, “Income Taxes (Topic 740): Balance Sheet Classification of Deferred Taxes”, which changes how deferred taxes are classified on company’s balance sheets. The ASU eliminates the current requirement to present deferred tax liabilities and assets as current and noncurrent on the balance sheet. Instead, companies will be required to classify all deferred tax assets and liabilities as noncurrent. The amendments are effective for annual financial statements beginning after December 15, 2016, and interim periods within those annual periods. The Company does not expect the adoption of ASU 2015-17 will have a material impact on its consolidated financial statements.

In August 2014, the FASB issued ASU 2014-15, "Presentation of Financial Statements-Going Concern (Subtopic 205-40): Disclosure of Uncertainties about an Entity's Ability to Continue as a Going Concern". ASU 2014-15 defines management's responsibility to assess an entity's ability to continue as a going concern, and to provide related footnote disclosures in certain circumstances. It is effective for annual reporting periods ending after December 15, 2016, and for annual and interim reporting periods thereafter. Early adoption is permitted. The Company does not expect the adoption of ASU 2014-15 will have a material impact on its financial statements.

In May 2014, the FASB issued ASU 2014-09, “Revenue from Contracts with Customers (Topic 606)”, which supersedes nearly all existing revenue recognition guidance under GAAP. The core principle of ASU 2014-09 is to recognize revenues when promised goods or services are transferred to customers in an amount that reflects the consideration to which an entity expects to be entitled for those goods or services. ASU 2014-09 defines a five-step process to achieve this core principle and, in doing so, more judgment and estimates may be required within the revenue recognition process than are required under existing GAAP. The revised revenue standard is effective for public entities for annual periods beginning after December 15, 2017, and interim periods therein, using either of the following transition methods: (i) a full retrospective approach reflecting the application of the standard in each prior reporting period with the option to elect certain practical expedients; or (ii) a retrospective approach with the cumulative effect of initially adopting ASU 2014-09 recognized at the date of adoption (which includes additional footnote disclosures). The Company is currently evaluating the impact of the Company’s pending adoption of ASU 2014-09 on the Company’s financial statements and has not yet determined the method by which it will adopt the standard in fiscal 2018.

Prior Year Reclassifications

During the three-month and nine-month periods ended October 2, 2015 the Company reclassified $224,000 and $375,000, respectively, from other income, net to royalty income in the condensed consolidated statements of operations.

STAAR SURGICAL COMPANY

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

Note 2 — Inventories

Inventories, net are stated at the lower of cost, determined on a first-in, first-out basis or market value and consisted of the following (in thousands):

	September 30,		January 1,
	2016		2016
Raw materials and purchased parts	$	2,177	$	2,317
Work-in-process		2,099		1,995
Finished goods		15,714		15,058
		19,990		19,370
Less: inventory reserves		4,095		3,449
	$	15,895	$	15,921

Note 3 — Prepayments, Deposits, and Other Current Assets

Prepayments, deposits, and other current assets consisted of the following (in thousands):

	September 30,		January 1,
	2016		2016
Prepayments and deposits	$	2,052	$	1,386
Income tax receivable		626		597
Consumption tax receivable		507		—
Value added tax (VAT) receivable		658		724
Deferred charges for foreign profits		182		182
Other current assets		624		747
	$	4,649	$	3,636

Note 4 — Property, Plant and Equipment

Property, plant and equipment, net consisted of the following (in thousands):

	September 30,		January 1,
	2016		2016
Machinery and equipment	$	18,934	$	17,094
Furniture and fixtures		8,255		6,980
Leasehold improvements		9,238		8,611
		36,427		32,685
Less: accumulated depreciation		24,709		22,590
	$	11,718	$	10,095

Note 5 –Intangible Assets

Intangible assets, net consisted of the following (in thousands):

	September 30, 2016							January 1, 2016
	Gross Carrying Amount		Accumulated Amortization			Net		Gross Carrying Amount		Accumulated Amortization			Net
Intangible assets:
Patents and licenses	$	9,312	$	(8,965	)	$	347	$	9,207	$	(8,891	)	$	316
Customer relationships		1,550		(1,356	)		194		1,305		(1,044	)		261
Developed technology		985		(919	)		66		829		(740	)		89
Total	$	11,847	$	(11,240	)	$	607	$	11,341	$	(10,675	)	$	666

STAAR SURGICAL COMPANY

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

Note 6 – Other Current Liabilities

Other current liabilities consisted of the following (in thousands):

	September 30, 2016		January 1, 2016
Accrued salaries and wages	$	2,452	$	1,909
Accrued bonuses		2,027		2,114
Consumption tax		482		157
Accrued insurance		144		540
Accrued audit fees		412		314
Other⁽¹⁾		2,051		1,271
	$	7,568	$	6,305

⁽¹⁾No individual item in “Other” above exceeds 5% of the total other current liabilities

Note 7 – Defined Benefit Pension Plans

The Company has defined benefit plans covering employees of its Switzerland and Japan operations.

The following table summarizes the components of net periodic pension cost recorded for the Company’s defined benefit pension plans (in thousands):

	Three Months Ended						Nine Months Ended
	September 30, 2016			October 2, 2015			September 30, 2016			October 2, 2015
Service cost	$	155		$	108		$	466		$	322
Interest cost		19			19			54			57
Expected return on plan assets		(24	)		(22	)		(69	)		(64	)
Net amortization of transitional obligation (a)		3			3			10			8
Actuarial loss recognized in current period (a)		24			11			70			36
Total	$	177		$	119		$	531		$	359

(a) Amounts reclassified from accumulated other comprehensive loss.

During the nine months ended September 30, 2016 and October 2, 2015, the Company made cash contributions of approximately $419,000 and $400,000, respectively, to its Swiss pension plan and the Company is not required to make additional cash contributions during the remainder of 2016. The Company is not required to and does not make contributions to its Japan pension plan.

Note 8 — Basic and Diluted Loss Per Share

The following table sets forth the computation of basic and diluted net loss per share (in thousands except per share amounts):

	Three Months Ended						Nine Months Ended
	September 30, 2016			October 2, 2015			September 30, 2016			October 2, 2015
Numerator:
Net loss	$	(1,778	)	$	(1,752	)	$	(11,962	)	$	(5,690	)

Denominator:
Weighted average common shares and denominator for basic and diluted calculation:
Weighted average common shares outstanding		40,501			39,851			40,242			39,533
Less: Unvested restricted stock		(15	)		(124	)		(15	)		(124	)
Denominator for basic and diluted calculation		40,486			39,727			40,227			39,409

Net loss per share – basic and diluted	$	(0.04	)	$	(0.04	)	$	(0.30	)	$	(0.14	)

STAAR SURGICAL COMPANY

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

The following table sets forth the weighted average number of options and warrants to purchase shares of common stock and restricted stock and units, which were not included in the calculation of diluted per share amounts because the effects would be anti-dilutive (in thousands).

	Three Months Ended				Nine Months Ended
	September 30, 2016		October 2, 2015		September 30, 2016		October 2, 2015
Options		2,134		2,615		2,937		2,446
Restricted stock and units		60		124		48		193
Warrants		—		—		—		345
Total		2,194		2,739		2,985		2,984

Note 9 — Geographic and Product Data

The Company markets and sells its products in over 60 countries and has manufacturing sites in the United States. Other than Japan, China, and the United States, the Company does not conduct business in any country in which its sales exceed 10% of consolidated sales. Sales are attributed to countries based on location of customers. The composition of the Company’s net sales to unaffiliated customers is set forth below (in thousands):

	Three Months Ended				Nine Months Ended
	September 30,		October 2,		September 30,		October 2,
	2016		2015		2016		2015
Japan	$	4,029	$	4,249	$	12,258	$	12,514
China		4,254		3,095		11,749		8,794
United States		2,419		2,873		7,355		8,464
Other		9,350		8,533		28,933		26,492
Total	$	20,052	$	18,750	$	60,295	$	56,264

Because 100% of the Company’s sales are generated from the ophthalmic surgical product segment and the chief operating decision maker makes operating decisions and allocates resources based on consolidated operating results, the Company operates as one operating segment for financial reporting purposes. The Company’s principal products are implantable Collamer lenses (“ICLs”) used in refractive surgery and intraocular lenses (“IOLs”) used in cataract surgery. The composition of the Company’s net sales by product line is as follows (in thousands):

	Three Months Ended				Nine Months Ended
	September 30,		October 2,		September 30,		October 2,
	2016		2015		2016		2015
ICLs	$	14,801	$	12,907	$	43,389	$	37,396
IOLs		4,649		4,390		14,783		14,952
Other surgical products		602		1,453		2,123		3,916
Total	$	20,052	$	18,750	$	60,295	$	56,264

One customer, our distributor in China, accounted for 21% and 19%, of net sales for the three and nine months ended September 30, 2016, respectively, and 16% and 14% of net sales for the three and nine months ended October 2, 2015, respectively.

As of September 30, 2016, two customers, our distributors in China and Korea, accounted for 20% and 11% of consolidated trade receivables. As of January 1, 2016, there was one customer, our distributor in China, which accounted for 24% of consolidated trade receivables.

The Company sells its products internationally, which subjects the Company to several potential risks, including regional/country economic conditions and regulatory requirements, fluctuating foreign currency exchange rates (to the extent the Company’s transactions are not in U.S. dollars), regulation of fund transfers by foreign governments, United States and foreign export and import duties and tariffs, and political instability.

STAAR SURGICAL COMPANY

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

Note 10 — Stock-Based Compensation

The cost that has been charged against income for stock-based compensation is set forth below (in thousands):

	Three Months Ended				Nine Months Ended
	September 30, 2016		October 2, 2015		September 30, 2016		October 2, 2015
Employee stock options	$	208	$	625	$	5,257	$	1,818
Restricted stock		32		88		259		396
Restricted stock units		146		210		2,569		484
Nonemployee stock options		—		—		58		49
Total	$	386	$	923	$	8,143	$	2,747

The Company recorded stock-based compensation costs in the following categories on the accompanying condensed consolidated statements of operations (in thousands):

	Three Months Ended				Nine Months Ended
	September 30, 2016		October 2, 2015		September 30, 2016		October 2, 2015
Cost of sales	$	—	$	9	$	560	$	33
General and administrative		248		543		3,936		1,667
Marketing and selling		72		184		1,544		539
Research and development		66		187		2,103		508
Total stock compensation expense		386		923		8,143		2,747
Amounts capitalized as part of inventory		39		130		227		258
Total	$	425	$	1,053	$	8,370	$	3,005

Stock Option Plan

The Amended and Restated 2003 Omnibus Equity Incentive Plan (“the Plan”) provides for various forms of stock-based incentives. To date, of the available forms of awards under the Plan, the Company has granted only stock options, restricted stock, unrestricted share grants, restricted stock units, and performance contingent stock units. Options under the plan are granted at fair market value on the date of grant, become exercisable over a three-year period, or as determined by the Board of Directors, and expire over periods not exceeding 10 years from the date of grant. Certain option and share awards provide for accelerated vesting if there is a change in control (as defined in the Plan). Pursuant to the Plan, options for 3,614,370 shares were outstanding at September 30, 2016 with exercise prices ranging between $0.95 and $17.62 per share. Restricted stock grants under the Plan generally vest over a period between one to four years. There were 23,140 shares of restricted stock and 266,050 restricted stock units (RSUs) outstanding at September 30, 2016. As of September 30, 2016, there were 2,222,972 shares authorized and available for grants under the Plan.

Immediate Vesting of All Unvested Equity Awards

On February 11, 2016, one of our shareholders increased its beneficial ownership of the Company’s common stock to approximately 26% of all shares outstanding. This triggered the “Change in Control” provision in the Plan, which resulted in the immediate vesting of all unvested equity awards outstanding under the Plan (“Acceleration Event”) and the recording of an aggregate $6.9 million non-cash charge to stock-based compensation in the condensed consolidated statements of operations on that date ($4.6 million for stock options and $2.3 million for restricted stock and RSUs). This charge was recorded and included in the following categories of the condensed consolidated statements of operations for the nine months ended September 30, 2016: $2.9 million in general and administrative expenses, $1.5 million in marketing and selling expenses, $1.9 million in research and development expenses and $0.6 million in manufacturing costs. Approximately $3.7 million of the $6.9 million of accelerated charges would have been recognized for stock-based compensation by the Company during fiscal year 2016 after the Change in Control provision was triggered.

STAAR SURGICAL COMPANY

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

Assumptions

The fair value of each option award is estimated on the date of grant using a Black-Scholes option valuation model applying the weighted-average assumptions noted in the following table. Expected volatilities are based on historical volatility of the Company’s stock. The expected term of options granted is derived from the historical exercises and post-vesting cancellations and represents the period of time that options granted are expected to be outstanding. The Company has calculated a 9% estimated forfeiture rate based on historical forfeiture experience. The risk-free rate is based on the U.S. Treasury yield curve corresponding to the expected term at the time of the grant.

	Three Months Ended						Nine Months Ended
	September 30, 2016			October 2, 2015			September 30, 2016			October 2, 2015
Expected dividend yield		0	%		0	%		0	%		0	%
Expected volatility		57	%		58	%		57	%		57	%
Risk-free interest rate		1.19	%		1.60	%		1.34	%		1.61	%
Expected term (in years)		5.57			5.62			5.57			5.61

A summary of option activity under the Plan for the nine-month period ended September 30, 2016 is presented below:

	Options Shares (000’s)
Outstanding at January 1, 2016		3,623
Granted		761
Exercised		(424	)
Forfeited or expired		(346	)
Outstanding at September 30, 2016		3,614
Exercisable at September 30, 2016		2,968

A summary of restricted stock and restricted stock unit’s activity under the Plan for the nine-month period ended September 30, 2016 is presented below:

	Restricted Shares (000’s)			Restricted Units (000’s)
Outstanding at January 1, 2016		124			339
Granted		23			313
Exercised		(124	)		(380	)
Forfeited		—			(6	)
Outstanding at September 30, 2016		23			266

Note 11 — Income Taxes

The Company’s quarterly provision for income taxes is determined by estimating an annual effective tax rate. This estimate may fluctuate throughout the year as new information becomes available affecting its underlying assumptions. The tax effect of unusual or infrequent transactions that occurred during the reporting period is calculated separately and added to the amount of tax estimated using the annual effective tax rate discussed above. All earnings from the Company’s subsidiaries are not considered to be permanently reinvested. Accordingly, the Company provides withholding and U.S. taxes on all unremitted foreign earnings.

The $1.7 million income tax benefit recorded during the first nine months of 2016, was attributable to (1) the Company’s net operating losses reported by its foreign operations principally due to an acceleration of stock-based compensation during the first quarter of 2016, and (2) a reduction in its foreign withholding taxes in connection with the dissolution of one of its foreign subsidiaries effective April 1, 2016. During the nine months ended October 2, 2015, the Company recorded an income tax provision of $114,000, primarily benefiting from the mix of pre-tax earnings in lower- and zero- rate foreign jurisdictions. There are no unrecognized tax benefits related to uncertain tax positions taken by the Company.

STAAR SURGICAL COMPANY

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

Note 12 - Commitments and Contingencies

Lines of Credit and Guarantee

The Company’s wholly owned Japanese subsidiary, STAAR Japan, has an agreement, dated December 28, 2012, with Mizuho Bank, which provides for borrowings of up to 500,000,000 Yen (approximately $4.9 million based on the rate of exchange on September 30, 2016), at an interest rate equal to the Tokyo short-term prime interest rate (approximately 1.475% as of September 30, 2016). The line of credit, as most recently amended, expires September 30, 2017 and is renewable annually. The Company had 500,000,000 Yen outstanding on the line of credit as of September 30, 2016 and January 1, 2016 (approximately $4.9 million and $4.2 million based on the foreign currency exchange rates on September 30, 2016 and January 1, 2016, respectively). As of September 30, 2016, there were no available borrowings under the line.

In August 2010, the Company’s wholly owned Swiss subsidiary, STAAR Surgical AG, entered into a credit agreement with Credit Suisse (the “Bank”). The credit agreement provides for borrowing of up to 1,000,000 CHF (Swiss Francs) (approximately $1.0 million at the rate of exchange on September 30, 2016), to be used for working capital purposes. Accrued interest and 0.25% commissions on average outstanding borrowings is payable quarterly and the interest rate will be determined by the Bank based on the then prevailing market conditions at the time of borrowing. The credit agreement is automatically renewed on an annual basis based on the same terms assuming there is no default. The credit agreement may be terminated by either party at any time in accordance with its general terms and conditions. The credit facility is not collateralized and contains certain conditions such as providing the Bank with notice of significant events or conditions, as defined in the credit agreement. The Bank may also declare all amounts outstanding to be immediately due and payable upon a change of control or a material qualification as defined in the agreement. There were no borrowings outstanding as of September 30, 2016 and January 1, 2016.

On June 7, 2016, the Company entered into a schedule of an existing master lease agreement with Farnam Street Financial, Inc. that provides for borrowings up to $2.0 million for an initial term of 24 months, at an annual rate of 3.94% for hardware equipment and 4.75% for non-hardware equipment of the purchase price. As of September 30, 2016, approximately $1.4 million of the line was used including a sale-leaseback transaction resulting in net proceeds to the Company of $1.2 million. Approximately $0.6 million of the line is available for future transactions.

Covenant Compliance

The Company believes it is in compliance with the covenants of its credit facilities as of the date of this report.

Litigation and Claims

From time to time the Company may be subject to various claims and legal proceedings arising out of the normal course of our business. These claims and legal proceedings may relate to contractual rights and obligations, employment matters, and claims of product liability. The most significant of these actions, proceedings and investigations are described below. STAAR maintains insurance coverage for product liability and certain securities claims. Legal proceedings can extend for several years, and the matters described below concerning the Company are at early stages of the legal and administrative process. As a result, these matters have not yet progressed sufficiently through discovery and/or development of important information and legal issues to enable the Company to determine whether the proceedings are material to the Company or to estimate a range of possible loss, if any. Unless otherwise disclosed, the Company is unable to estimate the possible loss or range of loss for the legal proceedings described below. While it is not possible to accurately predict or determine outcomes of these items, an adverse determination in one or more of these items currently pending could have a material adverse effect on the Company’s consolidated results of operations, financial position or cash flows.

Stockholder Securities Litigation: Todd Action

On July 8, 2014, a putative securities class action lawsuit was filed by Edward Todd against STAAR and three officers in the U.S. District Court for the Central District of California. The plaintiff claims that STAAR made misleading statements to and omitted material information from our investors between February 27, 2013 and June 30, 2014 about alleged regulatory violations at STAAR’s Monrovia manufacturing facility. On October 20, 2014, plaintiff amended its complaint, dismissed two Company officers, added one other officer, reduced the alleged Class Period to November 1, 2013 through June 30, 2014, and demanded compensatory damages and attorneys’ fees. On August 19, 2016, plaintiff filed a Motion for Class Certification, which the court scheduled for hearing on December 12, 2016. Although the ultimate outcome of this action cannot be determined with certainty, the Company believes that the allegations in the Complaint are without merit. The Company intends to vigorously defend itself against this lawsuit. The Company has not recorded any loss or accrual in the accompanying condensed consolidated financial statements at September 30, 2016 and January 1, 2016 for this matter as the likelihood and amount of loss, if any, has not been determined and is not currently estimable.

STAAR SURGICAL COMPANY

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

Stockholder Derivative Litigation: Forestal Action

On June 22, 2016, Kevin Forestal filed a stockholder derivative complaint against our then-current Board of Directors, which included Caren Mason, Mark B. Logan, Stephen C. Farrell, Richard A. Meier, John C. Moore, J. Steven Roush, Louis E. Silverman, and William P. Wall, and STAAR as well as Barry G. Caldwell and John S. Santos in the U.S. District Court for the Central District of California. The plaintiff alleges breaches of fiduciary duties by, among other things, allowing STAAR to disseminate misleading statements to investors regarding the condition of the Company’s Quality System, failing to properly oversee the Company, and unjust enrichment. The complaint seeks damages, restitution and governance reforms, attorneys’ fees and costs. On August 15, 2016, the Company as nominal defendant filed a Motion to Dismiss, which the court scheduled for hearing on December 5, 2016. Although the ultimate outcome of this action cannot be determined with certainty, the Company believes that the allegations in the Complaint are without merit. The Company has not recorded any loss or accrual in the accompanying condensed consolidated financial statements at September 30, 2016 for this matter as the likelihood and amount of loss, if any, has not been determined and is not currently estimable.

Employment Agreements

The Company’s Chief Executive Officer and certain officers have as provisions of their agreements certain rights, including continuance of cash compensation and benefits, upon a “change in control,” which may include an acquisition of substantially all its assets, or termination “without cause or for good reason” as defined in the employment agreements.

ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The matters addressed in this Item 2 that are not historical information constitute “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Readers can recognize forward-looking statements by the use of words like “anticipate,” “estimate,” “expect,” “intend,” “plan,” “believe,” “will,” “forecast” and similar expressions in connection with any discussion of future operating or financial performance. In particular, these include statements about any of the following: any projections of earnings, revenue, sales, profit margins, cash, effective tax rate or any other financial items; the plans, strategies, and objectives of management for future operations or prospects for achieving such plans; statements regarding new, existing, or improved products, including but not limited to, expectations for success of new, existing, and improved products in the U.S. or international markets or government approval of a new or improved products (including the Toric ICL in the U.S.); or commercialization of new or improved products; the nature, timing and likelihood of resolving issues cited in the FDA’s 2014 Warning Letter or 2015 FDA-483; future economic conditions or size of market opportunities; expected costs of quality system remediation efforts; statements of belief, including as to achieving 2016 business plans; expected regulatory activities and approvals, product launches, and any statements of assumptions underlying any of the foregoing.

Although we believe that the expectations reflected in these forward-looking statements are reasonable, such statements are inherently subject to risks and we can give no assurance that our expectations will prove to be correct. Actual results could differ from those described in this report because of numerous factors, many of which are beyond our control. These factors include, without limitation, those described in our Annual Report on Form 10-K in “Item 1A. Risk Factors” filed on March 11, 2016. We undertake no obligation to update these forward-looking statements after the date of this report to reflect future events or circumstances or to reflect actual outcomes.

The following discussion should be read in conjunction with the unaudited condensed consolidated financial statements of STAAR, including the related notes, provided in this report.

Overview

STAAR Surgical Company designs, develops, manufactures and sells implantable lenses for the eye and companion delivery systems used to deliver the lenses into the eye. We are the leading maker of lenses used worldwide in corrective or “refractive” surgery. Our goal is to position our refractive lenses throughout the world as primary and premium solutions for patients seeking visual freedom from wearing glasses or contact lenses while achieving excellent visual acuity through refractive vision correction. We also make lenses for use in surgery that treats cataracts. Unless the context indicates otherwise, “we,” “us,” the “Company,” and “STAAR” refer to STAAR Surgical Company and its consolidated subsidiaries.

STAAR has significant operations globally. Activities outside the United States (“U.S.”) accounted for 88% of our total sales in the third quarter of 2016, primarily due to the pacing of product approvals and commercialization that tend to occur first outside the U.S. STAAR sells its products in more than 60 countries, with direct distribution in the U.S., Canada, Japan, Germany, the U.K. and Spain, and independent distribution in the remainder of the world. STAAR maintains operational and administrative facilities in the U.S., Switzerland and Japan. We also maintain offices in Germany, Spain, and China.

Recent Developments and Strategic Priorities for 2016

In the third quarter of 2016, worldwide ICL revenues increased 14.7% compared to the prior year quarter. In the regional markets, Asia Pacific ICL revenues increased 28.5% and units increased 29.5%; Europe, Middle East and Africa ICL revenues increased 6.2% and units increased 4.4%; and North America ICL revenues decreased 13.0% and units decreased 19.5%. Worldwide ICL units grew 15.3% compared to the prior year quarter. In regional markets, compared to the prior year quarter, Asia Pacific IOL revenues increased 11.8% and units decreased by 7.4%; and North America IOL revenues decreased 18.5% and units decreased by 16.6%. Worldwide IOL units declined 2.6% compared to prior year quarter driven by decreased U.S. sales. Overall third quarter of 2016 net sales were $20.1 million, a 6.9% increase over the third quarter of 2015.

During the third quarter, we entered into new strategic cooperation agreements with leading providers in South East Europe and India. Generally, under these strategic agreements we will provide additional training, marketing and pricing support to these accounts in exchange for unit growth of our products and participation in our patient registry, marketing, generating clinical data, and new product development efforts.

On September 21, 2016, we were notified that the Medical Devices Bureau of Health Canada approved for distribution in Canada the toric version of our EVO Visian ICL, which is the ICL with a central port.

For the rest of 2016, our four strategic priorities remain as follows:

FDA Remediation and Continuation of Quality Systems Overhaul: We expect to achieve our internal remediation and quality system plan commitments while also maintaining our global quality certifications, continuing to hire employees in the Quality and Regulatory departments, and qualifying equipment such as a MasterControl Quality Management System;

Creating the Visual Freedom Market for Implantable Lenses: We seek to position the ICL as a primary and premium refractive procedure with clinical validation, new corporate and product branding, new digital and social media marketing, and by entering into strategic partnerships with large refractive surgical providers operating eye hospitals and clinics. During the third quarter, we reported record global ICL unit sales;

Beginning our Clinical Validation and Regulatory Rebirth: The expanded Global Clinical and Medical Affairs teams will assist in supporting submissions to and responding to queries from regulatory agencies and will monitor clinical data, conduct clinical studies, begin building patient registries and enhance medical communications protocol; and

Innovating and Developing New Products, Materials and Delivery Systems: We are expanding our R&D team, upgrading our labs and testing apparatus, and focusing on our research and development priorities. During the third quarter and continuing in the fourth quarter, we are implanting EVO+ Visian ICLs with EDOF (extended depth of field), in the first human subjects. The initial results are positive and the clinical study for these lenses continues.

Immediate Vesting of All Unvested Equity Awards

See Note 10 of the Condensed Consolidated Financial Statements.

Critical Accounting Policies

This Management's Discussion and Analysis of Financial Condition and Results of Operations discusses and analyzes data in our unaudited Condensed Consolidated Financial Statements, which we have prepared in accordance with U.S. generally accepted accounting principles. Preparation of these financial statements requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue and expenses, and related disclosure of contingent assets and liabilities. Management bases its estimates on historical experience and on various other assumptions that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Senior management has discussed the development, selection and disclosure of these estimates with the Audit Committee of our Board of Directors. Actual conditions may differ from our assumptions and actual results may differ from our estimates.

An accounting policy is deemed critical if it requires an accounting estimate to be made based on assumptions about matters that are highly uncertain at the time the estimate is made, if different estimates reasonably could have been used, or if changes in the estimate that are reasonably likely to occur could materially impact the financial statements. Management believes that there have been no significant changes during the nine months ended September 30, 2016 to the items that we disclosed as our critical accounting policies and estimates in Management's Discussion and Analysis of Financial Condition and Results of Operations in our Annual Report on Form 10-K for the fiscal year ended January 1, 2016.

Results of Operations

The following table shows the percentage of our total sales represented by the specific items listed in our condensed consolidated statements of operations for the periods indicated, and the percentage by which these items increased or decreased over the prior period.

	Percentage of Net Sales for Three Months						Percentage of Net Sales for Nine Months
	September 30, 2016			October 2, 2015			September 30, 2016			October 2, 2015
Net sales		100.0	%		100.0	%		100.0	%		100.0	%
Cost of sales		25.8			31.7			29.5			32.4
Gross profit		74.2			68.3			70.5			67.6

General and administrative		24.9			25.9			30.5			26.2
Marketing and selling		35.7			33.5			36.5			31.6
Research and development		22.2			19.6			26.6			19.2
		82.8			79.0			93.6			77.0
Operating loss		(8.6	)		(10.7	)		(23.1	)		(9.4	)
Other income (expense), net		0.2			1.3			0.5			(0.5	)
Loss before provision (benefit) for income taxes		(8.4	)		(9.4	)		(22.6	)		(9.9	)
Provision (benefit) for income taxes		0.4			(0.1	)		(2.8	)		0.2
Net loss		(8.8	)%		(9.3	)%		(19.8	)%		(10.1	)%

Net Sales

	Three Months Ended				Percentage Change			Nine Months Ended				Percentage Change
	September 30, 2016		October 2, 2015		2016 vs. 2015			September 30, 2016		October 2, 2015		2016 vs. 2015
Net sales	$	20,052	$	18,750		6.9	%	$	60,295	$	56,264		7.2	%

ICL		14,801		12,907		14.7			43,389		37,396		16.0
IOL		4,649		4,390		5.9			14,783		14,952		(1.1	)
Other		602		1,453		(58.6	)		2,123		3,916		(45.8	)

Net sales for the three months ended September 30, 2016 were $20.1 million, an increase of 6.9% compared with $18.8 million reported during the same period of 2015. Net sales for the nine months ended September 30, 2016 were $60.3 million, an increase of 7.2% compared with $56.3 million reported during the same period of 2015. The effect of exchange rate changes of the Japanese Yen had a favorable impact on net sales of $0.6 million and $1.2 million, respectively, during the three and nine months ended September 30, 2016.

Total ICL sales for the three months ended September 30, 2016 were $14.8 million, an increase of 14.7% compared with $12.9 million reported during the same period of 2015. APAC ICL sales were $8.2 million during the third quarter, an increase of 28.5% compared to the prior year period, due to a 29.5% increase in units, driven by a 42.2% increase in China sales. EMEA ICL sales were $5.1 million during the third quarter, an increase of 6.2% compared to the prior year period, with an increase of 4.4% in units. North America ICL sales were $1.5 million during the third quarter, a decrease of 13.0% and a decrease of 19.5% in units compared to the prior year period.

Total ICL sales for the nine months ended September 30, 2016 and October 2, 2015 were $43.4 million and $37.4 million, respectively, an increase of 16.0%. The sales increase was driven by higher ICL unit sales in APAC and EMEA, partially offset by a decrease in NA sales.

Total IOL sales for the three months ended September 30, 2016 were $4.6 million, an increase of 5.9% compared with $4.4 million reported during the same period of 2015. Total IOL sales for the nine months ended September 30, 2016 were $14.8 million, a 1.1% decrease compared with $15.0 million reported during the same period in 2015. The decline for both the three and nine-month periods was due to a planned phase-out of IOL sales in China, and decreased IOL sales in the U.S. due to the discontinuance of the silicone IOL product line, partially offset by the favorable impact of foreign exchange on sales of $0.5 million and $0.9 million, respectively, for the three and nine months ended September 30, 2016. The Company expects U.S. silicone IOL sales will continue to decline in the fourth quarter of 2016, and we plan to cease selling them at the end of the fourth quarter of 2016. Although programs are in place to convert silicone IOL accounts to our NanoFLEX IOL, we can give no assurance these programs will be successful. The Company will continue to sell pre-loaded silicone IOLs internationally. Preloaded IOL sales represented 80% of the Company’s IOL sales in the first nine months of 2016, compared to 77% in the first nine months of 2015.

Other product sales for the three and nine months ended September 30, 2016 were $0.6 million and $2.1, respectively, a decrease of 58.6% and 45.8%, respectively, compared with the $1.5 million and $3.9 million, respectively, reported during the same period of 2015. The decrease in other product sales is due to a decrease in injector part sales largely related to the repair and replacement at no charge to STAAR of allegedly defective injectors manufactured by our third-party manufacturer and previously sold by STAAR.

Gross Profit

	Three Months Ended						Percentage Change			Nine Months Ended						Percentage Change
	September 30, 2016			October 2, 2015			201 vs. 2015			September 30, 2016			October 2, 2015			2016 vs. 2015
Gross Profit	$	14,872		$	12,799			16.2	%	$	42,491		$	38,058			11.6	%
Gross Profit Margin		74.2	%		68.3	%					70.5	%		67.6	%

Gross profit for the third quarter was $14.9 million, or 74.2% of revenue, compared with $12.8 million, or 68.3% of revenue, in the prior year period. We attribute improved margins to an increased mix of higher margin ICL units, lower ICL unit costs, partially offset by higher IOL unit costs and other cost of sales and lower inventory reserves.

During the first nine months of 2016, gross profit was $42.5 million, or 70.5% of net sales, compared with $38.1 million, or 67.6% of net sales, in the prior year period. The increase in gross margin for the first nine months of 2016 is due to an increased mix of higher margin ICL units, higher average selling prices, and partially offset by the $0.6 million non-cash charge related to the immediate vesting of all unvested equity awards because of the triggering of “Change of Control” provision of the Company’s equity incentive plan.

General and Administrative

	Three Months Ended						Percentage Change			Nine Months Ended						Percentage Change
	September 30, 2016			October 2, 2015			2016 vs. 2015			September 30, 2016			October 2, 2015			2016 vs. 2015
General and Administrative	$	4,985		$	4,853			2.7	%	$	18,378		$	14,748			24.6	%
Percentage of Net Sales		24.9	%		25.9	%					30.5	%		26.2	%

General and administrative expenses for the quarter ended September 30, 2016 were $5.0 million, an increase of 2.7% when compared with $4.9 million reported for the same period last year. The increase was primarily due to the unfavorable impact of the Japanese yen on expenses.

General and administrative expenses for the nine months ended September 30, 2016 were $18.4 million, an increase of 24.6% when compared with $14.7 million reported for the same period last year. The increase was primarily due to a $2.9 million non-cash charge related to the immediate vesting of all unvested equity awards because of the triggering of the “Change of Control” provision of the Company’s equity incentive plan, local taxes in Japan, and the unfavorable impact of the Japanese yen on expenses.

Marketing and Selling

	Three Months Ended						Percentage Change			Nine Months Ended						Percentage Change
	September 30, 2016			October 2, 2015			2016 vs. 2015			September 30, 2016			October 2, 2015			2016 vs. 2015
Marketing and Selling	$	7,149		$	6,284			13.8	%	$	22,006		$	17,784			23.7	%
Percentage of Net Sales		35.7	%		33.5	%					36.5	%		31.6	%

Marketing and selling expenses for the quarter ended September 30, 2016 were $7.1 million, an increase of 13.8% when compared with $6.3 million reported for the same period last year. The increase was primarily due to increased marketing costs related to our rebranding efforts, increased international selling and promotional costs, increased trade show costs, and the unfavorable impact of the Japanese yen on expenses.

Marketing and selling expenses for the nine months ended September 30, 2016 were $22.0 million, an increase of 23.7% when compared with $17.8 million reported for the same period last year. The increase was primarily due to a $1.5 million non-cash charge related to the immediate vesting of all unvested equity awards because of the triggering of the “Change of Control” provision of the Company’s equity incentive plan, and increased marketing costs related to our rebranding efforts and increased international selling and promotional costs, partially offset by the optimization of North American selling costs.

Research and Development

	Three Months Ended						Percentage Change			Nine Months Ended						Percentage Change
	September 30, 2016			October 2, 2015			2016 vs. 2015			September 30, 2016			October 2, 2015			2016 vs. 2015
Research and Development	$	4,453		$	3,684			20.9	%	$	16,018		$	10,800			48.3	%
Percentage of Net Sales		22.2	%		19.6	%					26.6	%		19.2	%

Research and development expenses for the quarter ended September 30, 2016 were $4.5 million, an increase of 20.9% when compared with $3.7 million reported last year. The increase was primarily due to increased costs related to quality system improvements, including increased headcount, and investments in clinical affairs and product development, partially offset by a decrease in FDA remediation expenses.

Research and development expense for the nine months ended September 30, 2016 were $16.0 million, an increase of 48.3%, when compared with $10.8 million reported in the same period last year. The increase was due to a $1.9 million non-cash charge related to the immediate vesting of all unvested equity awards as a result of the triggering of the “Change of Control” provision of the Company’s equity incentive plan and increased costs related to quality system improvements including increased headcount, and investments in clinical affairs and product development, partially offset by a decrease in FDA remediation expenses.

Research and development expense consists primarily of compensation and related costs for personnel responsible for the research and development of new and existing products, costs of intellectual property protection and the regulatory, quality, and clinical activities required to acquire and maintain product approvals globally. These costs are expensed as incurred.

Other Income (Expense), Net

	Three Months Ended				Percentage Change			Nine Months Ended					Percentage Change
	September 30, 2016		October 2, 2015		2016 vs. 2015			September 30, 2016		October 2, 2015			2016 vs. 2015
Other Income (Expense), Net	$	8	$	259		(96.9	)%	$	285	$	(302	)		—	*

* Denotes change is greater than +100%

The year over year change in other income (expense), net for the three and nine-month period is primarily due to changes in foreign currency gains and losses and royalty income.

Income Taxes

	Three Months Ended					Percentage Change			Nine Months Ended					Percentage Change
	September 30, 2016		October 2, 2015			2016 vs. 2015			September 30, 2016			October 2, 2015		2016 vs. 2015
Provision (benefit) for income taxes	$	71	$	(11	)		—	*	$	(1,664	)	$	114		—	*

* Denotes change is greater than +100%

We recorded an income tax benefit of $1.7 million and a provision for income taxes of $114,000, respectively, for the nine months ended September 30, 2016 and October 2, 2015. The income tax benefit for the nine months ended September 30, 2016 was attributable to: 1) the Company’s net operating losses reported by its foreign operations principally due to the acceleration of stock-based compensation during the first quarter of 2016 and 2) a reduction in its foreign withholding taxes in connection with the dissolution of one of its foreign subsidiaries effective April 1, 2016. There are no unrecognized tax benefits related to uncertain tax positions taken by the Company.

The provision (benefit) for income taxes is determined using an estimated annual effective tax rate. Based on current information and subject to future events and circumstances, we expect the estimated annual effective tax rate for 2016 to be approximately 32%.

Liquidity and Capital Resources

STAAR’s liquidity requirements arise from the funding of our working capital needs, primarily inventory and accounts receivable. Our primary sources for working capital and capital expenditures are cash flows from operating activities, proceeds from the exercise of stock options, and borrowings under our credit facilities. Our liquidity also depends, in part, on customers paying within credit terms, and any extended delays in payments or changes in credit terms given to major customers may have an impact on STAAR’s cash flow. In addition, any abnormal product returns or pricing adjustments may also affect our short-term funding. We may, in the future elect to supplement this with further debt or commercial borrowing.

STAAR believes its current cash balances, coupled with cash flows from operating activities will be sufficient to meet its working capital requirements for the foreseeable future, including the approximate $2 million cost in 2016 associated with our FDA remediation efforts, of which $1.5 million was incurred in the first nine months of 2016. Although we anticipate these costs will continue, we cannot currently estimate the amount but will provide an update as more information becomes available. If the need for financing arises, which we cannot rule out, STAAR cannot assure that it will be available on acceptable terms, or if at all. STAAR’s Japanese and Swiss subsidiaries have bank lines of credit in place for working capital purposes, but STAAR does not maintain such a credit line in the U.S. STAAR Japan’s line of credit is currently fully drawn.

To the extent STAAR’s cash balances exceed levels needed for working capital and as a cushion for unforeseen demand, STAAR intends to invest its cash in expanding and improving its business. It does not anticipate paying dividends from its earnings for the foreseeable future.

Overview of Changes in Cash and Cash Equivalents and Other Working Capital Accounts.

As of September 30, 2016, and January 1, 2016, respectively, STAAR had $14.3 million and $13.4 million, of cash and cash equivalents, respectively.

Net cash provided by operating activities was $0.9 million for the nine months ended September 30, 2016 and net cash used by operating activities was $0.3 million for the nine months ended October 2, 2015. The net cash provided by operating activities for the nine months ended September 30, 2016, consisted of the net loss of $12.0 million, plus $8.9 million in non-cash items and $3.9 million increase in net working capital.

Net cash used in investing activities was $2.6 million for the nine months ended September 30, 2016, compared to $1.3 million in net cash used in investing activities for the nine months ended October 2, 2015. Net cash used in investing activities was primarily due to the acquisition of property, plant and equipment.

Net cash provided by financing activities was $1.9 million for the nine months ended September 30, 2016, compared with $4.6 million in net cash provided by financing activities for the nine months ended October 2, 2015. Cash provided by financing activities resulted from the proceeds of sale-leaseback transactions of $1.2 million and exercises of stock options of $1.7 million, partially offset by the repurchase of employee common stock for taxes withheld of $0.6 million and repayment of capital lease obligations of $0.3 million.

Credit Facilities and Commitments

Lines of Credit and Guarantee

See Note 12 of the accompanying Condensed Consolidated Financial Statements.

Covenant Compliance

The Company believes it is in compliance with the covenants of its credit facilities as of the date of this report.

Employment Agreements

See Note 12 of the accompanying Condensed Consolidated Financial Statements.

Off-Balance Sheet Arrangements

We do not have any off-balance sheet arrangements, as that term is defined in the rules of the SEC, that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that are material to investors.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

There have been no material changes in the Company’s qualitative and quantitative market risk since the disclosure in the Company’s Annual Report on Form 10-K for the year ended January 1, 2016.

ITEM 4. CONTROLS AND PROCEDURES

Disclosure Controls and Procedures

As of the end of the period covered by this report, we carried out an evaluation, under the supervision and with the participation of our management, including our CEO and CFO, of the effectiveness of the design and operation of the disclosure controls and procedures of STAAR Surgical Company and its subsidiaries (the “Company”). Based on that evaluation, our CEO and CFO concluded, as of the end of the period covered by this quarterly report on Form 10-Q, that our disclosure controls and procedures were effective. For purposes of this statement, the term “disclosure controls and procedures” means controls and other procedures of the Company that are designed to ensure that information required to be disclosed by the Company in the reports that it files or submits under the Securities Exchange Act (15 U.S.C. 78a et seq.) is recorded, processed, summarized and reported, within the time periods specified in the Commission's rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by an issuer in the reports that it files or submits under the Act is accumulated and communicated to the issuer's management, including its principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.

Our management, including the CEO and the CFO, do not expect that our disclosure controls and procedures or our internal control over financial reporting will necessarily prevent all fraud or material errors. An internal control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations on all internal control systems, our internal control system can provide only reasonable assurance of achieving its objectives and no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within our Company have been detected. These inherent limitations include the realities that judgments in decision-making can be faulty, and that breakdowns can occur because of simple error or mistake. Additionally, controls can be circumvented by the individual acts of some persons, by collusion of two or more people, or by management override of the control. The design of any system of internal control is also based in part upon certain assumptions about the likelihood of future events, and can provide only reasonable, not absolute, assurance that any design will succeed in achieving its stated goals under all potential future conditions. Over time, controls may become inadequate because of changes in circumstances, or the degree of compliance with the policies and procedures may deteriorate.

Changes in Internal Control over Financial Reporting

There were no changes in our internal control over financial reporting during the quarter ended September 30, 2016 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

PART II – OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

Litigation and Claims

From time to time, the Company is involved in various legal proceedings and other matters arising in the normal course of business. Certain legal proceedings in which we are currently involved are discussed under “Litigation and Claims” in Note 12, “Commitments and Contingencies,” to our Condensed Consolidated Financial Statements provided in this report, and such discussions are hereby incorporated by reference.

ITEM 1A. RISK FACTORS

Our short and long-term success is subject to many factors that are beyond our control. Investors and prospective investors should consider carefully information contained in this report and the risks and uncertainties described in “Part I—Item 1A—Risk Factors” of the Company’s Form 10-K for the fiscal year ended January 1, 2016. Such risks and uncertainties could materially adversely affect our business, financial condition or operating results.

ITEM 4. MINE SAFETY DISCLOSURES

Not Applicable.

ITEM 5. OTHER INFORMATION

None.

ITEM 6. EXHIBITS

3.1	Certificate of Incorporation, as amended to date. (1)

3.2	Amended and Restated By-laws. (2)

4.4	Form of Certificate for Common Stock, par value $0.01 per share. (3)

†4.5	Amended and Restated STAAR Surgical Company Omnibus Equity Incentive Plan, effective February 25, 2016. (4)

31.1	Certification Pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934, Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. *

31.2	Certification Pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934, Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. *

32.1	Certification Pursuant to 18 U.S.C. Section 1350, Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. **

101	Financial statements from the quarterly report on Form 10-Q of STAAR Surgical Company for the quarter ended September 30, 2016, formatted in Extensible Business Reporting Language (XBRL), are filed herewith and include: (i) the Condensed Consolidated Balance Sheets, (ii) the Condensed Consolidated Statements of Operations, (iii) the Condensed Consolidated Statements of Comprehensive Loss, (iv) the Condensed Consolidated Statements of Cash Flows, and (v) the Notes to Condensed Consolidated Financial Statements tagged as blocks of text. *

(1)	Incorporated by reference to the Company’s Current Report on Form 8-K filed with the Commission on June 11, 2014.

(2)	Incorporated by reference to the Company’s Current Report on Form 8-K filed with the Commission on June 27, 2016.

(3)	Incorporated by reference to Exhibit 4.1 to Amendment No. 1 to the Company’s Registration Statement on Form 8-A/A, filed on April 18, 2003.

(4)	Incorporated by reference to Appendix 1 of the Company’s Proxy Statement filed on May 2, 2016.

*	Filed herewith.
**	Furnished herewith.
†	Management contract or compensatory plan.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	STAAR SURGICAL COMPANY

Date: November 3, 2016	By:	/s/ STEPHEN P. BROWN
		Stephen P. Brown

		Chief Financial Officer
		(on behalf of the Registrant and as its
		principal financial officer)

EX-31.1 2 v451100_ex31-1.htm EXHIBIT 31.1

Exhibit 31.1

Certifications

I, Caren Mason, certify that:

1. I have reviewed this quarterly report on Form 10-Q of STAAR Surgical Company;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: November 3, 2016

/s/ CAREN MASON

Caren Mason

President, Chief Executive Officer, and
Director (principal executive officer)

EX-31.2 3 v451100_ex31-2.htm EXHIBIT 31.2

Exhibit 31.2

Certifications

I, Stephen P. Brown, certify that:

1. I have reviewed this quarterly report on Form 10-Q of STAAR Surgical Company;

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: November 3, 2016

/s/ STEPHEN P. BROWN

Stephen P. Brown

Chief Financial Officer
(principal financial officer)

EX-32.1 4 v451100_ex32-1.htm EXHIBIT 32.1

Exhibit 32.1

Certification pursuant to 18 U.S.C. Section 1350,

As adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

In connection with the filing of the Quarterly Report on Form 10-Q for the period ended September 30, 2016 (the “Report”) by STAAR Surgical Company (“Registrant”), each of the undersigned hereby certifies that:

1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Registrant as of and for the periods presented in the Report.

Dated: November 3, 2016		/s/ CAREN MASON
		Caren Mason President, Chief Executive Officer, and Director (principal executive officer)

Dated: November 3, 2016		/s/ STEPHEN P. BROWN
		Stephen P. Brown Chief Financial Officer (principal financial officer)

A signed original of this written statement required by 18 U.S.C. Section 1350 has been provided to STAAR Surgical Company and will be furnished to the Securities and Exchange Commission or its staff upon request.

EX-101.INS 5 staa-20160930.xml XBRL INSTANCE DOCUMENT 0000718937 2016-01-01 0000718937 2016-01-02 2016-09-30 0000718937 2015-01-03 2015-10-02 0000718937 2016-02-11 0000718937 2016-07-02 2016-09-30 0000718937 2015-07-04 2015-10-02 0000718937 2016-09-30 0000718937 2016-10-24 0000718937 2015-01-02 0000718937 2015-10-02 0000718937 staa:RoyaltyIncomeMember 2015-07-04 2015-10-02 0000718937 staa:RoyaltyIncomeMember 2015-01-03 2015-10-02 0000718937 staa:PatentsAndLicensesMember 2016-01-01 0000718937 us-gaap:CustomerRelationshipsMember 2016-01-01 0000718937 us-gaap:DevelopedTechnologyRightsMember 2016-01-01 0000718937 staa:PatentsAndLicensesMember 2016-09-30 0000718937 us-gaap:CustomerRelationshipsMember 2016-09-30 0000718937 us-gaap:DevelopedTechnologyRightsMember 2016-09-30 0000718937 staa:SwissPlanMember 2016-01-02 2016-09-30 0000718937 staa:SwissPlanMember 2015-01-03 2015-10-02 0000718937 us-gaap:EmployeeStockOptionMember 2015-01-03 2015-10-02 0000718937 us-gaap:RestrictedStockUnitsRSUMember 2015-01-03 2015-10-02 0000718937 us-gaap:WarrantMember 2015-01-03 2015-10-02 0000718937 us-gaap:EmployeeStockOptionMember 2016-01-02 2016-09-30 0000718937 us-gaap:WarrantMember 2016-01-02 2016-09-30 0000718937 us-gaap:RestrictedStockUnitsRSUMember 2016-01-02 2016-09-30 0000718937 us-gaap:EmployeeStockOptionMember 2015-07-04 2015-10-02 0000718937 us-gaap:RestrictedStockUnitsRSUMember 2015-07-04 2015-10-02 0000718937 us-gaap:WarrantMember 2015-07-04 2015-10-02 0000718937 us-gaap:EmployeeStockOptionMember 2016-07-02 2016-09-30 0000718937 us-gaap:WarrantMember 2016-07-02 2016-09-30 0000718937 us-gaap:RestrictedStockUnitsRSUMember 2016-07-02 2016-09-30 0000718937 country:JP 2016-01-02 2016-09-30 0000718937 country:US 2016-01-02 2016-09-30 0000718937 staa:OtherCountriesMember 2016-01-02 2016-09-30 0000718937 country:JP 2015-01-03 2015-10-02 0000718937 country:US 2015-01-03 2015-10-02 0000718937 country:CN 2016-01-02 2016-09-30 0000718937 country:CN 2015-01-03 2015-10-02 0000718937 staa:OtherCountriesMember 2015-01-03 2015-10-02 0000718937 country:JP 2016-07-02 2016-09-30 0000718937 country:US 2016-07-02 2016-09-30 0000718937 staa:OtherCountriesMember 2016-07-02 2016-09-30 0000718937 country:JP 2015-07-04 2015-10-02 0000718937 country:US 2015-07-04 2015-10-02 0000718937 country:CN 2016-07-02 2016-09-30 0000718937 country:CN 2015-07-04 2015-10-02 0000718937 staa:OtherCountriesMember 2015-07-04 2015-10-02 0000718937 staa:ImplantableCollamerLensesMember 2015-01-03 2015-10-02 0000718937 staa:IntraocularLensesMember 2015-01-03 2015-10-02 0000718937 staa:OtherSurgicalProductsMember 2015-01-03 2015-10-02 0000718937 staa:ImplantableCollamerLensesMember 2016-01-02 2016-09-30 0000718937 staa:IntraocularLensesMember 2016-01-02 2016-09-30 0000718937 staa:OtherSurgicalProductsMember 2016-01-02 2016-09-30 0000718937 staa:ImplantableCollamerLensesMember 2015-07-04 2015-10-02 0000718937 staa:IntraocularLensesMember 2015-07-04 2015-10-02 0000718937 staa:OtherSurgicalProductsMember 2015-07-04 2015-10-02 0000718937 staa:ImplantableCollamerLensesMember 2016-07-02 2016-09-30 0000718937 staa:IntraocularLensesMember 2016-07-02 2016-09-30 0000718937 staa:OtherSurgicalProductsMember 2016-07-02 2016-09-30 0000718937 staa:Customer1Member us-gaap:SalesRevenueNetMember 2016-07-02 2016-09-30 0000718937 staa:Customer1Member us-gaap:SalesRevenueNetMember 2016-01-02 2016-09-30 0000718937 us-gaap:SalesRevenueNetMember staa:Customer1Member 2015-07-04 2015-10-02 0000718937 us-gaap:SalesRevenueNetMember staa:Customer1Member 2015-01-03 2015-10-02 0000718937 staa:Customer2Member country:CN us-gaap:AccountsReceivableMember 2016-01-02 2016-09-30 0000718937 country:KR staa:Customer2Member us-gaap:AccountsReceivableMember 2016-01-02 2016-09-30 0000718937 staa:Customer1Member us-gaap:AccountsReceivableMember 2015-01-02 2016-01-01 0000718937 us-gaap:EmployeeStockOptionMember 2016-01-02 2016-09-30 0000718937 us-gaap:RestrictedStockMember 2016-01-02 2016-09-30 0000718937 us-gaap:RestrictedStockUnitsRSUMember 2016-01-02 2016-09-30 0000718937 staa:NonemployeeStockOptionsMember 2016-01-02 2016-09-30 0000718937 us-gaap:EmployeeStockOptionMember 2015-01-03 2015-10-02 0000718937 us-gaap:RestrictedStockMember 2015-01-03 2015-10-02 0000718937 us-gaap:RestrictedStockUnitsRSUMember 2015-01-03 2015-10-02 0000718937 staa:NonemployeeStockOptionsMember 2015-01-03 2015-10-02 0000718937 us-gaap:EmployeeStockOptionMember 2016-07-02 2016-09-30 0000718937 us-gaap:RestrictedStockMember 2016-07-02 2016-09-30 0000718937 us-gaap:RestrictedStockUnitsRSUMember 2016-07-02 2016-09-30 0000718937 staa:NonemployeeStockOptionsMember 2016-07-02 2016-09-30 0000718937 us-gaap:EmployeeStockOptionMember 2015-07-04 2015-10-02 0000718937 us-gaap:RestrictedStockMember 2015-07-04 2015-10-02 0000718937 us-gaap:RestrictedStockUnitsRSUMember 2015-07-04 2015-10-02 0000718937 staa:NonemployeeStockOptionsMember 2015-07-04 2015-10-02 0000718937 us-gaap:CostOfSalesMember 2016-01-02 2016-09-30 0000718937 us-gaap:GeneralAndAdministrativeExpenseMember 2016-01-02 2016-09-30 0000718937 us-gaap:SellingAndMarketingExpenseMember 2016-01-02 2016-09-30 0000718937 us-gaap:ResearchAndDevelopmentExpenseMember 2016-01-02 2016-09-30 0000718937 us-gaap:CostOfSalesMember 2015-01-03 2015-10-02 0000718937 us-gaap:GeneralAndAdministrativeExpenseMember 2015-01-03 2015-10-02 0000718937 us-gaap:SellingAndMarketingExpenseMember 2015-01-03 2015-10-02 0000718937 us-gaap:ResearchAndDevelopmentExpenseMember 2015-01-03 2015-10-02 0000718937 us-gaap:CostOfSalesMember 2016-07-02 2016-09-30 0000718937 us-gaap:GeneralAndAdministrativeExpenseMember 2016-07-02 2016-09-30 0000718937 us-gaap:SellingAndMarketingExpenseMember 2016-07-02 2016-09-30 0000718937 us-gaap:ResearchAndDevelopmentExpenseMember 2016-07-02 2016-09-30 0000718937 us-gaap:CostOfSalesMember 2015-07-04 2015-10-02 0000718937 us-gaap:GeneralAndAdministrativeExpenseMember 2015-07-04 2015-10-02 0000718937 us-gaap:SellingAndMarketingExpenseMember 2015-07-04 2015-10-02 0000718937 us-gaap:ResearchAndDevelopmentExpenseMember 2015-07-04 2015-10-02 0000718937 staa:OmnibusPlanMember 2016-01-02 2016-09-30 0000718937 staa:OmnibusPlanMember us-gaap:RestrictedStockMember 2016-09-30 0000718937 us-gaap:RestrictedStockMember 2016-09-30 0000718937 us-gaap:RestrictedStockUnitsRSUMember 2016-09-30 0000718937 us-gaap:MinimumMember 2016-09-30 0000718937 us-gaap:MaximumMember 2016-09-30 0000718937 staa:OmnibusEquityIncentivePlan2003Member 2016-01-02 2016-09-30 0000718937 staa:OmnibusEquityIncentivePlan2003Member us-gaap:EmployeeStockOptionMember 2016-01-02 2016-09-30 0000718937 staa:OmnibusEquityIncentivePlan2003Member staa:RestrictedStockAndRestrictedStockUnitsMember 2016-01-02 2016-09-30 0000718937 staa:OmnibusEquityIncentivePlan2003Member us-gaap:GeneralAndAdministrativeExpenseMember 2016-01-02 2016-09-30 0000718937 staa:OmnibusEquityIncentivePlan2003Member us-gaap:SellingAndMarketingExpenseMember 2016-01-02 2016-09-30 0000718937 staa:OmnibusEquityIncentivePlan2003Member us-gaap:ResearchAndDevelopmentExpenseMember 2016-01-02 2016-09-30 0000718937 staa:OmnibusEquityIncentivePlan2003Member us-gaap:CostOfSalesMember 2016-01-02 2016-09-30 0000718937 us-gaap:RestrictedStockMember 2016-01-01 0000718937 us-gaap:RestrictedStockUnitsRSUMember 2016-01-01 0000718937 staa:MizuhoBankMember 2012-12-28 0000718937 staa:MizuhoBankMember us-gaap:PrimeRateMember 2016-09-30 0000718937 staa:MizuhoBankMember 2016-09-30 0000718937 staa:CreditSuisseMember 2016-01-02 2016-09-30 0000718937 staa:CreditSuisseMember 2010-08-31 0000718937 staa:MizuhoBankMember 2016-01-02 2016-09-30 0000718937 staa:CreditSuisseMember 2016-09-30 0000718937 staa:MizuhoBankMember 2016-01-01 0000718937 staa:LeaseLineOfCreditMember 2016-06-07 0000718937 staa:LeaseLineOfCreditMember 2016-06-01 2016-06-07 0000718937 staa:LeaseLineOfCreditMember staa:HardwareEquipmentMember 2016-06-01 2016-06-07 0000718937 staa:LeaseLineOfCreditMember staa:NonHardwareEquipmentMember 2016-06-01 2016-06-07 0000718937 staa:LeaseLineOfCreditMember 2016-09-30 0000718937 staa:LeaseLineOfCreditMember 2016-01-02 2016-09-30 xbrli:shares iso4217:USD iso4217:USD xbrli:shares iso4217:JPY iso4217:CHF xbrli:pure

13402000

14284000

15675000

14372000

15921000

15895000

3636000 4649000

439000

518000

49073000

49718000

10095000

11718000

666000

607000

1786000

717000

1670000

617000

835000

62954000

66334000

4159000

4941000

6691000

7973000

370000

362000

398000

6305000

7568000

17887000

21250000

204000

1676000

1888000

1005000

156000

225000

24108000

28604000

399000

406000

187007000

196411000

-1580000

-145000

-146980000

-158942000

38846000

37730000

62954000

66334000

68000

87000

4380000

3886000

56264000

60295000

17804000

18206000

18378000

14748000

22006000

17784000

16018000

10800000

-13911000

-5274000

86000

97000

13000

-692000

507000

375000

-150000

62000

285000

-302000

42491000

38058000

-1664000

114000

-11962000

-5690000

-13626000

-5576000

-0.3

-0.14

40227000

39409000

18750000

20052000

5180000

5951000

4985000

4853000

7149000

6284000

4453000

3684000

-1715000

-2022000

29000

-29000

20000

134000

224000

-68000

43000

8000

259000

14872000

12799000

71000

-11000

-1778000

-1752000

-1707000

-1763000

-0.04

40486000

39727000

16587000

14821000

56402000

43332000

1000

50000

54000

2000000

53000

1435000

-5637000

-10527000

-34000

-27000

-80000

-44000

611000

18000

288000

232000

194000

181000

-1558000

-1597000

-11000

-9000

-27000

-14000

67000

99000

1563000

1933000

154000

171000

-148000

-1806000

136000

390000

2747000

8143000

331000

99000

2040000

-1707000

-1497000

-1601000

-737000 1118000

-991000

594000

1387000

1104000

-317000

856000

1283000

2709000

-1281000

-2644000

306000

302000

4643000

1893000

23000

777000

13013000

16081000

65000

2000

882000

3068000

1154000

2800000

224000

375000

2317000

2177000

1995000

2099000

15058000

15714000

3449000

4095000

2052000

1386000

724000

658000

747000

624000

597000

626000

182000

18934000

17094000

6980000

8255000

8611000

9238000

22590000

24709000

11341000

9207000

1305000

829000

11847000

9312000

1550000

985000

10675000

8891000

1044000

740000

11240000

8965000

1356000

919000

316000

261000

89000

347000

194000

66000

1909000

2452000

2114000

2027000

314000

412000

540000

144000

2051000

1271000

466000

322000

54000

57000

69000

64000

10000

8000

-70000

-36000

155000

108000

19000

24000

22000

3000

-24000

-11000

177000

119000

531000

359000

419000

400000

39533000

40242000

15000 124000

39851000

40501000

15000 124000

2984000

2446000

193000

345000

2985000

2937000

48000

2739000

2615000

124000

2194000

2134000

60000

12258000

7355000

28933000

12514000

8464000

11749000

8794000

26492000

4029000

2419000

9350000

4249000

2873000

4254000

3095000

8533000

37396000

14952000

3916000

43389000

14783000

2123000

12907000

4390000

1453000

14801000

4649000

602000

0.21

0.19

0.16

0.14

0.2

0.11

0.24

0.1

5257000

259000

2569000

58000

1818000

396000

484000

49000

208000

32000

146000

386000

625000

923000

88000

210000

8143000

2747000

560000

3936000

1544000

2103000

33000

1667000

539000

508000

227000

258000

8370000

3005000

386000

923000

248000

72000

66000

9000

543000

184000

187000

39000

130000

425000

1053000

P10Y

2222972

23140

266050

0.95

17.62

6900000

4600000

2300000

2900000

1500000

1900000

600000

0.26

3700000

0.57

0.0134

0.0161

P5Y6M25D

P5Y7M10D

0.57

0.58

0.0119

0.016

P5Y6M25D

P5Y7M13D

124000

339000

23000

313000

6000

23000

266000

3623000

761000

424000

346000

3614000

2968000

500000000

0.01475

500000000

0.0025

1000000

2017-09-30

4900000

1000000

4200000

10-Q false 2016-09-30 2016 Q3 STAAR SURGICAL CO 0000718937 --12-30 Accelerated Filer STAA 40609093

2039000

1877000

0.01

60000000

40607000

39887000

611000

<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><b>Note 1  Basis of Presentation and Significant Accounting Policies</b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><b> </b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>The condensed consolidated financial statements of the Company present the financial position, results of operations, and cash flows of STAAR Surgical Company and its wholly owned subsidiaries. All significant intercompany accounts and transactions have been eliminated. The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X of the Securities Exchange Commission. In accordance with those rules and regulations certain information and footnote disclosures normally included in comprehensive financial statements have been condensed or omitted pursuant to such rules and regulations. The consolidated balance sheet as of January 1, 2016 was derived from the audited financial statements at that date, but does not include all the information and footnotes required by GAAP. These financial statements should be read in conjunction with the audited financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended January 1, 2016.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The accompanying interim condensed consolidated financial statements, in the opinion of management, include all adjustments, consisting only of normal recurring adjustments, necessary for a fair presentation of the Company’s financial condition and results of operations. The condensed consolidated results of operations are not necessarily indicative of the results to be expected for any other interim period or for the entire year.  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">Each of the Company's reporting periods ends on the Friday nearest to the quarter ending date and generally consists of 13 weeks.  Unless the context indicates otherwise “we,” “us,” the “Company,” and “STAAR” refer to STAAR Surgical Company and its consolidated subsidiaries.</div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 13.2pt; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><i><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>Recent Accounting Pronouncements</i></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><i> </i></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">In August of 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2016-15, “Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments” (“ASU 2016-15”), which clarifies how companies present and classify certain cash receipts and cash payments in the statement of cash flows. ASU 2016-15 is effective for fiscal years beginning after December 15, 2017 and early adoption is permitted. The Company is currently evaluating the impact ASU 2016-15 will have on its consolidated financial statements.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">In May 2016, the FASB issued ASU 2016-12, <i> “</i>Revenue from Contracts with Customers (Topic 606): Narrow-Scope Improvements and Practical Expedients” (“ASU 2016-12”). The amendments in ASU 2016-12 provide clarifying guidance in certain narrow areas and add some practical expedients. Specifically, the amendments in this update (1) clarify the objective of the collectability criterion in step 1, and provides additional clarification for when to recognize revenue for a contract that fails step 1, (2) permit an entity, as an accounting policy election, to exclude amounts collected from customers for all sales (and other similar) taxes from the transaction price, (3) specify that the measurement date for noncash consideration is contract inception, and clarifies that the variable consideration guidance applies only to variability resulting from reasons other than the form of the consideration, (4) provide a practical expedient that permits an entity to reflect the aggregate effect of all modifications that occur before the beginning of the earliest period presented when identifying the satisfied and unsatisfied performance obligations, determining the transaction price, and allocating the transaction price to the satisfied and unsatisfied performance obligations, and (5) clarifies that a completed contract for purposes of transition is a contract for which all (or substantially all) of the revenue was recognized under legacy GAAP before the date of initial application. Further, accounting for elements of a contract that do not affect revenue under legacy GAAP are irrelevant to the assessment of whether a contract is complete. In addition, the amendments permit an entity to apply the modified retrospective transition method either to all contracts or only to contracts that are not completed contracts, and clarifies that an entity that retrospectively applies the guidance in Topic 606 to each prior reporting period is not required to disclose the effect of the accounting change for the period of adoption. However, an entity is still required to disclose the effect of the changes on any prior periods retrospectively adjusted. The effective date and transition requirements for the amendments are the same as the effective date and transition requirements in Topic 606. The guidance is effective for the Company beginning January 1, 2018, although early adoption is permitted beginning January 1, 2017. The Company is currently evaluating the effects of ASU 2016-12 on its consolidated financial statements.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><i> </i></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">In April 2016, the FASB issued ASU 2016-10, “Revenue from Contracts with Customers (Topic 606): Identifying Performance Obligations and Licensing.” The amendments clarify two aspects of Topic 606: (a) identifying performance obligations; and (b) the licensing implementation guidance. The update is effective for annual periods beginning after December 15, 2017 including interim reporting periods therein. The Company is currently evaluating the impact the adoption of ASU 2016-10 will have on its consolidated financial statements.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 13.2pt; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">In March 2016, the FASB issued ASU 2016-09, “CompensationStock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting”, which simplifies several aspects of the accounting for share-based payment transactions, including the income tax consequences, forfeitures, classification of awards as either equity or liabilities, and classification of awards on the statement of cash flows. The update is effective for fiscal years beginning after December 15, 2016. The Company is currently evaluating the impact of the adoption of ASU 2016-09 will have on its consolidated financial statements.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 13.2pt; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">In February 2016, the FASB issued ASU 2016-02, “Leases (Topic 842)”, which requires lessees to recognize assets and liabilities for leases with lease terms greater than twelve months in the statement of financial position. Leases will be classified as either finance or operating, with classification affecting the pattern of expense recognition in the income statement. ASU 2016-02 also requires improved disclosures to help users of financial statements better understand the amount, timing and uncertainty of cash flows arising from leases. The update is effective for fiscal years beginning after December 15, 2018, including interim reporting periods within that reporting period. Early adoption is permitted. The Company is currently evaluating the impact the adoption of ASU 2016-02 will have on its consolidated financial statements.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">In November 2015, the FASB issued ASU 2015-17, “Income Taxes (Topic 740): Balance Sheet Classification of Deferred Taxes”, which changes how deferred taxes are classified on company’s balance sheets. The ASU eliminates the current requirement to present deferred tax liabilities and assets as current and noncurrent on the balance sheet. Instead, companies will be required to classify all deferred tax assets and liabilities as noncurrent. The amendments are effective for annual financial statements beginning after December 15, 2016, and interim periods within those annual periods. The Company does not expect the adoption of ASU 2015-17 will have a material impact on its consolidated financial statements.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="BACKGROUND-COLOR: transparent">In August 2014, the FASB issued ASU 2014-15, "Presentation of Financial Statements-Going Concern (Subtopic 205-40): Disclosure of Uncertainties about an Entity's Ability to Continue as a Going Concern". ASU 2014-15 defines management's responsibility to assess an entity's ability to continue as a going concern, and to provide related footnote disclosures in certain circumstances. It is effective for annual reporting periods ending after December 15, 2016, and for annual and interim reporting periods thereafter. Early adoption is permitted. The Company does not expect the adoption of ASU 2014-15 will have a material impact on its financial statements.</font></div>   <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">In May 2014, the FASB issued ASU 2014-09, “Revenue from Contracts with Customers (Topic 606)”, which supersedes nearly all existing revenue recognition guidance under GAAP. The core principle of ASU 2014-09 is to recognize revenues when promised goods or services are transferred to customers in an amount that reflects the consideration to which an entity expects to be entitled for those goods or services. ASU 2014-09 defines a five-step process to achieve this core principle and, in doing so, more judgment and estimates may be required within the revenue recognition process than are required under existing GAAP. The revised revenue standard is effective for public entities for annual periods beginning after December 15, 2017, and interim periods therein, using either of the following transition methods: (i) a full retrospective approach reflecting the application of the standard in each prior reporting period with the option to elect certain practical expedients; or (ii) a retrospective approach with the cumulative effect of initially adopting ASU 2014-09 recognized at the date of adoption (which includes additional footnote disclosures). The Company is currently evaluating the impact of the Company’s pending adoption of ASU 2014-09 on the Company’s financial statements and has not yet determined the method by which it will adopt the standard in fiscal 2018.</div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><i><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>Prior Year Reclassifications</i></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><i> </i></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">During the three-month and nine-month periods ended October 2, 2015 the Company reclassified $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">224,000</font> and $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">375,000</font>, respectively, from other income, net to royalty income in the condensed consolidated statements of operations.<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>

<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The condensed consolidated financial statements of the Company present the financial position, results of operations, and cash flows of STAAR Surgical Company and its wholly owned subsidiaries. All significant intercompany accounts and transactions have been eliminated. The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X of the Securities Exchange Commission. In accordance with those rules and regulations certain information and footnote disclosures normally included in comprehensive financial statements have been condensed or omitted pursuant to such rules and regulations. The consolidated balance sheet as of January 1, 2016 was derived from the audited financial statements at that date, but does not include all the information and footnotes required by GAAP. These financial statements should be read in conjunction with the audited financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended January 1, 2016.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The accompanying interim condensed consolidated financial statements, in the opinion of management, include all adjustments, consisting only of normal recurring adjustments, necessary for a fair presentation of the Company’s financial condition and results of operations. The condensed consolidated results of operations are not necessarily indicative of the results to be expected for any other interim period or for the entire year.  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">Each of the Company's reporting periods ends on the Friday nearest to the quarter ending date and generally consists of 13 weeks.  Unless the context indicates otherwise “we,” “us,” the “Company,” and “STAAR” refer to STAAR Surgical Company and its consolidated subsidiaries.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>

<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 13.2pt; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><i>Recent Accounting Pronouncements</i></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><i> </i></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">In August of 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2016-15, “Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments” (“ASU 2016-15”), which clarifies how companies present and classify certain cash receipts and cash payments in the statement of cash flows. ASU 2016-15 is effective for fiscal years beginning after December 15, 2017 and early adoption is permitted. The Company is currently evaluating the impact ASU 2016-15 will have on its consolidated financial statements.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">In May 2016, the FASB issued ASU 2016-12, <i> “</i>Revenue from Contracts with Customers (Topic 606): Narrow-Scope Improvements and Practical Expedients” (“ASU 2016-12”). The amendments in ASU 2016-12 provide clarifying guidance in certain narrow areas and add some practical expedients. Specifically, the amendments in this update (1) clarify the objective of the collectability criterion in step 1, and provides additional clarification for when to recognize revenue for a contract that fails step 1, (2) permit an entity, as an accounting policy election, to exclude amounts collected from customers for all sales (and other similar) taxes from the transaction price, (3) specify that the measurement date for noncash consideration is contract inception, and clarifies that the variable consideration guidance applies only to variability resulting from reasons other than the form of the consideration, (4) provide a practical expedient that permits an entity to reflect the aggregate effect of all modifications that occur before the beginning of the earliest period presented when identifying the satisfied and unsatisfied performance obligations, determining the transaction price, and allocating the transaction price to the satisfied and unsatisfied performance obligations, and (5) clarifies that a completed contract for purposes of transition is a contract for which all (or substantially all) of the revenue was recognized under legacy GAAP before the date of initial application. Further, accounting for elements of a contract that do not affect revenue under legacy GAAP are irrelevant to the assessment of whether a contract is complete. In addition, the amendments permit an entity to apply the modified retrospective transition method either to all contracts or only to contracts that are not completed contracts, and clarifies that an entity that retrospectively applies the guidance in Topic 606 to each prior reporting period is not required to disclose the effect of the accounting change for the period of adoption. However, an entity is still required to disclose the effect of the changes on any prior periods retrospectively adjusted. The effective date and transition requirements for the amendments are the same as the effective date and transition requirements in Topic 606. The guidance is effective for the Company beginning January 1, 2018, although early adoption is permitted beginning January 1, 2017. The Company is currently evaluating the effects of ASU 2016-12 on its consolidated financial statements.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><i> </i></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">In April 2016, the FASB issued ASU 2016-10, “Revenue from Contracts with Customers (Topic 606): Identifying Performance Obligations and Licensing.” The amendments clarify two aspects of Topic 606: (a) identifying performance obligations; and (b) the licensing implementation guidance. The update is effective for annual periods beginning after December 15, 2017 including interim reporting periods therein. The Company is currently evaluating the impact the adoption of ASU 2016-10 will have on its consolidated financial statements.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 13.2pt; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">In March 2016, the FASB issued ASU 2016-09, “CompensationStock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting”, which simplifies several aspects of the accounting for share-based payment transactions, including the income tax consequences, forfeitures, classification of awards as either equity or liabilities, and classification of awards on the statement of cash flows. The update is effective for fiscal years beginning after December 15, 2016. The Company is currently evaluating the impact of the adoption of ASU 2016-09 will have on its consolidated financial statements.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 13.2pt; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">In February 2016, the FASB issued ASU 2016-02, “Leases (Topic 842)”, which requires lessees to recognize assets and liabilities for leases with lease terms greater than twelve months in the statement of financial position. Leases will be classified as either finance or operating, with classification affecting the pattern of expense recognition in the income statement. ASU 2016-02 also requires improved disclosures to help users of financial statements better understand the amount, timing and uncertainty of cash flows arising from leases. The update is effective for fiscal years beginning after December 15, 2018, including interim reporting periods within that reporting period. Early adoption is permitted. The Company is currently evaluating the impact the adoption of ASU 2016-02 will have on its consolidated financial statements.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">In November 2015, the FASB issued ASU 2015-17, “Income Taxes (Topic 740): Balance Sheet Classification of Deferred Taxes”, which changes how deferred taxes are classified on company’s balance sheets. The ASU eliminates the current requirement to present deferred tax liabilities and assets as current and noncurrent on the balance sheet. Instead, companies will be required to classify all deferred tax assets and liabilities as noncurrent. The amendments are effective for annual financial statements beginning after December 15, 2016, and interim periods within those annual periods. The Company does not expect the adoption of ASU 2015-17 will have a material impact on its consolidated financial statements.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="BACKGROUND-COLOR: transparent">In August 2014, the FASB issued ASU 2014-15, "Presentation of Financial Statements-Going Concern (Subtopic 205-40): Disclosure of Uncertainties about an Entity's Ability to Continue as a Going Concern". ASU 2014-15 defines management's responsibility to assess an entity's ability to continue as a going concern, and to provide related footnote disclosures in certain circumstances. It is effective for annual reporting periods ending after December 15, 2016, and for annual and interim reporting periods thereafter. Early adoption is permitted. The Company does not expect the adoption of ASU 2014-15 will have a material impact on its financial statements.</font></div>   <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">In May 2014, the FASB issued ASU 2014-09, “Revenue from Contracts with Customers (Topic 606)”, which supersedes nearly all existing revenue recognition guidance under GAAP. The core principle of ASU 2014-09 is to recognize revenues when promised goods or services are transferred to customers in an amount that reflects the consideration to which an entity expects to be entitled for those goods or services. ASU 2014-09 defines a five-step process to achieve this core principle and, in doing so, more judgment and estimates may be required within the revenue recognition process than are required under existing GAAP. The revised revenue standard is effective for public entities for annual periods beginning after December 15, 2017, and interim periods therein, using either of the following transition methods: (i) a full retrospective approach reflecting the application of the standard in each prior reporting period with the option to elect certain practical expedients; or (ii) a retrospective approach with the cumulative effect of initially adopting ASU 2014-09 recognized at the date of adoption (which includes additional footnote disclosures). The Company is currently evaluating the impact of the Company’s pending adoption of ASU 2014-09 on the Company’s financial statements and has not yet determined the method by which it will adopt the standard in fiscal 2018.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>

19990000

19370000

<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 19.8pt; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 19.8pt; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> Prepayments, deposits, and other current assets consisted of the following (in thousands):</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 19.8pt; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="MARGIN: 0in 0in 0in 1in; WIDTH: 65%; BORDER-COLLAPSE: collapse; OVERFLOW: visible" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="40%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="10%" colspan="2"> <div>September 30,</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="10%" colspan="2"> <div>January 1,</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="40%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="10%" colspan="2"> <div>2016</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="10%" colspan="2"> <div>2016</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="40%"> <div>Prepayments and deposits</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="9%"> <div>2,052</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="9%"> <div>1,386</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="40%"> <div>Income tax receivable</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>626</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>597</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="40%"> <div>Consumption tax receivable</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="9%"> <div>507</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="9%"> <div></div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="40%"> <div>Value added tax (VAT) receivable</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>658</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>724</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="40%"> <div>Deferred charges for foreign profits</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>182</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>182</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="40%"> <div>Other current assets</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>624</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>747</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="40%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="9%"> <div>4,649</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="9%"> <div>3,636</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> </table> </div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <strong>Note 3  Prepayments, Deposits, and Other Current Assets</strong></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 19.8pt; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 19.8pt; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>Prepayments, deposits, and other current assets consisted of the following (in thousands):</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 19.8pt; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="MARGIN: 0in 0in 0in 1in; WIDTH: 65%; BORDER-COLLAPSE: collapse; OVERFLOW: visible" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="40%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="10%" colspan="2"> <div>September 30,</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="10%" colspan="2"> <div>January 1,</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="40%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="10%" colspan="2"> <div>2016</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="10%" colspan="2"> <div>2016</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="40%"> <div>Prepayments and deposits</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="9%"> <div>2,052</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="9%"> <div>1,386</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="40%"> <div>Income tax receivable</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>626</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>597</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="40%"> <div>Consumption tax receivable</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="9%"> <div>507</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="9%"> <div></div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="40%"> <div>Value added tax (VAT) receivable</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>658</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>724</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="40%"> <div>Deferred charges for foreign profits</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>182</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>182</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="40%"> <div>Other current assets</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>624</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>747</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="40%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="9%"> <div>4,649</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="9%"> <div>3,636</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> </table> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>

36427000

32685000

<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 19.8pt; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> Intangible assets, net consisted of the following (in thousands):</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 19.8pt; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="MARGIN: 0in 0in 0in 0.25in; WIDTH: 96%; BORDER-COLLAPSE: collapse; OVERFLOW: visible" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="25%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="33%" colspan="8"> <div>September 30, 2016</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="33%" colspan="8"> <div>January 1, 2016</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="25%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="10%" colspan="2"> <div>Gross</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="9%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="9%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="10%" colspan="2"> <div>Gross</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="9%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="9%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="25%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="10%" colspan="2"> <div>Carrying</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="10%" colspan="2"> <div>Accumulated</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="9%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="10%" colspan="2"> <div>Carrying</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="10%" colspan="2"> <div>Accumulated</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="9%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="25%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="10%" colspan="2"> <div>Amount</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="10%" colspan="2"> <div>Amortization</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="10%" colspan="2"> <div>Net</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="10%" colspan="2"> <div>Amount</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="10%" colspan="2"> <div>Amortization</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="10%" colspan="2"> <div>Net</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="25%"> <div>Intangible assets:</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="9%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="9%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="9%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="9%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="9%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="9%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="25%"> <div>Patents and licenses</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>9,312</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>(8,965)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>347</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>9,207</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>(8,891)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>316</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="25%"> <div>Customer relationships</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>1,550</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>(1,356)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>194</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>1,305</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>(1,044)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>261</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="25%"> <div>Developed technology</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>985</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>(919)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>66</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>829</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>(740)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>89</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="25%"> <div>Total</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="9%"> <div>11,847</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="9%"> <div>(11,240)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="9%"> <div>607</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="9%"> <div>11,341</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="9%"> <div>(10,675)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="9%"> <div>666</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt"></div> </div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>

<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The following table summarizes the components of net periodic pension cost recorded for the Company’s defined benefit pension plans (in thousands):</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="MARGIN: 0in 0in 0in 0.3in; WIDTH: 90%; BORDER-COLLAPSE: collapse; OVERFLOW: visible" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="45%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="21%" colspan="5"> <div>Three Months Ended</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="21%" colspan="5"> <div>Nine Months Ended</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="45%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="10%" colspan="2"> <div>September 30,<br/> 2016</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="10%" colspan="2"> <div>October 2,<br/> 2015</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="10%" colspan="2"> <div>September 30,<br/> 2016</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="10%" colspan="2"> <div>October 2,<br/> 2015</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="45%"> <div>Service cost</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="9%"> <div>155</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="9%"> <div>108</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="9%"> <div>466</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="9%"> <div>322</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="45%"> <div>Interest cost</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>19</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>19</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>54</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>57</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="45%"> <div>Expected return on plan assets</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>(24)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>(22)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>(69)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>(64)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="45%"> <div>Net amortization of transitional obligation (a)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>3</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>3</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>10</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>8</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="45%"> <div>Actuarial loss recognized in current period (a)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>24</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>11</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>70</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>36</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="45%"> <div>Total</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="9%"> <div>177</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="9%"> <div>119</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="9%"> <div>531</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="9%"> <div>359</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> </table> </div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 13.2pt; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 13.2pt; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">(a) Amounts reclassified from accumulated other comprehensive loss.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>

<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The following table sets forth the computation of basic and diluted net loss per share (in thousands except per share amounts):</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="MARGIN: 0in; WIDTH: 100%; BORDER-COLLAPSE: collapse; OVERFLOW: visible" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="51%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="23%" colspan="5"> <div>Three Months Ended</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="23%" colspan="5"> <div>Nine Months Ended</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="51%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>September 30,<br/> 2016</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>October 2,<br/> 2015</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>September 30,<br/> 2016</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>October 2,<br/> 2015</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div>Numerator:</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div>Net loss</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>(1,778)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>(1,752)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>(11,962)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>(5,690)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div>Denominator:</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div>Weighted average common shares and denominator for basic and diluted calculation:</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div>Weighted average common shares outstanding</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>40,501</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>39,851</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>40,242</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>39,533</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div>Less: Unvested restricted stock</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>(15)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>(124)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>(15)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>(124)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div>Denominator for basic and diluted calculation</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>40,486</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>39,727</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>40,227</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>39,409</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div>Net loss per share  basic and diluted</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>(0.04)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>(0.04)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>(0.30)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>(0.14)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> </table> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>

<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The following table sets forth the weighted average number of options and warrants to purchase shares of common stock and restricted stock and units, which were not included in the calculation of diluted per share amounts because the effects would be anti-dilutive (in thousands).</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:center; TEXT-INDENT: 0in; WIDTH: 100%" align="center"> <table style="MARGIN: 0px:auto; WIDTH: 75%; BORDER-COLLAPSE: collapse; OVERFLOW: visible" cellspacing="0" cellpadding="0" align="center"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="36%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="18%" colspan="5"> <div>Three Months Ended</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="18%" colspan="5"> <div>Nine Months Ended</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="36%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="8%" colspan="2"> <div>September 30,<br/> 2016</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="8%" colspan="2"> <div>October 2,<br/> 2015</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="8%" colspan="2"> <div>September 30,<br/> 2016</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="8%" colspan="2"> <div>October 2,<br/> 2015</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="36%"> <div>Options</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="7%"> <div>2,134</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="7%"> <div>2,615</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="7%"> <div>2,937</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="7%"> <div>2,446</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="36%"> <div>Restricted stock and units</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="7%"> <div>60</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="7%"> <div>124</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="7%"> <div>48</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="7%"> <div>193</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="36%"> <div>Warrants</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="7%"> <div></div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="7%"> <div></div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="7%"> <div></div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="7%"> <div>345</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="36%"> <div>Total</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="7%"> <div>2,194</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="7%"> <div>2,739</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="7%"> <div>2,985</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="7%"> <div>2,984</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt"></div> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>

<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;BACKGROUND-COLOR: transparent; TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="BACKGROUND-COLOR: transparent">The composition of the Company’s net sales to unaffiliated customers is set forth below (in thousands):</font></div> <font style="BACKGROUND-COLOR: transparent"> </font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:center; TEXT-INDENT: 0in; WIDTH: 100%" align="center"> <table style="MARGIN: 0px:auto; WIDTH: 75%; BORDER-COLLAPSE: collapse; OVERFLOW: visible" cellspacing="0" cellpadding="0" align="center"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="36%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="18%" colspan="5"> <div style="CLEAR:both;CLEAR: both"> Three Months Ended</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="18%" colspan="5"> <div style="CLEAR:both;CLEAR: both"> Nine Months Ended</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="36%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="8%" colspan="2"> <div style="CLEAR:both;CLEAR: both">September 30,</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="8%" colspan="2"> <div style="CLEAR:both;CLEAR: both">October 2,</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="8%" colspan="2"> <div style="CLEAR:both;CLEAR: both">September 30,</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="8%" colspan="2"> <div style="CLEAR:both;CLEAR: both">October 2,</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="36%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="8%" colspan="2"> <div style="CLEAR:both;CLEAR: both">2016</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="8%" colspan="2"> <div style="CLEAR:both;CLEAR: both">2015</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="8%" colspan="2"> <div style="CLEAR:both;CLEAR: both">2016</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="8%" colspan="2"> <div style="CLEAR:both;CLEAR: both">2015</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="36%"> <div style="CLEAR:both;CLEAR: both">Japan</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="7%"> <div style="CLEAR:both;CLEAR: both">4,029</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="7%"> <div style="CLEAR:both;CLEAR: both">4,249</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="7%"> <div style="CLEAR:both;CLEAR: both">12,258</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="7%"> <div style="CLEAR:both;CLEAR: both">12,514</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="36%"> <div style="CLEAR:both;CLEAR: both">China</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="7%"> <div style="CLEAR:both;CLEAR: both">4,254</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="7%"> <div style="CLEAR:both;CLEAR: both">3,095</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="7%"> <div style="CLEAR:both;CLEAR: both">11,749</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="7%"> <div style="CLEAR:both;CLEAR: both">8,794</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="36%"> <div style="CLEAR:both;CLEAR: both">United States</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="7%"> <div style="CLEAR:both;CLEAR: both">2,419</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="7%"> <div style="CLEAR:both;CLEAR: both">2,873</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="7%"> <div style="CLEAR:both;CLEAR: both">7,355</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="7%"> <div style="CLEAR:both;CLEAR: both">8,464</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="36%"> <div style="CLEAR:both;CLEAR: both">Other</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="7%"> <div style="CLEAR:both;CLEAR: both">9,350</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="7%"> <div style="CLEAR:both;CLEAR: both">8,533</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="7%"> <div style="CLEAR:both;CLEAR: both">28,933</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="7%"> <div style="CLEAR:both;CLEAR: both">26,492</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="36%"> <div style="CLEAR:both;CLEAR: both">Total</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="7%"> <div style="CLEAR:both;CLEAR: both">20,052</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="7%"> <div style="CLEAR:both;CLEAR: both">18,750</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="7%"> <div style="CLEAR:both;CLEAR: both">60,295</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="7%"> <div style="CLEAR:both;CLEAR: both">56,264</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both"> </div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both"> </div> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>

<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;BACKGROUND-COLOR: transparent; TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="BACKGROUND-COLOR: transparent">The composition of the Company’s net sales by product line is as follows (in thousands):</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;BACKGROUND-COLOR: transparent; TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="BACKGROUND-COLOR: transparent">  </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="MARGIN: 0in; WIDTH: 100%; BORDER-COLLAPSE: collapse; OVERFLOW: visible" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="51%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="23%" colspan="5"> <div>Three Months Ended</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="23%" colspan="5"> <div>Nine Months Ended</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="51%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>September 30,</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>October 2,</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>September 30,</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>October 2,</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="51%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>2016</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>2015</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>2016</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>2015</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div>ICLs</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>14,801</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>12,907</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>43,389</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>37,396</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div>IOLs</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>4,649</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>4,390</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>14,783</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>14,952</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div>Other surgical products</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>602</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>1,453</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>2,123</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>3,916</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div>Total</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>20,052</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>18,750</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>60,295</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>56,264</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> </table> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>

<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><strong>Note 10  Stock-Based Compensation</strong></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="BACKGROUND-COLOR: transparent"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>The cost that has been charged against income for stock-based compensation is set forth below (in thousands):</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;BACKGROUND-COLOR: transparent; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="MARGIN: 0in 0in 0in 0.25in; WIDTH: 92%; BORDER-COLLAPSE: collapse; OVERFLOW: visible" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="46%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="21%" colspan="5"> <div>Three Months Ended</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="21%" colspan="5"> <div>Nine Months Ended</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="46%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="10%" colspan="2"> <div>September 30,<br/> 2016</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="10%" colspan="2"> <div>October 2,<br/> 2015</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="10%" colspan="2"> <div>September 30,<br/> 2016</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="10%" colspan="2"> <div>October 2,<br/> 2015</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="46%"> <div>Employee stock options</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="9%"> <div>208</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="9%"> <div>625</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="9%"> <div>5,257</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="9%"> <div>1,818</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="46%"> <div>Restricted stock</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>32</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>88</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>259</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>396</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="46%"> <div>Restricted stock units</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>146</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>210</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>2,569</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>484</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="46%"> <div>Nonemployee stock options</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div></div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div></div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>58</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>49</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="46%"> <div>Total</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="9%"> <div>386</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="9%"> <div>923</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="9%"> <div>8,143</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="9%"> <div>2,747</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> </table> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;BACKGROUND-COLOR: transparent; TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="BACKGROUND-COLOR: transparent">  </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;BACKGROUND-COLOR: transparent; TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="BACKGROUND-COLOR: transparent"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>The Company recorded stock-based compensation costs in the following categories on the accompanying condensed consolidated statements of operations (in thousands):</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;BACKGROUND-COLOR: transparent; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="MARGIN: 0in 0in 0in 0.25in; WIDTH: 92%; BORDER-COLLAPSE: collapse; OVERFLOW: visible" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="46%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="21%" colspan="5"> <div>Three Months Ended</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="21%" colspan="5"> <div>Nine Months Ended</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="46%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="10%" colspan="2"> <div>September 30,<br/> 2016</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="10%" colspan="2"> <div>October 2,<br/> 2015</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="10%" colspan="2"> <div>September 30,<br/> 2016</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="10%" colspan="2"> <div>October 2,<br/> 2015</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="46%"> <div>Cost of sales</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="9%"> <div></div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="9%"> <div>9</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="9%"> <div>560</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="9%"> <div>33</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="46%"> <div>General and administrative</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>248</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>543</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>3,936</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>1,667</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="46%"> <div>Marketing and selling</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>72</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>184</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>1,544</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>539</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="46%"> <div>Research and development</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>66</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>187</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>2,103</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>508</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="46%"> <div>Total stock compensation expense</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="9%"> <div>386</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="9%"> <div>923</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="9%"> <div>8,143</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="9%"> <div>2,747</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="46%"> <div>Amounts capitalized as part of inventory</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>39</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>130</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>227</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>258</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="46%"> <div>Total</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="9%"> <div>425</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="9%"> <div>1,053</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="9%"> <div>8,370</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="9%"> <div>3,005</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> </table> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;BACKGROUND-COLOR: transparent; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0in; MARGIN: 0pt 0px; FONT: italic 10pt Times New Roman, Times, Serif"> <font style="FONT-WEIGHT: normal">Stock Option Plan</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The Amended and Restated 2003 Omnibus Equity Incentive Plan (“the Plan”) provides for various forms of stock-based incentives. To date, of the available forms of awards under the Plan, the Company has granted only stock options, restricted stock, unrestricted share grants, restricted stock units, and performance contingent stock units. Options under the plan are granted at fair market value on the date of grant, become exercisable over a three-year period, or as determined by the Board of Directors, and expire over periods not exceeding <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">10</font> years from the date of grant. Certain option and share awards provide for accelerated vesting if there is a change in control (as defined in the Plan). Pursuant to the Plan, options for <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 3,614,370</font> shares were outstanding at September 30, 2016 with exercise prices ranging between $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">0.95</font> and $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">17.62</font> per share. Restricted stock grants under the Plan generally vest over a period between one to four years. There were <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 23,140</font> shares of restricted stock and <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 266,050</font> restricted stock units (RSUs) outstanding at September 30, 2016. As of September 30, 2016, there were <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 2,222,972</font> shares authorized and available for grants under the Plan.</div>  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="BACKGROUND-COLOR: transparent"><i> Immediate Vesting of All Unvested Equity Awards</i></font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="BACKGROUND-COLOR: transparent">  </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">On February 11, 2016, one of our shareholders increased its beneficial ownership of the Company’s common stock to approximately <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 26</font>% of all shares outstanding. This triggered the “Change in Control” provision in the Plan, which resulted in the immediate vesting of all unvested equity awards outstanding under the Plan (“Acceleration Event”) and the recording of an aggregate $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">6.9</font> million non-cash charge to stock-based compensation in the condensed consolidated statements of operations on that date ($<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">4.6</font> million for stock options and $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">2.3</font> million for restricted stock and RSUs). This charge was recorded and included in the following categories of the condensed consolidated statements of operations for the nine months ended September 30, 2016: $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">2.9</font> million in general and administrative expenses, $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">1.5</font> million in marketing and selling expenses, $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">1.9</font> million in research and development expenses and $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">0.6</font> million in manufacturing costs. Approximately $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">3.7</font> million of the $6.9 million of accelerated charges would have been recognized for stock-based compensation by the Company during fiscal year 2016 after the Change in Control provision was triggered.</div>  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0in; MARGIN: 0pt 0px; FONT: italic 10pt Times New Roman, Times, Serif"> <font style="FONT-WEIGHT: normal">Assumptions</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;BACKGROUND-COLOR: transparent; TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="BACKGROUND-COLOR: transparent">  </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;BACKGROUND-COLOR: transparent; TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="BACKGROUND-COLOR: transparent">The fair value of each option award is estimated on the date of grant using a Black-Scholes option valuation model applying the weighted-average assumptions noted in the following table. Expected volatilities are based on historical volatility of the Company’s stock. The expected term of options granted is derived from the historical exercises and post-vesting cancellations and represents the period of time that options granted are expected to be outstanding. The Company has calculated a <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">9</font>% estimated forfeiture rate based on historical forfeiture experience. <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>The risk-free rate is based on the U.S. Treasury yield curve corresponding to the expected term at the time of the grant.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;BACKGROUND-COLOR: transparent; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="MARGIN: 0in 0in 0in 0.25in; WIDTH: 92%; BORDER-COLLAPSE: collapse; OVERFLOW: visible" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="43%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="22%" colspan="5"> <div>Three Months Ended</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="2%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="22%" colspan="5"> <div>Nine Months Ended</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="43%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="10%" colspan="2"> <div>September 30,<br/> 2016</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="2%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="10%" colspan="2"> <div>October 2,<br/> 2015</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="2%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="10%" colspan="2"> <div>September 30,<br/> 2016</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="2%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="10%" colspan="2"> <div>October 2,<br/> 2015</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="43%"> <div>Expected dividend yield</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="9%"> <div>0</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="2%"> <div>%</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="9%"> <div>0</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="2%"> <div>%</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="9%"> <div>0</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="2%"> <div>%</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="9%"> <div>0</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>%</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="43%"> <div>Expected volatility</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>57</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="2%"> <div>%</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>58</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="2%"> <div>%</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>57</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="2%"> <div>%</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>57</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>%</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="43%"> <div>Risk-free interest rate</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>1.19</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="2%"> <div>%</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>1.60</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="2%"> <div>%</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>1.34</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="2%"> <div>%</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>1.61</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>%</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="43%"> <div>Expected term (in years)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>5.57</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="2%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>5.62</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="2%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>5.57</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="2%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>5.61</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt"></div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 22.5pt; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 22.5pt; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font>A summary of option activity under the Plan for the nine-month period ended September 30, 2016 is presented below:</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:center; TEXT-INDENT: 0in; WIDTH: 100%" align="center"> <table style="MARGIN: 0px:auto; WIDTH: 45%; BORDER-COLLAPSE: collapse; OVERFLOW: visible" cellspacing="0" cellpadding="0" align="center"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="33%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="10%" colspan="2"> <div>Options<br/> Shares<br/> (000’s)</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="33%"> <div>Outstanding at January 1, 2016</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="9%"> <div>3,623</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="33%"> <div>Granted</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>761</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="33%"> <div>Exercised</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>(424)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="33%"> <div>Forfeited or expired</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>(346)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="33%"> <div>Outstanding at September 30, 2016</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="9%"> <div>3,614</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="33%"> <div>Exercisable at September 30, 2016</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="9%"> <div>2,968</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt"></div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font>A summary of restricted stock and restricted stock unit’s activity under the Plan for the nine-month period ended September 30, 2016 is presented below:</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:center; TEXT-INDENT: 0in; WIDTH: 100%" align="center"> <table style="MARGIN: 0px:auto; WIDTH: 58%; BORDER-COLLAPSE: collapse; OVERFLOW: visible" cellspacing="0" cellpadding="0" align="center"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="41%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="7%" colspan="2"> <div>Restricted<br/> Shares<br/> (000’s)</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="7%" colspan="2"> <div>Restricted<br/> Units<br/> (000’s)</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="41%"> <div>Outstanding at January 1, 2016</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="6%"> <div>124</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="6%"> <div>339</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="41%"> <div>Granted</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="6%"> <div>23</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="6%"> <div>313</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="41%"> <div>Exercised</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="6%"> <div>(124)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="6%"> <div>(380)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="41%"> <div>Forfeited</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="6%"> <div></div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="6%"> <div>(6)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="41%"> <div>Outstanding at September 30, 2016</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="6%"> <div>23</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="6%"> <div>266</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt"></div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>

4900000

<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="BACKGROUND-COLOR: transparent">The cost that has been charged against income for stock-based compensation is set forth below (in thousands):</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;BACKGROUND-COLOR: transparent; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="MARGIN: 0in 0in 0in 0.25in; WIDTH: 92%; BORDER-COLLAPSE: collapse; OVERFLOW: visible" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="46%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="21%" colspan="5"> <div>Three Months Ended</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="21%" colspan="5"> <div>Nine Months Ended</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="46%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="10%" colspan="2"> <div>September 30,<br/> 2016</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="10%" colspan="2"> <div>October 2,<br/> 2015</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="10%" colspan="2"> <div>September 30,<br/> 2016</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="10%" colspan="2"> <div>October 2,<br/> 2015</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="46%"> <div>Employee stock options</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="9%"> <div>208</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="9%"> <div>625</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="9%"> <div>5,257</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="9%"> <div>1,818</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="46%"> <div>Restricted stock</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>32</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>88</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>259</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>396</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="46%"> <div>Restricted stock units</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>146</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>210</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>2,569</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>484</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="46%"> <div>Nonemployee stock options</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div></div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div></div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>58</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>49</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="46%"> <div>Total</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="9%"> <div>386</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="9%"> <div>923</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="9%"> <div>8,143</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="9%"> <div>2,747</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> </table> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>

<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;BACKGROUND-COLOR: transparent; TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;BACKGROUND-COLOR: transparent; TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="BACKGROUND-COLOR: transparent">The Company recorded stock-based compensation costs in the following categories on the accompanying condensed consolidated statements of operations (in thousands):</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;BACKGROUND-COLOR: transparent; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="MARGIN: 0in 0in 0in 0.25in; WIDTH: 92%; BORDER-COLLAPSE: collapse; OVERFLOW: visible" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="46%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="21%" colspan="5"> <div>Three Months Ended</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="21%" colspan="5"> <div>Nine Months Ended</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="46%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="10%" colspan="2"> <div>September 30,<br/> 2016</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="10%" colspan="2"> <div>October 2,<br/> 2015</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="10%" colspan="2"> <div>September 30,<br/> 2016</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="10%" colspan="2"> <div>October 2,<br/> 2015</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="46%"> <div>Cost of sales</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="9%"> <div></div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="9%"> <div>9</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="9%"> <div>560</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="9%"> <div>33</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="46%"> <div>General and administrative</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>248</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>543</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>3,936</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>1,667</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="46%"> <div>Marketing and selling</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>72</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>184</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>1,544</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>539</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="46%"> <div>Research and development</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>66</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>187</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>2,103</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>508</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="46%"> <div>Total stock compensation expense</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="9%"> <div>386</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="9%"> <div>923</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="9%"> <div>8,143</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="9%"> <div>2,747</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="46%"> <div>Amounts capitalized as part of inventory</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>39</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>130</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>227</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>258</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="46%"> <div>Total</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="9%"> <div>425</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="9%"> <div>1,053</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="9%"> <div>8,370</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="9%"> <div>3,005</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> </table> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>

<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 22.5pt; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 22.5pt; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">A summary of option activity under the Plan for the nine-month period ended September 30, 2016 is presented below:</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:center; TEXT-INDENT: 0in; WIDTH: 100%" align="center"> <table style="MARGIN: 0px:auto; WIDTH: 45%; BORDER-COLLAPSE: collapse; OVERFLOW: visible" cellspacing="0" cellpadding="0" align="center"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="33%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="10%" colspan="2"> <div>Options<br/> Shares<br/> (000’s)</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="33%"> <div>Outstanding at January 1, 2016</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="9%"> <div>3,623</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="33%"> <div>Granted</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>761</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="33%"> <div>Exercised</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>(424)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="33%"> <div>Forfeited or expired</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>(346)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="33%"> <div>Outstanding at September 30, 2016</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="9%"> <div>3,614</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="33%"> <div>Exercisable at September 30, 2016</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="9%"> <div>2,968</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt"></div> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>

<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">A summary of restricted stock and restricted stock unit’s activity under the Plan for the nine-month period ended September 30, 2016 is presented below:</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:center; TEXT-INDENT: 0in; WIDTH: 100%" align="center"> <table style="MARGIN: 0px:auto; WIDTH: 58%; BORDER-COLLAPSE: collapse; OVERFLOW: visible" cellspacing="0" cellpadding="0" align="center"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="41%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="7%" colspan="2"> <div>Restricted<br/> Shares<br/> (000’s)</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="7%" colspan="2"> <div>Restricted<br/> Units<br/> (000’s)</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="41%"> <div>Outstanding at January 1, 2016</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="6%"> <div>124</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="6%"> <div>339</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="41%"> <div>Granted</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="6%"> <div>23</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="6%"> <div>313</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="41%"> <div>Exercised</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="6%"> <div>(124)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="6%"> <div>(380)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="41%"> <div>Forfeited</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="6%"> <div></div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="6%"> <div>(6)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="41%"> <div>Outstanding at September 30, 2016</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="6%"> <div>23</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="6%"> <div>266</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt"></div> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>

0.09 124000 380000 0.05

40607000

39887000

2000000

P24M

0.0394

0.0475

1400000

1200000

600000

1652000

2149000

482000

157000

507000 0 No individual item in “Other” above exceeds 5% of the total other current liabilities Amounts reclassified from accumulated other comprehensive loss.

EX-101.SCH 6 staa-20160930.xsd XBRL TAXONOMY EXTENSION SCHEMA 101 - Document - Document And Entity Information link:presentationLink link:definitionLink link:calculationLink 102 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS link:presentationLink link:definitionLink link:calculationLink 103 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) link:presentationLink link:definitionLink link:calculationLink 104 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS link:presentationLink link:definitionLink link:calculationLink 105 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS link:presentationLink link:definitionLink link:calculationLink 106 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS link:presentationLink link:definitionLink link:calculationLink 107 - Disclosure - Basis of Presentation and Significant Accounting Policies link:presentationLink link:definitionLink link:calculationLink 108 - Disclosure - Inventories link:presentationLink link:definitionLink link:calculationLink 109 - Disclosure - Prepayments, Deposits, and Other Current Assets link:presentationLink link:definitionLink link:calculationLink 110 - Disclosure - Property, Plant and Equipment link:presentationLink link:definitionLink link:calculationLink 111 - Disclosure - Intangible Assets link:presentationLink link:definitionLink link:calculationLink 112 - Disclosure - Other Current Liabilities link:presentationLink link:definitionLink link:calculationLink 113 - Disclosure - Defined Benefit Pension Plans link:presentationLink link:definitionLink link:calculationLink 114 - Disclosure - Basic and Diluted Loss Per Share link:presentationLink link:definitionLink link:calculationLink 115 - Disclosure - Geographic and Product Data link:presentationLink link:definitionLink link:calculationLink 116 - Disclosure - Stock-Based Compensation link:presentationLink link:definitionLink link:calculationLink 117 - Disclosure - Income Taxes link:presentationLink link:definitionLink link:calculationLink 118 - Disclosure - Commitments and Contingencies link:presentationLink link:definitionLink link:calculationLink 119 - Disclosure - Basis of Presentation and Significant Accounting Policies (Policies) link:presentationLink link:definitionLink link:calculationLink 120 - Disclosure - Inventories (Tables) link:presentationLink link:definitionLink link:calculationLink 121 - Disclosure - Prepayments, Deposits, and Other Current Assets (Tables) link:presentationLink link:definitionLink link:calculationLink 122 - Disclosure - Property, Plant and Equipment (Tables) link:presentationLink link:definitionLink link:calculationLink 123 - Disclosure - Intangible Assets (Tables) link:presentationLink link:definitionLink link:calculationLink 124 - Disclosure - Other Current Liabilities (Tables) link:presentationLink link:definitionLink link:calculationLink 125 - Disclosure - Defined Benefit Pension Plans (Tables) link:presentationLink link:definitionLink link:calculationLink 126 - Disclosure - Basic and Diluted Loss Per Share (Tables) link:presentationLink link:definitionLink link:calculationLink 127 - Disclosure - Geographic and Product Data (Tables) link:presentationLink link:definitionLink link:calculationLink 128 - Disclosure - Stock-Based Compensation (Tables) link:presentationLink link:definitionLink link:calculationLink 129 - Disclosure - Basis of Presentation and Significant Accounting Policies (Details Textual) link:presentationLink link:definitionLink link:calculationLink 130 - Disclosure - Inventories (Details) link:presentationLink link:definitionLink link:calculationLink 131 - Disclosure - Prepayments, Deposits, and Other Current Assets (Details) link:presentationLink link:definitionLink link:calculationLink 132 - Disclosure - Property, Plant and Equipment (Details) link:presentationLink link:definitionLink link:calculationLink 133 - Disclosure - Intangible Assets (Details) link:presentationLink link:definitionLink link:calculationLink 134 - Disclosure - Other Current Liabilities (Details) link:presentationLink link:definitionLink link:calculationLink 135 - Disclosure - Other Current Liabilities (Details Textual) link:presentationLink link:definitionLink link:calculationLink 136 - Disclosure - Defined Benefit Pension Plans (Details) link:presentationLink link:definitionLink link:calculationLink 137 - Disclosure - Defined Benefit Pension Plans (Details Textual) link:presentationLink link:definitionLink link:calculationLink 138 - Disclosure - Basic and Diluted Loss Per Share (Details) link:presentationLink link:definitionLink link:calculationLink 139 - Disclosure - Basic and Diluted Loss Per Share (Details 1) link:presentationLink link:definitionLink link:calculationLink 140 - Disclosure - Geographic and Product Data (Details) link:presentationLink link:definitionLink link:calculationLink 141 - Disclosure - Geographic and Product Data (Details 1) link:presentationLink link:definitionLink link:calculationLink 142 - Disclosure - Geographic and Product Data (Details Textual) link:presentationLink link:definitionLink link:calculationLink 143 - Disclosure - Stock-Based Compensation (Details) link:presentationLink link:definitionLink link:calculationLink 144 - Disclosure - Stock-Based Compensation (Details 1) link:presentationLink link:definitionLink link:calculationLink 145 - Disclosure - Stock-Based Compensation (Details 2) link:presentationLink link:definitionLink link:calculationLink 146 - Disclosure - Stock-Based Compensation (Details 3) link:presentationLink link:definitionLink link:calculationLink 147 - Disclosure - Stock-Based Compensation (Details 4) link:presentationLink link:definitionLink link:calculationLink 148 - Disclosure - Stock-Based Compensation (Details Textual) link:presentationLink link:definitionLink link:calculationLink 149 - Disclosure - Income Taxes (Details Textual) link:presentationLink link:definitionLink link:calculationLink 150 - Disclosure - Commitments and Contingencies (Details Textual) link:presentationLink link:definitionLink link:calculationLink EX-101.CAL 7 staa-20160930_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 8 staa-20160930_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 9 staa-20160930_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Property, Plant and Equipment [Abstract] Property, Plant and Equipment Disclosure [Text Block] Other Liabilities Disclosure [Abstract] Other Liabilities Disclosure [Text Block] Other Liabilities Disclosure [Text Block] Earnings Per Share [Abstract] Earnings Per Share [Text Block] Earnings Per Share [Text Block] Segment Reporting [Abstract] Segment Reporting Disclosure [Text Block] Segment Reporting Disclosure [Text Block] Disclosure of Compensation Related Costs, Share-based Payments [Abstract] Disclosure of Compensation Related Costs, Share-based Payments [Text Block] Income Tax Disclosure [Abstract] Income Tax Disclosure [Text Block] Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure [Text Block] Statement Of Financial Position [Abstract] Statement [Table] Class of Stock [Axis] Class of Stock [Domain] Statement [Line Items] Assets [Abstract] ASSETS Assets, Current [Abstract] Current assets: Cash and Cash Equivalents, at Carrying Value, Total Cash and cash equivalents Cash and cash equivalents, at beginning of the period Cash and cash equivalents, at end of the period Accounts Receivable, Net, Current, Total Accounts receivable trade, net of allowance for doubtful accounts of $2,039 and $1,877, respectively FIFO Inventory Amount Inventories, net Inventory, Net Prepaid Expenses Deposits and Other Assets Current Prepayments, deposits and other current assets Prepayments, deposits, and other current assets The prepaid amount, deposits and other current assets as of the balance sheet date. Deferred Tax Assets, Net of Valuation Allowance, Current, Total Deferred income taxes Assets, Current, Total Total current assets Property, Plant and Equipment, Net, Total Property, plant and equipment, net Property, plant and equipment, net Intangible Assets, Net (Excluding Goodwill), Total Intangible assets, net Long-lived intangible assets, Net Goodwill Goodwill Deferred Tax Assets, Net of Valuation Allowance, Noncurrent, Total Deferred income taxes Other Assets, Noncurrent Other assets Assets, Total Total assets Liabilities and Equity [Abstract] LIABILITIES AND STOCKHOLDERS’ EQUITY Liabilities [Abstract] Current liabilities: Line Of Credit, Current Line of credit Accounts Payable, Current Accounts payable Deferred Tax Liabilities, Net, Current Deferred income taxes Capital Lease Obligations, Current Obligations under capital leases Other Liabilities, Current Other current liabilities Other current liabilities Liabilities, Current, Total Total current liabilities Capital Lease Obligations, Noncurrent Obligations under capital leases Deferred Tax Liabilities, Net, Noncurrent Deferred income taxes Asset Retirement Obligations, Noncurrent, Total Asset retirement obligations Deferred Rent Credit, Noncurrent Deferred rent Defined Benefit Pension Plan, Liabilities, Noncurrent Pension liability Liabilities, Total Total liabilities Common Stock, Value, Issued Common stock, $0.01 par value; 60,000 shares authorized; 40,607 and 39,887 shares issued and outstanding at September 30, 2016 and January 1, 2016, respectively Additional Paid In Capital, Common Stock Additional paid-in capital Accumulated Other Comprehensive Income (Loss), Net of Tax, Total Accumulated other comprehensive loss Balance Balance Retained Earnings (Accumulated Deficit), Total Accumulated deficit Stockholders Equity Attributable to Parent, Total Total stockholders’ equity Balance Balance Commitments and Contingencies Commitments and contingencies (Note 12) Accounting Policies [Abstract] Basis of Accounting, Policy [Policy Text Block] New Accounting Pronouncements, Policy [Policy Text Block] Inventory Disclosure [Abstract] Schedule Of Inventory, Current [Table Text Block] Schedule of Inventory, Current [Table Text Block] Prepaid Expenses and Other Current Assets Disclosure [Abstract] Prepayments, Deposits, and Other Current Assets Disclosure [Abstract] Property, Plant and Equipment [Table Text Block] Property, Plant and Equipment [Table Text Block] Schedule Of Accrued Liabilities [Table Text Block] Schedule of Accrued Liabilities [Table Text Block] Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Revenue from External Customers by Geographic Areas [Table Text Block] Revenue from External Customers by Geographic Areas [Table Text Block] Revenue From External Customers By Products and Services [Table Text Block] Revenue from External Customers by Products and Services [Table Text Block] Schedule Of Compensation Cost [Table Text Block] Schedule Of Compensation Cost [Table Text Block] Tabular disclosure of compensation cost that has been charged against income. Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table Text Block] Schedule Of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Schedule Of Share-Based Compensation, Stock Options, Activity [Table Text Block] Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block] Allowance for Doubtful Accounts Receivable, Current Common Stock, Par or Stated Value Per Share Common stock, par value (in dollars per share) Common Stock, Shares Authorized Common stock, shares authorized Common Stock, Shares, Issued Common stock, shares issued Common Stock, Shares, Outstanding Common stock, shares outstanding Public Utilities, Inventory [Table] Legal Entity [Axis] Entity [Domain] Inventory [Line Items] Inventory, Raw Materials, Gross Raw materials and purchased parts Inventory, Work in Process, Gross Work-in-process Inventory, Finished Goods, Gross Finished goods Inventory, Gross, Total Inventory, Gross Inventory Valuation Reserves Less: inventory reserves Prepaid Expenses Deposits and Other Current Assets Disclosure [Abstract] Prepayments, Deposits, and Other Current Assets Disclosure [Abstract] Prepaid Expense and Other Assets, Current [Table] Prepayments, Deposits, and Other Current Assets [Table] Prepaid Expense and Other Assets, Current [Line Items] Prepayments, Deposits, and Other Current Assets [Line Items] Line items represents the prepaid expense and other assets current. Prepaid Expense, Current, Total Prepayments and deposits Income Taxes Receivable, Current Income tax receivable Consumption tax receivable It refers amount of consumption tax receivables. Value Added Tax Receivable, Current Value added tax (VAT) receivable Property, Plant and Equipment [Table] Property, Plant and Equipment [Line Items] Machinery and Equipment, Gross Machinery and equipment Furniture and Fixtures, Gross Furniture and fixtures Leasehold Improvements, Gross Leasehold improvements Property, Plant and Equipment, Gross, Total Property, Plant and Equipment, Gross Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Less: accumulated depreciation Goodwill and Intangible Assets Disclosure [Abstract] Schedule of Finite-Lived Intangible Assets [Table] Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets, Major Class Name [Domain] Patents and Licenses [Member] Customer Relationships [Member] Customer relationships [Member] Developed Technology Rights [Member] Developed technology [Member] Finite-Lived Intangible Assets [Line Items] Finite-Lived Intangible Assets, Net [Abstract] Long-lived intangible assets: Finite-Lived Intangible Assets, Gross Long-lived intangible assets, Gross Carrying Amount Finite-Lived Intangible Assets, Accumulated Amortization Long-lived intangible assets, Accumulated Amortization Other Liabilities, Current [Table] Other Liabilities, Current [Line Items] Line items represents the other current liabilities. Accrued Salaries, Current Accrued salaries and wages Accrued Bonuses, Current Accrued bonuses Sales and Excise Tax Payable, Current Consumption tax Accrued Insurance, Current Accrued insurance Accrued Professional Fees, Current Accrued audit fees Class of Warrant or Right [Axis] Class of Warrant or Right [Domain] Percentage Of Other Current Liabilities Represent the percentage of total other current liabilities. Defined Benefit Pension Plans and Defined Benefit Postretirement Plans Disclosure [Abstract] Defined benefit pension plans: Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Table] Defined Benefit Plans and Other Postretirement Benefit Plans [Axis] Defined Benefit Plan and Other Postretirement Benefit Plan [Domain] Defined Benefit Plan, Asset Categories [Axis] Plan Asset Categories [Domain] Fair Value, Hierarchy [Axis] Fair Value Hierarchy [Domain] All Countries [Axis] All Countries [Domain] Swiss Plan [Member] Swiss Plan [Member] Swiss Pension Plan [Member] Age Limitation [Axis] Information of age limitation categories. Age Limitation [Domain] Information of age limitation categories for Differentiate. Range [Axis] Range [Domain] Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] Defined Benefit Plan, Contributions By Employer Defined Benefit Plan, Contributions By Employer Employer contributions Schedule Of Basic And Diluted Income Per Share [Table] Award Type [Axis] Equity Award [Domain] Schedule Of Basic And Diluted Income Per Share [Line Items] Numerator [Abstract] Numerator: Net Income (Loss) Attributable to Parent, Total Net loss Net loss Net loss Net loss Net income (loss) Denominator [Abstract] Denominator: Weighted Average Number of Shares Outstanding, Basic [Abstract] Weighted average common shares and denominator for basic and diluted calculation: Weighted Average Number Of Shares, Common Stock Subject To Repurchase Or Cancellation Weighted average common shares outstanding Incremental Common Shares Attributable to Dilutive Effect of Nonvested Restricted Stock Less: Unvested restricted stock Incremental common shares attributable to dilutive effect of nonvested restricted stock. Weighted Average Number of Shares Outstanding, Basic and Diluted Denominator for basic and diluted calculation Weighted average shares outstanding - basic and diluted (in shares) Income Statement [Abstract] Revenue, Net, Total Net sales Cost of Goods and Services Sold, Total Cost of sales Gross Profit, Total Gross profit Gross profit General and Administrative Expense, Total General and administrative Selling and Marketing Expense, Total Marketing and selling Research and Development Expense, Total Research and development Selling, General and Administrative Expense, Total Total selling, general and administrative expenses Investment Income, Interest Interest income Interest Expense, Total Interest expense Foreign Currency Transaction Gain (Loss), before Tax Gain (loss) on foreign currency transactions Royalty Income, Nonoperating Royalty income Other Nonoperating Income (Expense), Total Other income, net Operating Income (Loss), Total Operating loss Other Income (Expense) Other income (expense): Income (Loss) from Continuing Operations before Income Taxes, Extraordinary Items, Noncontrolling Interest, Total Loss before provision for income taxes Income Tax Expense (Benefit) Provision (benefit) for income taxes Provision (benefit) for income taxes Effective tax provision (benefit) rate Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Antidilutive Securities [Axis] Antidilutive Securities, Name [Domain] Employee Stock Option [Member] Options [Member] Employee stock options [Member] Restricted Stock Units (RSUs) [Member] Restricted stock units [Member] Warrant [Member] Warrants [Member] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Geographic and Product Data [Table] Geographical [Axis] Geographical [Domain] JAPAN Japan [Member] CHINA China [Member] UNITED STATES United States [Member] United States [Member] Other Countries [Member] Other [Member] Geographic And Sales [Line Items] Schedule of Product Information [Table] Products and Services [Axis] Products and Services [Domain] Implantable Collamer Lenses [Member] ICLs [Member] Intraocular Lenses [Member] IOLs [Member] Other Surgical Products [Member] Other surgical products [Member] Customer [Axis] Customer [Domain] Concentration Risk Type [Axis] Concentration Risk Type [Domain] Related Party [Axis] Disclosure On Geographic Areas, Description Of Revenue From External Customers Disclosure on Geographic Areas, Description of Revenue from External Customers EX-101.PRE 10 staa-20160930_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 11 R1.htm IDEA: XBRL DOCUMENT

Document And Entity Information - shares	9 Months Ended
Document And Entity Information - shares	Sep. 30, 2016	Oct. 24, 2016
Document Information [Line Items]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Sep. 30, 2016
Document Fiscal Year Focus	2016
Document Fiscal Period Focus	Q3
Entity Registrant Name	STAAR SURGICAL CO
Entity Central Index Key	0000718937
Current Fiscal Year End Date	--12-30
Entity Filer Category	Accelerated Filer
Trading Symbol	STAA
Entity Common Stock, Shares Outstanding		40,609,093

XML 12 R2.htm IDEA: XBRL DOCUMENT

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Sep. 30, 2016	Jan. 01, 2016
Current assets:
Cash and cash equivalents	$ 14,284	$ 13,402
Accounts receivable trade, net of allowance for doubtful accounts of $2,039 and $1,877, respectively	14,372	15,675
Inventories, net	15,895	15,921
Prepayments, deposits and other current assets	4,649	3,636
Deferred income taxes	518	439
Total current assets	49,718	49,073
Property, plant and equipment, net	11,718	10,095
Intangible assets, net	607	666
Goodwill	1,786	1,786
Deferred income taxes	1,670	717
Other assets	835	617
Total assets	66,334	62,954
Current liabilities:
Line of credit	4,941	4,159
Accounts payable	7,973	6,691
Deferred income taxes	370	370
Obligations under capital leases	398	362
Other current liabilities	7,568	6,305
Total current liabilities	21,250	17,887
Obligations under capital leases	1,676	204
Deferred income taxes	1,005	1,888
Asset retirement obligations	225	156
Deferred rent	68	87
Pension liability	4,380	3,886
Total liabilities	28,604	24,108
Commitments and contingencies (Note 12)
Stockholders' equity:
Common stock, $0.01 par value; 60,000 shares authorized; 40,607 and 39,887 shares issued and outstanding at September 30, 2016 and January 1, 2016, respectively	406	399
Additional paid-in capital	196,411	187,007
Accumulated other comprehensive loss	(145)	(1,580)
Accumulated deficit	(158,942)	(146,980)
Total stockholders’ equity	37,730	38,846
Total liabilities and stockholders’ equity	$ 66,334	$ 62,954

XML 13 R3.htm IDEA: XBRL DOCUMENT

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) shares in Thousands, $ in Thousands	Sep. 30, 2016	Jan. 01, 2016
Allowance for Doubtful Accounts Receivable, Current	$ 2,039	$ 1,877
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common stock, shares authorized	60,000	60,000
Common stock, shares issued	40,607	39,887
Common stock, shares outstanding	40,607	39,887

XML 14 R4.htm IDEA: XBRL DOCUMENT

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2016	Oct. 02, 2015	Sep. 30, 2016	Oct. 02, 2015
Net sales	$ 20,052	$ 18,750	$ 60,295	$ 56,264
Cost of sales	5,180	5,951	17,804	18,206
Gross profit	14,872	12,799	42,491	38,058
General and administrative	4,985	4,853	18,378	14,748
Marketing and selling	7,149	6,284	22,006	17,784
Research and development	4,453	3,684	16,018	10,800
Total selling, general and administrative expenses	16,587	14,821	56,402	43,332
Operating loss	(1,715)	(2,022)	(13,911)	(5,274)
Other income (expense):
Interest income	0	1	1	50
Interest expense	(29)	(29)	(86)	(97)
Gain (loss) on foreign currency transactions	(29)	20	13	(692)
Royalty income	134	224	507	375
Other income, net	(68)	43	(150)	62
Other income (expense), net	8	259	285	(302)
Loss before provision for income taxes	(1,707)	(1,763)	(13,626)	(5,576)
Provision (benefit) for income taxes	71	(11)	(1,664)	114
Net loss	$ (1,778)	$ (1,752)	$ (11,962)	$ (5,690)
Net loss per share - basic and diluted (in dollars per share)	$ (0.04)	$ (0.04)	$ (0.3)	$ (0.14)
Weighted average shares outstanding - basic and diluted (in shares)	40,486	39,727	40,227	39,409

XML 15 R5.htm IDEA: XBRL DOCUMENT

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2016	Oct. 02, 2015	Sep. 30, 2016	Oct. 02, 2015
Net loss	$ (1,778)	$ (1,752)	$ (11,962)	$ (5,690)
Defined benefit pension plans:
Net change in plan assets	(11)	(9)	(34)	(27)
Reclassification into earnings	27	14	80	44
Foreign currency translation gain	232	288	2,000	54
Tax effect	(67)	(99)	(611)	(18)
Other comprehensive income, net of tax	181	194	1,435	53
Comprehensive loss	$ (1,597)	$ (1,558)	$ (10,527)	$ (5,637)

XML 16 R6.htm IDEA: XBRL DOCUMENT

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2016	Oct. 02, 2015
Cash flows from operating activities:
Net loss	$ (11,962)	$ (5,690)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Depreciation of property, plant and equipment	1,933	1,563
Amortization of intangibles	171	154
Deferred income taxes	(1,806)	(148)
Change in net pension liability	390	136
Stock-based compensation expense	8,143	2,747
Provision for sales returns and bad debts	99	331
Changes in working capital:
Accounts receivable	1,707	(2,040)
Inventories, net	1,601	1,497
Prepayments, deposits and other current assets	(1,118)	737
Accounts payable	594	(991)
Other current liabilities	1,104	1,387
Net cash provided by (used in) operating activities	856	(317)
Cash flows from investing activities:
Acquisition of property, plant and equipment	(2,709)	(1,283)
Cash proceeds from sale of property, plant and equipment	65	2
Net cash used in investing activities	(2,644)	(1,281)
Cash flows from financing activities:
Repayment of capital lease obligations	(302)	(306)
Proceeds from sale-leaseback transactions	1,154	0
Repurchase of employee common stock for taxes withheld	(611)	0
Proceeds from exercise of stock options	1,652	2,149
Proceeds from exercise of warrants	0	2,800
Net cash provided by financing activities	1,893	4,643
Effect of exchange rate changes on cash and cash equivalents	777	23
Increase in cash and cash equivalents	882	3,068
Cash and cash equivalents, at beginning of the period	13,402	13,013
Cash and cash equivalents, at end of the period	$ 14,284	$ 16,081

XML 17 R7.htm IDEA: XBRL DOCUMENT

Basis of Presentation and Significant Accounting Policies

9 Months Ended

Sep. 30, 2016

Accounting Policies [Abstract]

Basis of Presentation and Significant Accounting Policies [Text Block]

Note 1 — Basis of Presentation and Significant Accounting Policies

Recent Accounting Pronouncements

Prior Year Reclassifications

XML 18 R8.htm IDEA: XBRL DOCUMENT

Inventories

9 Months Ended

Sep. 30, 2016

Inventory Disclosure [Abstract]

Inventory Disclosure [Text Block]

Note 2 — Inventories

Inventories, net are stated at the lower of cost, determined on a first-in, first-out basis or market value and consisted of the following (in thousands):

	September 30,		January 1,
	2016		2016
Raw materials and purchased parts	$	2,177	$	2,317
Work-in-process		2,099		1,995
Finished goods		15,714		15,058
		19,990		19,370
Less: inventory reserves		4,095		3,449
	$	15,895	$	15,921

XML 19 R9.htm IDEA: XBRL DOCUMENT

Prepayments, Deposits, and Other Current Assets

9 Months Ended

Sep. 30, 2016

Prepaid Expenses Deposits and Other Current Assets Disclosure [Abstract]

Prepayments, Deposits, and Other Current Assets Disclosure [Text Block]

Note 3 — Prepayments, Deposits, and Other Current Assets

Prepayments, deposits, and other current assets consisted of the following (in thousands):

	September 30,		January 1,
	2016		2016
Prepayments and deposits	$	2,052	$	1,386
Income tax receivable		626		597
Consumption tax receivable		507		—
Value added tax (VAT) receivable		658		724
Deferred charges for foreign profits		182		182
Other current assets		624		747
	$	4,649	$	3,636

XML 20 R10.htm IDEA: XBRL DOCUMENT

Property, Plant and Equipment

9 Months Ended

Sep. 30, 2016

Property, Plant and Equipment [Abstract]

Property, Plant and Equipment Disclosure [Text Block]

Note 4 — Property, Plant and Equipment

Property, plant and equipment, net consisted of the following (in thousands):

	September 30,		January 1,
	2016		2016
Machinery and equipment	$	18,934	$	17,094
Furniture and fixtures		8,255		6,980
Leasehold improvements		9,238		8,611
		36,427		32,685
Less: accumulated depreciation		24,709		22,590
	$	11,718	$	10,095

XML 21 R11.htm IDEA: XBRL DOCUMENT

Intangible Assets

9 Months Ended

Sep. 30, 2016

Goodwill and Intangible Assets Disclosure [Abstract]

Intangible Assets Disclosure [Text Block]

Note 5 –Intangible Assets

Intangible assets, net consisted of the following (in thousands):

	September 30, 2016						January 1, 2016
	Gross						Gross
	Carrying		Accumulated				Carrying		Accumulated
	Amount		Amortization		Net		Amount		Amortization		Net
Intangible assets:
Patents and licenses	$	9,312	$	(8,965)	$	347	$	9,207	$	(8,891)	$	316
Customer relationships		1,550		(1,356)		194		1,305		(1,044)		261
Developed technology		985		(919)		66		829		(740)		89
Total	$	11,847	$	(11,240)	$	607	$	11,341	$	(10,675)	$	666

XML 22 R12.htm IDEA: XBRL DOCUMENT

Other Current Liabilities

9 Months Ended

Sep. 30, 2016

Other Liabilities Disclosure [Abstract]

Other Liabilities Disclosure [Text Block]

Note 6 – Other Current Liabilities

Other current liabilities consisted of the following (in thousands):

	September 30, 2016		January 1, 2016
Accrued salaries and wages	$	2,452	$	1,909
Accrued bonuses		2,027		2,114
Consumption tax		482		157
Accrued insurance		144		540
Accrued audit fees		412		314
Other⁽¹⁾		2,051		1,271
	$	7,568	$	6,305

⁽¹⁾ No individual item in “Other” above exceeds 5% of the total other current liabilities

XML 23 R13.htm IDEA: XBRL DOCUMENT

Defined Benefit Pension Plans

9 Months Ended

Sep. 30, 2016

Defined Benefit Pension Plans and Defined Benefit Postretirement Plans Disclosure [Abstract]

Pension and Other Postretirement Benefits Disclosure [Text Block]

Note 7 – Defined Benefit Pension Plans

The Company has defined benefit plans covering employees of its Switzerland and Japan operations.

The following table summarizes the components of net periodic pension cost recorded for the Company’s defined benefit pension plans (in thousands):

	Three Months Ended				Nine Months Ended
	September 30, 2016		October 2, 2015		September 30, 2016		October 2, 2015
Service cost	$	155	$	108	$	466	$	322
Interest cost		19		19		54		57
Expected return on plan assets		(24)		(22)		(69)		(64)
Net amortization of transitional obligation (a)		3		3		10		8
Actuarial loss recognized in current period (a)		24		11		70		36
Total	$	177	$	119	$	531	$	359

(a) Amounts reclassified from accumulated other comprehensive loss.

XML 24 R14.htm IDEA: XBRL DOCUMENT

Basic and Diluted Loss Per Share

9 Months Ended

Sep. 30, 2016

Earnings Per Share [Abstract]

Earnings Per Share [Text Block]

Note 8 — Basic and Diluted Loss Per Share

The following table sets forth the computation of basic and diluted net loss per share (in thousands except per share amounts):

	Three Months Ended				Nine Months Ended
	September 30, 2016		October 2, 2015		September 30, 2016		October 2, 2015
Numerator:
Net loss	$	(1,778)	$	(1,752)	$	(11,962)	$	(5,690)

Denominator:
Weighted average common shares and denominator for basic and diluted calculation:
Weighted average common shares outstanding		40,501		39,851		40,242		39,533
Less: Unvested restricted stock		(15)		(124)		(15)		(124)
Denominator for basic and diluted calculation		40,486		39,727		40,227		39,409

Net loss per share – basic and diluted	$	(0.04)	$	(0.04)	$	(0.30)	$	(0.14)

	Three Months Ended				Nine Months Ended
	September 30, 2016		October 2, 2015		September 30, 2016		October 2, 2015
Options		2,134		2,615		2,937		2,446
Restricted stock and units		60		124		48		193
Warrants		—		—		—		345
Total		2,194		2,739		2,985		2,984

XML 25 R15.htm IDEA: XBRL DOCUMENT

Geographic and Product Data

9 Months Ended

Sep. 30, 2016

Segment Reporting [Abstract]

Segment Reporting Disclosure [Text Block]

Note 9 — Geographic and Product Data

	Three Months Ended				Nine Months Ended
	September 30,		October 2,		September 30,		October 2,
	2016		2015		2016		2015
Japan	$	4,029	$	4,249	$	12,258	$	12,514
China		4,254		3,095		11,749		8,794
United States		2,419		2,873		7,355		8,464
Other		9,350		8,533		28,933		26,492
Total	$	20,052	$	18,750	$	60,295	$	56,264

	Three Months Ended				Nine Months Ended
	September 30,		October 2,		September 30,		October 2,
	2016		2015		2016		2015
ICLs	$	14,801	$	12,907	$	43,389	$	37,396
IOLs		4,649		4,390		14,783		14,952
Other surgical products		602		1,453		2,123		3,916
Total	$	20,052	$	18,750	$	60,295	$	56,264

- Definition

The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 34
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8981-108599

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 41
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e9038-108599

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 33
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8971-108599

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8595-108599

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8380-108599

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8933-108599

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 26
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8844-108599

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 35
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8984-108599

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 40
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e9031-108599

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 42
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e9054-108599

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8538-108599

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 29
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8864-108599

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8924-108599

Reference 14: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8906-108599

+ Details

XML 26 R16.htm IDEA: XBRL DOCUMENT

Stock-Based Compensation

9 Months Ended

Sep. 30, 2016

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Disclosure of Compensation Related Costs, Share-based Payments [Text Block]

Note 10 — Stock-Based Compensation

The cost that has been charged against income for stock-based compensation is set forth below (in thousands):

	Three Months Ended				Nine Months Ended
	September 30, 2016		October 2, 2015		September 30, 2016		October 2, 2015
Employee stock options	$	208	$	625	$	5,257	$	1,818
Restricted stock		32		88		259		396
Restricted stock units		146		210		2,569		484
Nonemployee stock options		—		—		58		49
Total	$	386	$	923	$	8,143	$	2,747

The Company recorded stock-based compensation costs in the following categories on the accompanying condensed consolidated statements of operations (in thousands):

	Three Months Ended				Nine Months Ended
	September 30, 2016		October 2, 2015		September 30, 2016		October 2, 2015
Cost of sales	$	—	$	9	$	560	$	33
General and administrative		248		543		3,936		1,667
Marketing and selling		72		184		1,544		539
Research and development		66		187		2,103		508
Total stock compensation expense		386		923		8,143		2,747
Amounts capitalized as part of inventory		39		130		227		258
Total	$	425	$	1,053	$	8,370	$	3,005

Stock Option Plan

Immediate Vesting of All Unvested Equity Awards

Assumptions

	Three Months Ended						Nine Months Ended
	September 30, 2016			October 2, 2015			September 30, 2016			October 2, 2015
Expected dividend yield		0	%		0	%		0	%		0	%
Expected volatility		57	%		58	%		57	%		57	%
Risk-free interest rate		1.19	%		1.60	%		1.34	%		1.61	%
Expected term (in years)		5.57			5.62			5.57			5.61

A summary of option activity under the Plan for the nine-month period ended September 30, 2016 is presented below:

	Options Shares (000’s)
Outstanding at January 1, 2016		3,623
Granted		761
Exercised		(424)
Forfeited or expired		(346)
Outstanding at September 30, 2016		3,614
Exercisable at September 30, 2016		2,968

A summary of restricted stock and restricted stock unit’s activity under the Plan for the nine-month period ended September 30, 2016 is presented below:

	Restricted Shares (000’s)		Restricted Units (000’s)
Outstanding at January 1, 2016		124		339
Granted		23		313
Exercised		(124)		(380)
Forfeited		—		(6)
Outstanding at September 30, 2016		23		266

- Definition

The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details.

+ References + Details

XML 27 R17.htm IDEA: XBRL DOCUMENT

Income Taxes

9 Months Ended

Sep. 30, 2016

Income Tax Disclosure [Abstract]

Income Tax Disclosure [Text Block]

Note 11 — Income Taxes

XML 28 R18.htm IDEA: XBRL DOCUMENT

Commitments and Contingencies

9 Months Ended

Sep. 30, 2016

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies Disclosure [Text Block]

Note 12 - Commitments and Contingencies

Lines of Credit and Guarantee

Covenant Compliance

The Company believes it is in compliance with the covenants of its credit facilities as of the date of this report.

Litigation and Claims

Stockholder Securities Litigation: Todd Action

Stockholder Derivative Litigation: Forestal Action

Employment Agreements

XML 29 R19.htm IDEA: XBRL DOCUMENT

Basis of Presentation and Significant Accounting Policies (Policies)

9 Months Ended

Sep. 30, 2016

Accounting Policies [Abstract]

Basis of Accounting, Policy [Policy Text Block]

New Accounting Pronouncements, Policy [Policy Text Block]

Recent Accounting Pronouncements

Reclassification, Policy [Policy Text Block]

Prior Year Reclassifications

XML 30 R20.htm IDEA: XBRL DOCUMENT

Inventories (Tables)

9 Months Ended

Sep. 30, 2016

Inventory Disclosure [Abstract]

Schedule of Inventory, Current [Table Text Block]

Inventories, net are stated at the lower of cost, determined on a first-in, first-out basis or market value and consisted of the following (in thousands):

	September 30,		January 1,
	2016		2016
Raw materials and purchased parts	$	2,177	$	2,317
Work-in-process		2,099		1,995
Finished goods		15,714		15,058
		19,990		19,370
Less: inventory reserves		4,095		3,449
	$	15,895	$	15,921

XML 31 R21.htm IDEA: XBRL DOCUMENT

Prepayments, Deposits, and Other Current Assets (Tables)

9 Months Ended

Sep. 30, 2016

Prepaid Expenses and Other Current Assets Disclosure [Abstract]

Schedule Of Prepayments, Deposits, and Other Current Assets Disclosure [Table Text Block]

Prepayments, deposits, and other current assets consisted of the following (in thousands):

	September 30,		January 1,
	2016		2016
Prepayments and deposits	$	2,052	$	1,386
Income tax receivable		626		597
Consumption tax receivable		507		—
Value added tax (VAT) receivable		658		724
Deferred charges for foreign profits		182		182
Other current assets		624		747
	$	4,649	$	3,636

XML 32 R22.htm IDEA: XBRL DOCUMENT

Property, Plant and Equipment (Tables)

9 Months Ended

Sep. 30, 2016

Property, Plant and Equipment [Abstract]

Property, Plant and Equipment [Table Text Block]

Property, plant and equipment, net consisted of the following (in thousands):

	September 30,		January 1,
	2016		2016
Machinery and equipment	$	18,934	$	17,094
Furniture and fixtures		8,255		6,980
Leasehold improvements		9,238		8,611
		36,427		32,685
Less: accumulated depreciation		24,709		22,590
	$	11,718	$	10,095

XML 33 R23.htm IDEA: XBRL DOCUMENT

Intangible Assets (Tables)

9 Months Ended

Sep. 30, 2016

Goodwill and Intangible Assets Disclosure [Abstract]

Schedule of Finite-Lived Intangible Assets [Table Text Block]

Intangible assets, net consisted of the following (in thousands):

	September 30, 2016						January 1, 2016
	Gross						Gross
	Carrying		Accumulated				Carrying		Accumulated
	Amount		Amortization		Net		Amount		Amortization		Net
Intangible assets:
Patents and licenses	$	9,312	$	(8,965)	$	347	$	9,207	$	(8,891)	$	316
Customer relationships		1,550		(1,356)		194		1,305		(1,044)		261
Developed technology		985		(919)		66		829		(740)		89
Total	$	11,847	$	(11,240)	$	607	$	11,341	$	(10,675)	$	666

XML 34 R24.htm IDEA: XBRL DOCUMENT

Other Current Liabilities (Tables)

9 Months Ended

Sep. 30, 2016

Other Liabilities Disclosure [Abstract]

Schedule of Accrued Liabilities [Table Text Block]

Other current liabilities consisted of the following (in thousands):

	September 30, 2016		January 1, 2016
Accrued salaries and wages	$	2,452	$	1,909
Accrued bonuses		2,027		2,114
Consumption tax		482		157
Accrued insurance		144		540
Accrued audit fees		412		314
Other⁽¹⁾		2,051		1,271
	$	7,568	$	6,305

⁽¹⁾ No individual item in “Other” above exceeds 5% of the total other current liabilities

XML 35 R25.htm IDEA: XBRL DOCUMENT

Defined Benefit Pension Plans (Tables)

9 Months Ended

Sep. 30, 2016

Defined Benefit Pension Plans and Defined Benefit Postretirement Plans Disclosure [Abstract]

Schedule of Net Benefit Costs [Table Text Block]

The following table summarizes the components of net periodic pension cost recorded for the Company’s defined benefit pension plans (in thousands):

	Three Months Ended				Nine Months Ended
	September 30, 2016		October 2, 2015		September 30, 2016		October 2, 2015
Service cost	$	155	$	108	$	466	$	322
Interest cost		19		19		54		57
Expected return on plan assets		(24)		(22)		(69)		(64)
Net amortization of transitional obligation (a)		3		3		10		8
Actuarial loss recognized in current period (a)		24		11		70		36
Total	$	177	$	119	$	531	$	359

(a) Amounts reclassified from accumulated other comprehensive loss.

XML 36 R26.htm IDEA: XBRL DOCUMENT

Basic and Diluted Loss Per Share (Tables)

9 Months Ended

Sep. 30, 2016

Earnings Per Share [Abstract]

Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]

The following table sets forth the computation of basic and diluted net loss per share (in thousands except per share amounts):

	Three Months Ended				Nine Months Ended
	September 30, 2016		October 2, 2015		September 30, 2016		October 2, 2015
Numerator:
Net loss	$	(1,778)	$	(1,752)	$	(11,962)	$	(5,690)

Denominator:
Weighted average common shares and denominator for basic and diluted calculation:
Weighted average common shares outstanding		40,501		39,851		40,242		39,533
Less: Unvested restricted stock		(15)		(124)		(15)		(124)
Denominator for basic and diluted calculation		40,486		39,727		40,227		39,409

Net loss per share – basic and diluted	$	(0.04)	$	(0.04)	$	(0.30)	$	(0.14)

Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]

	Three Months Ended				Nine Months Ended
	September 30, 2016		October 2, 2015		September 30, 2016		October 2, 2015
Options		2,134		2,615		2,937		2,446
Restricted stock and units		60		124		48		193
Warrants		—		—		—		345
Total		2,194		2,739		2,985		2,984

XML 37 R27.htm IDEA: XBRL DOCUMENT

Geographic and Product Data (Tables)

9 Months Ended

Sep. 30, 2016

Segment Reporting [Abstract]

Revenue from External Customers by Geographic Areas [Table Text Block]

The composition of the Company’s net sales to unaffiliated customers is set forth below (in thousands):

	Three Months Ended				Nine Months Ended
	September 30,		October 2,		September 30,		October 2,
	2016		2015		2016		2015
Japan	$	4,029	$	4,249	$	12,258	$	12,514
China		4,254		3,095		11,749		8,794
United States		2,419		2,873		7,355		8,464
Other		9,350		8,533		28,933		26,492
Total	$	20,052	$	18,750	$	60,295	$	56,264

Revenue from External Customers by Products and Services [Table Text Block]

The composition of the Company’s net sales by product line is as follows (in thousands):

	Three Months Ended				Nine Months Ended
	September 30,		October 2,		September 30,		October 2,
	2016		2015		2016		2015
ICLs	$	14,801	$	12,907	$	43,389	$	37,396
IOLs		4,649		4,390		14,783		14,952
Other surgical products		602		1,453		2,123		3,916
Total	$	20,052	$	18,750	$	60,295	$	56,264

XML 38 R28.htm IDEA: XBRL DOCUMENT

Stock-Based Compensation (Tables)

9 Months Ended

Sep. 30, 2016

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Schedule Of Compensation Cost [Table Text Block]

The cost that has been charged against income for stock-based compensation is set forth below (in thousands):

	Three Months Ended				Nine Months Ended
	September 30, 2016		October 2, 2015		September 30, 2016		October 2, 2015
Employee stock options	$	208	$	625	$	5,257	$	1,818
Restricted stock		32		88		259		396
Restricted stock units		146		210		2,569		484
Nonemployee stock options		—		—		58		49
Total	$	386	$	923	$	8,143	$	2,747

Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table Text Block]

The Company recorded stock-based compensation costs in the following categories on the accompanying condensed consolidated statements of operations (in thousands):

	Three Months Ended				Nine Months Ended
	September 30, 2016		October 2, 2015		September 30, 2016		October 2, 2015
Cost of sales	$	—	$	9	$	560	$	33
General and administrative		248		543		3,936		1,667
Marketing and selling		72		184		1,544		539
Research and development		66		187		2,103		508
Total stock compensation expense		386		923		8,143		2,747
Amounts capitalized as part of inventory		39		130		227		258
Total	$	425	$	1,053	$	8,370	$	3,005

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]

The risk-free rate is based on the U.S. Treasury yield curve corresponding to the expected term at the time of the grant.

	Three Months Ended						Nine Months Ended
	September 30, 2016			October 2, 2015			September 30, 2016			October 2, 2015
Expected dividend yield		0	%		0	%		0	%		0	%
Expected volatility		57	%		58	%		57	%		57	%
Risk-free interest rate		1.19	%		1.60	%		1.34	%		1.61	%
Expected term (in years)		5.57			5.62			5.57			5.61

Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]

A summary of option activity under the Plan for the nine-month period ended September 30, 2016 is presented below:

	Options Shares (000’s)
Outstanding at January 1, 2016		3,623
Granted		761
Exercised		(424)
Forfeited or expired		(346)
Outstanding at September 30, 2016		3,614
Exercisable at September 30, 2016		2,968

Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity [Table Text Block]

A summary of restricted stock and restricted stock unit’s activity under the Plan for the nine-month period ended September 30, 2016 is presented below:

	Restricted Shares (000’s)		Restricted Units (000’s)
Outstanding at January 1, 2016		124		339
Granted		23		313
Exercised		(124)		(380)
Forfeited		—		(6)
Outstanding at September 30, 2016		23		266

XML 39 R29.htm IDEA: XBRL DOCUMENT

Basis of Presentation and Significant Accounting Policies (Details Textual) - USD ($)	3 Months Ended	9 Months Ended
	Oct. 02, 2015	Oct. 02, 2015
Royalty Income [Member]
Prior Period Reclassification Adjustment	$ 224,000	$ 375,000

XML 40 R30.htm IDEA: XBRL DOCUMENT

Inventories (Details) - USD ($) $ in Thousands	Sep. 30, 2016	Jan. 01, 2016
Inventory [Line Items]
Raw materials and purchased parts	$ 2,177	$ 2,317
Work-in-process	2,099	1,995
Finished goods	15,714	15,058
Inventory, Gross	19,990	19,370
Less: inventory reserves	4,095	3,449
Inventory, Net	$ 15,895	$ 15,921

XML 41 R31.htm IDEA: XBRL DOCUMENT

Prepayments, Deposits, and Other Current Assets (Details) - USD ($) $ in Thousands	Sep. 30, 2016	Jan. 01, 2016
Prepayments, Deposits, and Other Current Assets [Line Items]
Prepayments and deposits	$ 2,052	$ 1,386
Income tax receivable	626	597
Consumption tax receivable	507	0
Value added tax (VAT) receivable	658	724
Deferred charges for foreign profits	182	182
Other current assets	624	747
Prepayments, deposits, and other current assets	$ 4,649	$ 3,636

XML 42 R32.htm IDEA: XBRL DOCUMENT

Property, Plant and Equipment (Details) - USD ($) $ in Thousands	Sep. 30, 2016	Jan. 01, 2016
Property, Plant and Equipment [Line Items]
Machinery and equipment	$ 18,934	$ 17,094
Furniture and fixtures	8,255	6,980
Leasehold improvements	9,238	8,611
Property, Plant and Equipment, Gross	36,427	32,685
Less: accumulated depreciation	24,709	22,590
Property, plant and equipment, net	$ 11,718	$ 10,095

XML 43 R33.htm IDEA: XBRL DOCUMENT

Intangible Assets (Details) - USD ($) $ in Thousands	Sep. 30, 2016	Jan. 01, 2016
Long-lived intangible assets:
Long-lived intangible assets, Gross Carrying Amount	$ 11,847	$ 11,341
Long-lived intangible assets, Accumulated Amortization	(11,240)	(10,675)
Long-lived intangible assets, Net	607	666
Patents and Licenses [Member]
Long-lived intangible assets:
Long-lived intangible assets, Gross Carrying Amount	9,312	9,207
Long-lived intangible assets, Accumulated Amortization	(8,965)	(8,891)
Long-lived intangible assets, Net	347	316
Customer relationships [Member]
Long-lived intangible assets:
Long-lived intangible assets, Gross Carrying Amount	1,550	1,305
Long-lived intangible assets, Accumulated Amortization	(1,356)	(1,044)
Long-lived intangible assets, Net	194	261
Developed technology [Member]
Long-lived intangible assets:
Long-lived intangible assets, Gross Carrying Amount	985	829
Long-lived intangible assets, Accumulated Amortization	(919)	(740)
Long-lived intangible assets, Net	$ 66	$ 89

XML 44 R34.htm IDEA: XBRL DOCUMENT

Other Current Liabilities (Details) - USD ($)
$ in Thousands

Sep. 30, 2016

Jan. 01, 2016

Other Liabilities, Current [Line Items]

Accrued salaries and wages

$ 2,452

$ 1,909

Accrued bonuses

2,027

2,114

Consumption tax

482

157

Accrued insurance

144

540

Accrued audit fees

412

314

Other

^[1]

2,051

1,271

Other current liabilities

$ 7,568

$ 6,305

[1]	No individual item in “Other” above exceeds 5% of the total other current liabilities

XML 45 R35.htm IDEA: XBRL DOCUMENT

Other Current Liabilities (Details Textual)	9 Months Ended
Other Current Liabilities (Details Textual)	Sep. 30, 2016
Other Liabilities, Current [Line Items]
Percentage Of Other Current Liabilities	5.00%

XML 46 R36.htm IDEA: XBRL DOCUMENT

Defined Benefit Pension Plans (Details) - USD ($)
$ in Thousands

3 Months Ended

9 Months Ended

Sep. 30, 2016

Oct. 02, 2015

Sep. 30, 2016

Oct. 02, 2015

Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]

Service cost

$ 155

$ 108

$ 466

$ 322

Interest cost

Expected return on plan assets

(24)

(22)

(69)

(64)

Net amortization of transitional obligation

^[1]

Actuarial loss recognized in current period

^[1]

Total

$ 177

$ 119

$ 531

$ 359

[1]	Amounts reclassified from accumulated other comprehensive loss.

XML 47 R37.htm IDEA: XBRL DOCUMENT

Defined Benefit Pension Plans (Details Textual) - USD ($)	9 Months Ended
	Sep. 30, 2016	Oct. 02, 2015
Swiss Pension Plan [Member]
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Defined Benefit Plan, Contributions By Employer	$ 419,000	$ 400,000

XML 48 R38.htm IDEA: XBRL DOCUMENT

Basic and Diluted Loss Per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2016	Oct. 02, 2015	Sep. 30, 2016	Oct. 02, 2015
Numerator:
Net loss	$ (1,778)	$ (1,752)	$ (11,962)	$ (5,690)
Weighted average common shares and denominator for basic and diluted calculation:
Weighted average common shares outstanding	40,501	39,851	40,242	39,533
Less: Unvested restricted stock	(15)	(124)	(15)	(124)
Denominator for basic and diluted calculation	40,486	39,727	40,227	39,409
Net loss per share - basic and diluted (in dollars per share)	$ (0.04)	$ (0.04)	$ (0.3)	$ (0.14)

XML 49 R39.htm IDEA: XBRL DOCUMENT

Basic and Diluted Loss Per Share (Details 1) - shares shares in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2016	Oct. 02, 2015	Sep. 30, 2016	Oct. 02, 2015
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	2,194	2,739	2,985	2,984
Options [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	2,134	2,615	2,937	2,446
Restricted Stock Units (RSUs) [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	60	124	48	193
Warrants [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	0	0	0	345

XML 50 R40.htm IDEA: XBRL DOCUMENT

Geographic and Product Data (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2016	Oct. 02, 2015	Sep. 30, 2016	Oct. 02, 2015
Geographic And Sales [Line Items]
Net sales	$ 20,052	$ 18,750	$ 60,295	$ 56,264
Japan [Member]
Geographic And Sales [Line Items]
Net sales	4,029	4,249	12,258	12,514
China [Member]
Geographic And Sales [Line Items]
Net sales	4,254	3,095	11,749	8,794
United States [Member]
Geographic And Sales [Line Items]
Net sales	2,419	2,873	7,355	8,464
Other [Member]
Geographic And Sales [Line Items]
Net sales	$ 9,350	$ 8,533	$ 28,933	$ 26,492

XML 51 R41.htm IDEA: XBRL DOCUMENT

Geographic and Product Data (Details 1) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2016	Oct. 02, 2015	Sep. 30, 2016	Oct. 02, 2015
Product Information [Line Items]
Net sales	$ 20,052	$ 18,750	$ 60,295	$ 56,264
ICLs [Member]
Product Information [Line Items]
Net sales	14,801	12,907	43,389	37,396
IOLs [Member]
Product Information [Line Items]
Net sales	4,649	4,390	14,783	14,952
Other surgical products [Member]
Product Information [Line Items]
Net sales	$ 602	$ 1,453	$ 2,123	$ 3,916

XML 52 R42.htm IDEA: XBRL DOCUMENT

Geographic and Product Data (Details Textual)	3 Months Ended		9 Months Ended		12 Months Ended
Geographic and Product Data (Details Textual)	Sep. 30, 2016	Oct. 02, 2015	Sep. 30, 2016	Oct. 02, 2015	Jan. 01, 2016
Geographic and Product Data [Line Items]
Disclosure on Geographic Areas, Description of Revenue from External Customers			The Company markets and sells its products in over 60 countries and has manufacturing sites in the United States. Other than Japan, China, and the United States, the Company does not conduct business in any country in which its sales exceed 10% of consolidated sales.
Number of Countries in which Entity Operates	60		60
Sales Exceed Percentage			10.00%
Customer One [Member] \| Accounts Receivable [Member]
Geographic and Product Data [Line Items]
Concentration Risk, Percentage					24.00%
Customer One [Member] \| Sales Revenue, Net [Member]
Geographic and Product Data [Line Items]
Concentration Risk, Percentage	21.00%	16.00%	19.00%	14.00%
Customer Two [Member] \| Accounts Receivable [Member] \| CHINA
Geographic and Product Data [Line Items]
Concentration Risk, Percentage			20.00%
Customer Two [Member] \| Accounts Receivable [Member] \| KOREA, REPUBLIC OF
Geographic and Product Data [Line Items]
Concentration Risk, Percentage			11.00%

XML 53 R43.htm IDEA: XBRL DOCUMENT

Stock-Based Compensation (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
Stock-Based Compensation (Details) - USD ($) $ in Thousands	Sep. 30, 2016	Oct. 02, 2015	Sep. 30, 2016	Oct. 02, 2015
Schedule of Employee Service Share-based Compensation [Line Items]
Share-based Compensation	$ 386	$ 923	$ 8,143	$ 2,747
Employee stock options [Member]
Schedule of Employee Service Share-based Compensation [Line Items]
Share-based Compensation	208	625	5,257	1,818
Restricted stock [Member]
Schedule of Employee Service Share-based Compensation [Line Items]
Share-based Compensation	32	88	259	396
Restricted stock units [Member]
Schedule of Employee Service Share-based Compensation [Line Items]
Share-based Compensation	146	210	2,569	484
Nonemployee stock options [Member]
Schedule of Employee Service Share-based Compensation [Line Items]
Share-based Compensation	$ 0	$ 0	$ 58	$ 49

XML 54 R44.htm IDEA: XBRL DOCUMENT

Stock-Based Compensation (Details 1) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2016	Oct. 02, 2015	Sep. 30, 2016	Oct. 02, 2015
Schedule of Employee Service Share-based Compensation [Line Items]
Allocated Share-based Compensation Expense	$ 386	$ 923	$ 8,143	$ 2,747
Amounts capitalized as part of inventory	39	130	227	258
Total	425	1,053	8,370	3,005
Cost of Sales [Member]
Schedule of Employee Service Share-based Compensation [Line Items]
Allocated Share-based Compensation Expense	0	9	560	33
General and administrative [Member]
Schedule of Employee Service Share-based Compensation [Line Items]
Allocated Share-based Compensation Expense	248	543	3,936	1,667
Marketing and selling [Member]
Schedule of Employee Service Share-based Compensation [Line Items]
Allocated Share-based Compensation Expense	72	184	1,544	539
Research and development [Member]
Schedule of Employee Service Share-based Compensation [Line Items]
Allocated Share-based Compensation Expense	$ 66	$ 187	$ 2,103	$ 508

XML 55 R45.htm IDEA: XBRL DOCUMENT

Stock-Based Compensation (Details 2)	3 Months Ended		9 Months Ended
Stock-Based Compensation (Details 2)	Sep. 30, 2016	Oct. 02, 2015	Sep. 30, 2016	Oct. 02, 2015
Schedule of Employee Service Share-based Compensation [Line Items]
Expected dividend yield	0.00%	0.00%	0.00%	0.00%
Expected volatility	57.00%	58.00%	57.00%	57.00%
Risk-free interest rate	1.19%	1.60%	1.34%	1.61%
Expected term (in years)	5 years 6 months 25 days	5 years 7 months 13 days	5 years 6 months 25 days	5 years 7 months 10 days

XML 56 R46.htm IDEA: XBRL DOCUMENT

Stock-Based Compensation (Details 3) shares in Thousands	9 Months Ended
Stock-Based Compensation (Details 3) shares in Thousands	Sep. 30, 2016 shares
Schedule of Employee Service Share-based Compensation [Line Items]
Options,Outstanding at January 1, 2016	3,623
Options, Granted, Shares	761
Options, Exercised, Shares	(424)
Options, Forfeited or expired, Shares	(346)
Options,Outstanding at September 30, 2016	3,614
Options,Exercisable at September 30, 2016	2,968

XML 57 R47.htm IDEA: XBRL DOCUMENT

Stock-Based Compensation (Details 4) shares in Thousands	9 Months Ended
Stock-Based Compensation (Details 4) shares in Thousands	Sep. 30, 2016 shares
Restricted Stock [Member]
Outstanding at January 1, 2016	124
Granted	23
Exercised	(124)
Forfeited	0
Outstanding at September 30, 2016	23
Restricted Stock Units (RSUs) [Member]
Outstanding at January 1, 2016	339
Granted	313
Exercised	(380)
Forfeited	(6)
Outstanding at September 30, 2016	266

XML 58 R48.htm IDEA: XBRL DOCUMENT

Stock-Based Compensation (Details Textual) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2016	Oct. 02, 2015	Sep. 30, 2016	Oct. 02, 2015	Feb. 11, 2016	Jan. 01, 2016
Schedule of Employee Service Share-based Compensation [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding	3,614,000		3,614,000			3,623,000
Estimated Forfeiture Rate			9.00%
Allocated Share-based Compensation Expense	$ 386	$ 923	$ 8,143	$ 2,747
Beneficial Ownership Percentage of Investor					26.00%
General and Administrative Expense [Member]
Schedule of Employee Service Share-based Compensation [Line Items]
Allocated Share-based Compensation Expense	248	543	3,936	1,667
Selling and Marketing Expense [Member]
Schedule of Employee Service Share-based Compensation [Line Items]
Allocated Share-based Compensation Expense	72	184	1,544	539
Research and Development Expense [Member]
Schedule of Employee Service Share-based Compensation [Line Items]
Allocated Share-based Compensation Expense	66	187	2,103	508
Cost of Sales [Member]
Schedule of Employee Service Share-based Compensation [Line Items]
Allocated Share-based Compensation Expense	$ 0	$ 9	$ 560	$ 33
Maximum [Member]
Schedule of Employee Service Share-based Compensation [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price, Beginning Balance	$ 17.62		$ 17.62
Minimum [Member]
Schedule of Employee Service Share-based Compensation [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price, Beginning Balance	$ 0.95		$ 0.95
Restricted Stock [Member]
Schedule of Employee Service Share-based Compensation [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding	23,140		23,140
Restricted Stock Units (RSUs) [Member]
Schedule of Employee Service Share-based Compensation [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding	266,050		266,050
Omnibus Plan [Member]
Schedule of Employee Service Share-based Compensation [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period			10 years
Omnibus Plan [Member] \| Restricted Stock [Member]
Schedule of Employee Service Share-based Compensation [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant	2,222,972		2,222,972
Omnibus Equity Incentive Plan 2003 [Member]
Schedule of Employee Service Share-based Compensation [Line Items]
Allocated Share-based Compensation Expense			$ 6,900
Share-based Compensation Arrangement by Share-based Payment Award Accelerated Compensation Cost			3,700
Omnibus Equity Incentive Plan 2003 [Member] \| General and Administrative Expense [Member]
Schedule of Employee Service Share-based Compensation [Line Items]
Allocated Share-based Compensation Expense			2,900
Omnibus Equity Incentive Plan 2003 [Member] \| Selling and Marketing Expense [Member]
Schedule of Employee Service Share-based Compensation [Line Items]
Allocated Share-based Compensation Expense			1,500
Omnibus Equity Incentive Plan 2003 [Member] \| Research and Development Expense [Member]
Schedule of Employee Service Share-based Compensation [Line Items]
Allocated Share-based Compensation Expense			1,900
Omnibus Equity Incentive Plan 2003 [Member] \| Cost of Sales [Member]
Schedule of Employee Service Share-based Compensation [Line Items]
Allocated Share-based Compensation Expense			600
Omnibus Equity Incentive Plan 2003 [Member] \| Employee Stock Option [Member]
Schedule of Employee Service Share-based Compensation [Line Items]
Allocated Share-based Compensation Expense			4,600
Omnibus Equity Incentive Plan 2003 [Member] \| Restricted Stock And Restricted Stock Units [Member]
Schedule of Employee Service Share-based Compensation [Line Items]
Allocated Share-based Compensation Expense			$ 2,300

XML 59 R49.htm IDEA: XBRL DOCUMENT

Income Taxes (Details Textual) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
Income Taxes (Details Textual) - USD ($) $ in Thousands	Sep. 30, 2016	Oct. 02, 2015	Sep. 30, 2016	Oct. 02, 2015
Income Taxes [Line Items]
Income Tax Expense (Benefit)	$ 71	$ (11)	$ (1,664)	$ 114

XML 60 R50.htm IDEA: XBRL DOCUMENT

Commitments and Contingencies (Details Textual) $ in Thousands		9 Months Ended
	Jun. 07, 2016 USD ($)	Sep. 30, 2016 USD ($)	Oct. 02, 2015 USD ($)	Sep. 30, 2016 JPY (¥)	Jan. 01, 2016 USD ($)	Dec. 28, 2012 JPY (¥)	Aug. 31, 2010 CHF (SFr)
Loss Contingencies [Line Items]
Line Of Credit, Current		$ 4,941			$ 4,159
Sale Leaseback Transaction, Net Proceeds, Financing Activities		1,154	$ 0
Lease Line Of Credit [Member]
Loss Contingencies [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity	$ 2,000	1,400
Sale Leaseback Transaction, Net Proceeds, Financing Activities		1,200
Sale Leaseback Transaction Net Proceeds Expiration Term	24 months
Line of Credit Facility, Remaining Borrowing Capacity		600
Hardware Equipment [Member] \| Lease Line Of Credit [Member]
Loss Contingencies [Line Items]
Sale Leaseback Transaction, Imputed Interest Rate	3.94%
Non Hardware Equipment [Member] \| Lease Line Of Credit [Member]
Loss Contingencies [Line Items]
Sale Leaseback Transaction, Imputed Interest Rate	4.75%
Mizuho Bank [Member]
Loss Contingencies [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity		4,900				¥ 500,000,000
Line Of Credit, Current		$ 4,900		¥ 500,000,000	$ 4,200
Line of Credit Facility, Expiration Date		Sep. 30, 2017
Mizuho Bank [Member] \| Prime Rate [Member]
Loss Contingencies [Line Items]
Line of Credit Facility, Interest Rate at Period End		1.475%		1.475%
Credit Suisse [Member]
Loss Contingencies [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity		$ 1,000					SFr 1,000,000
Commission On Outstanding Borrowings, Percentage		0.25%

EXCEL 61 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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

P"Z!: E /DF\1EDTGS&$ARI1H:S7(HS2W+MJH9O/>?9!*Y]@\?"4^H) -L09[<+#Z& 7"*TYAD8@7 L$ MF5T@L@I$1B#Z+X-L4^3LDQB??O9)4&BGQ%9*O*?$_H82[RAI\L5A)E9(8H$$ M&TBR@WR+4&2GI%9*:J&@#27=4\(HL5,.5LK!0@DWE(/E6H(O:LFLE,Q"B3:4 M;$=!6;+]1[W5FZ+ &],ZA%.RL3>-:F5=NM,C,F_RT[W(!]S 3\R;KA?.A4GU MLLW[JQF3H'+Q']0_TJK^N2P(U%)/4S7G6;G7D2>\:NJJX:^"$=>&2/BWX'6O-NYR+U-O%:7 M4ID)+\^\T>Y4,=K(BC>.H.>=NT?; PJ-Q"K^5+23D[YC@C]R_F8&OTX[US'?R22/O/Z;W52I8[6=YT3 M/9-KK5YY]Y,.>XB,PX+7TGZ=XBH59S<3UV'DLV^KQK9=OQ(E@QEL@ <#/!I@ MWP;>@VR8WXDB>29XYXC^;%MB?B':8GT0A9FT^[9K.E"I9S_R((HR[\,X&C2' M7H,G&C0J/.U]1& (<< +\R!,80TUL-4V_ M21S"D B$1 DG4&B!00',",&&3' V,P8\8+Q;74G"4A)EI38GU&2!<6'$2F( M2 $$FB'2AP]K S(V"P9.(]B!25PH.?P'+LX@FL89!)L5SDH2H@?NSB"ZXZ"5 M T%@)NX1?N#^#**["Q2D*W\7P1F+@)1=7*%!= =:26L$YS4"$GMQC= RLW$\ MYWB3]Y)1<;%E03H%OS:V"DUFQ]*SQ_:]_9+G64LN]#<1EZJ1SI$K_6K;M_7, MN:(Z%O])/P"E+H[CH*9G9;J)[HN^7/0#Q=M;]1M+/9-M@0 %T: 9 >&PO=V]R:W-H965T=-/XG"W6J_;>]V*]RJ]5'^)I4/_+;'ZK/030.=WE2MO^=W;6L\O339.&D M\>_N\YRUG[?NE\#KS; ![0WHW> ^#C9@O0'[,N#_:\![ SYU!-$;B*DCR-Y M3C7P>P-?,W"[ZK9S$\55O%X5^UO]>R4]=V/ M-9-TY7XTCGK,IL/0 4;R,20R(>2.<.L [E%0%,6&&N9:#%L3(846PT,GKX^= M?#,A3+(QY@T,)'"V#-: E]8B( 8B'3QGL%*"*E9?Z(16:)F9AOH0Z!&OE"Z(SR8N$A M;$IYF9&NKZLQP)# V!, 2'"N5]=$"69+"\LA 7KH6_8?@H6)B!G%Q;)#INA. M#QIF*W7= 1@2^'IQ31 EGJX\ "4\BR@0+#T$Z JUN<#"0H(9Q<720L(IQ0T- MH?7TVIJ04*^L"1'2TPMK@AC#&5$L=11(W8!G8Q=85"B97E>*1852$(6VBC8] M*!@N2/]);Q.CA[!Q0%BB*) HGUM<8#F@?$99L!Q0T(2891%&OMY3:'2E#U#C M<+"T4" MPM(344QCZL\H"J8Q10V"WG;VH)$NL;J?U*OR"#8."(L"-46!!K9. M'+.0>=/+PC +&=C:C;+TH%&^4GI"K\MCW#@DS&J&6&TKC.6,,N.0PC /&=J6 MI9XP EEZ*X;)RA!9+3L4PP1C^B_4&ZQH G <%*8L M Y0-;&L)DXS-Z.HY)AF?T-5'/6BXH\K0=KKDF(H<4#$@^D FQ>I6W#80)A@' M! LL4\,QP?BLX3-8(S!KQ!36"' VMBEA>8HUX[ H,!W$A,-B),S3&[>GBTDC &D" MR_XJ,!W$C..;P'00$XYOD3#/5,T#1FT@=_!D.U7%L7UK43J[_)I539"#N_3*NW=^0Y9: ^Q%9OG;O/;[7^*C^BHOC.2N=][RJ\K1]:G[(\TK5 MP7M/]9HXJ7A__Y*H0]5<^O5UT;W]Z+Y4^>7S9<[]C=+Z/U!+ P04 " #Y M@&-)Q(M^&/@! !L!0 &0 'AL+W=O(-%PP)DA M48(\QXD0Q55M)[&)O? D9JTD50TOW!(MI9C_W0-AW]GQM[TXF>VLQUM 0BD4BM@-5S@ M (1H(97X?="\I=3$Z?RJ_MV<5KD_8P$'1OY4F2R56<>V,LAQ2^0KZW[ <(10 M"Z:,"/.UTE9(1J\4VZ+XHQ^KVHQ=OQ-& VV=X T$;R2,>=8)_D#P;X3@4T(P M$(*O9@@'0CC+@/JSF\H=L<1)S%EG\?ZV&ZP?E;L-U=VD.FBNPNRIV@D5O23^ MXV.,+EIHP.Q[C#?!1,$]Y+B$N","*0.C"V_-Q=Y;T+W[!(8=YHS)D%9=Q[4RR]5ZQL7!'*IIQLUYWTWZ!>2 M-=?>-C;8Y!]02P,$% @ ^8!C21[8A8@A P U X !D !X;"]W;W)K M&ULE5?;%6D0EY6>Z<^5BS=MJ0B=ZCKADZ19J6]F+7W7JK%C)]$ MGI7LI;+J4U&DU=\ER_EY;A/[,&TB)^9>Q<7YU;3?"OG+\U%]^W<]MM8F YVXC&1"H/[VS%\KRQ)#W_448_ M?3;$Z_.+]:=VN3+\U[1F*Y[_SK;B(*-U;6O+=NDI%S_Y>(K@327XBN!/)02*$$PE MA(H03B5$BA!-)<2*$'\2O#:]73K:9#ZD(EW,*GZVJJX"CVE3Z.0^EN6R:6ZV MU=$^D^FLY=WWA9>0F?/>&%*898>A PP=8E8(XPTQ#PCC#S&/"!,,,4\($PXQ MSP@3#3%KA(E[C"/WK=\\"C>/M@:\@8$$&_"@ :\UX%\9\%U7V]D.$[68LL,D MOI:B)P B@2$4'X;B@U T+ZL.$UYY(230,OC@CT)Q<1P!C", <5!L((0&PNE) MB:"!"$2@E?(R&BU23@,]<]%XNZ[3.P@EAJ'$$Y(2C[U0DY<$>DF %RVK2X0) ML)-F5J!.XP(3H=Y&W-%J0M-BB*&C$> G,IC NB8W")M@91,D[5AOK AD\H-E M2X!NB6G#L.)(<,-JL>9(.&6U $2(P0^6)@':)(;N0+"D2'S#:K%>"!*#IU=R M,JID/]%;Q+-"-67?PP)7_0RC",N+(GGI'4F!HB^#>E2H_P35#1YDT=A^*%8L M!8HE^GY"D&_P8QC7%)@P-#&*94V]Z=5#L6(I4JS>!R$HTO/T-6@8#-8^!>.6 MF-Z!L/;I#0.78EG3"2-W1<1YU7UT=1>" M'R_?D/V'[.(?4$L#!!0 ( /F 8TD=<#&POUX+/O5V0H6G')B"(:^]*6%8'FTJ+4W:1) MMC0.Q3P4@2115J$*KH5L*.Z#OV)N3,2=Q_D1?XJ_9,Z2F96%K"H [&Z/Y;J0,EN&+[OM]O#ET@^BKT0>!7_)Y7&<1]D?ONIW.U]]^TT:?/M- M]NU)/,N7,LK$-)J+TR@+LK4XCWC,(([$D4@7?B+3;UYFWW[S$OMPOXEX%T?9 M(H4^S+*6Z/:K'YKUV(OX^6T027&>R67Z/VL[ MW*Q7[QKV=!>G,#\6?I)^(,_C1.=W-EFK>RK9_[&W^HL!X)>^#-$M\&.:]OW07 M>S.=7HGK#U=OSH^G;\7Q1 X O_>CEFAWJN^#/EP_ M3666OG(>^^E"P*!BAA_D7_+@P0^AO3,)'!Y>_E0D[R4/BZ(S1YT?7:O0G-]Z+CC4 DLT#729 29-L[8E5B)<%%X GN<*552[\/ +$N _P M#'G(RE9OXGC^&(0.(E[0YJK7PNNM?J91(0S\VR ,,CA6!Q^(4 *D9G P@;,B M@P1P[(@!SLINP^">2&X*'&..(/!7 :XHE'[JGNY%"4S6NIK!T-!PBCL'I,J" M1!(!C(LEU2( #NH 548IL@X]EX.A)\)8%W 7F\!G)IM4RN@3;F?K(6B3LWW?3H'G(-#AW-= M^<'\"(B>PI\*1,R7>4BD7-WU> G'M4"H/4@1QFD5!3-]YO(NF+GXS3!-K;/] M^U__MSK=K?"G_>[6=S?Z?W#I(V8N )F!+QY:_$!#PV(*WA8F,2U1YQ--G7IU?3FW-H\&GGWFN49T=U&K)9A6'&0 M5T">_&3& L1?57"L>Q!/WM:L0\B/H)%6,8H5R&RZGZF8S&U%L_$"- M<>B00^"Z$L"7J9:UC]4 SN&!(B0.@&UT@&]Y%B2K,U2D-1ZL\J6).9>FY<$M0 =0YW!K M'T3/*FCHWPM: #?HUD^#&>-)$.9(@G>C&C_!&2^PN?\ &' O*ZYW[>CGWT&[\Q]/Q=N+Z]W%<1 K0(B:"W608J4D"10.78$+3VNV &E0 MXJ#8ID9Z P(=PI, &! R8[=]3_*.3=';#F M&B&MQ%\M7$5"!/A1092W\./=X#"]_DZ"EB0SOP M/()[).<$:FC/ ML]00P\L2:2%&A%)WGD0L!]WZR!%N*Y006A?QT,!,1CM=Z9E',U)Y[?WN.8O:OM5JY\VVZ!5(%0N&6W M5UK-)LW0UNB:U*M+9XM'U.?6G_W2S"SE*@>I@H:_$W*Y"N.UE(B61LPCK".N M)!Z#;+&0H2-:E:>7'V4R"WA$'B%>[;!JN]NCGZ MK)+?.3A8=:Z.\8C(+>WQ MHV(!:)Q2["!%(6.VJWGF/ *-'4\LV*-3K?''0XWN5MX'$3(7HO +B5PZB%WI MNW$0B9IB4_?7P+K)-G2)RB[0,[I3.-XU\"_B=FA<9E* B[F,PV!6I?F[3<3/ MTUL4+6>98_5]\K3BYQOY,1.O0\"AS5%K='?6],7?_E,\?=8;.$"TI"U7?K3& M)P%*J\$2K0IS)-!D7TBA^9P47(5_I,W"#\I&!LB!D(A7(',SY5KZ$4A5;*@" MIA[F]9X<0Q;P@TY=1:,NXI,$<#W?*0[8>*GL-R6G0B-9NO["%0$(WBS"PN M"%$>GY,X]2#UBG1?8/>WK(_,Z#QQ']%:&1OTX3-*"WA&] BZPP8#F&<-',N'N*EX1N.[8[2V 3:UBD3[H(+ -__4ON)S EML2. MN$TZ&Z5*P4X4C&C3G9YXE/(7.*0/$3#FE(9 \Q-BKMHRTA? MI??WO_X?_)2G] G[P#>U;OH)9X2?R/"/WQ,TH.$2E2L@3^[14J'W2NW1(EL" M3IK?IL$\\-&JVQ+GD9CF]SGKLVPAHE,PN&!=AFL4^/T$SNIU#'_$ :SE;'K] M&I9RJ"U3E.R\(TM@5.C2D@]R'RR4I8^^N526:;QH-3,>E9<@2<>%P&@!PCU"0P+X%C$ MCX(O.'Y3MX4I*\\-0%93$JE-["F9 :DI]3U/[8W-#.=O"6LM<'!*[L=+@&A\ MQVX81.'48@+^'2+@"4Q*5CX\.QB"C830%%#0GS-/Q2$!M9=!!O#FBZHQ IXH M(RZTEV@^8O$,5QM $V"']MK0^BT6/M[.R,6D*AI'&/4.+I"%2X B!CW,X%T" M/>'?"DC!UO9M:G\E'V242Q8.CN.(F O+(.(8L!B4HL0@SK ]!,0YGR--N".B M?2D3,9O@UF**1']RW$&*+WVM&8*BP!+>XQ!O40:1)==#//*W'@ MPQVPIEI94UE"VN]IKH/;0]IJJ.?$PP_I!)6&F,,90U>&7L[WQ\$4/XIRM-4J M,K8=5YC#V.S+)89(E&00[8TW^-%@()R-!;JGXQ$:M[9@1GOB:3JIE::__2>I M4\+^32/%J#-&I%BBL"B-OGFJA5SR'1Z])CU,41"+I@%F:+J1(L28<*3R@>UI M!6)D2EQ0I)!T-!J9-3PMSMM2N&=!AX[5F'[HM$"PDX 0T P&NY,!J'KX9>:0 M1?^1:*X/R!(0LV03.#))RUCNV83-[1UO(6!-6+D7_1KNC6?Z=*M0K3UY*JJ= MR=N$'"7;L(WIUEMRIVF<&O>[AQ9J)'CB:"1#WB^E,6B A/FK=CC2\=O."SPY M=M(Q-6/U#HYLF8I[4"WP\#)03( $R1!VMV2K=A6G*39)'EDXI)9XJX>&TP&Y M2@,>#7L&4;B?1$PQBKO'J]E %)\!K@"S\H'1)!$K4F2MT-M5=C(;G\U*6_:A M@LR;QL7!!7P]T9R8SL(X15S'4P0]!4! MKL%2V]3S2''S;%W&;A!4 Z+)Q&08)I\1X\?>3F08CYU.SL^^1MN*>T:U2>YL&1YT1W:9S1HT;LB=H.MU'J>^U'Q)*7F-$5(4,:%S( MU->Z@UJ'1Z%NKANQP0+U$ O_42>^4Y9?[.0/4[EAE131N=Y+%-2(EDQ MK,-=Q"P+=WU0LW%"&%4SD7VP62E(,&Z_%I?[I,Q\=;FA8Q=ZE%%RTJ,W,1X0 M2*\SI)H'U_EMQHI.>W!$6']BJ!Z.\<$0*H+6;9PCPJA8/]!GIVQ11M@?4XA# MCDP&-EV:YZN6O51RP$6V.R9=P+0,D"Y M^3Y&R* P+9,'T)V8/)$4K>D<8*7958 &+,7[-2>]"TE&5Q:9%%"3[5/8DW=M MD%T!T=BB\,=0V:*85#GK:95VI2^9#X!\D$= OE?L>&!WEC];!+!/& NY=/E\ M #?)7#BG2Y7&'@A\T.#/^?Q^J3D&.AN6Q)&6@ XV&S#T5%8"R:P!Y4D\0=.1 MH68@7( /AB$(Z.%29=QQ;^E!=M]%=5J+J$T4P\D0.RKI%:E#]S% M&&!#H@VB V]T*0%.\Q2T\^ 0H9"'2#:R)-8Q4,)?P6'X)+039FC9"'X/+3E# MR=AJRX @V 6@!7O;I!Q\M=C,JQ%+XM"&Q*WP"I*A#A%L'N"M_CUBT4% RZQ9 MH1E7A5%1O(9Q800(6[)$,KV!]=BH:*[6'+T". J)LJCQ:?)TP.BOK-" M44T M6!71/GRJYF;;G%>:9%?12%BVDH2JS=26W('HLO"9]*XERE^H.5$8 /9G/$"_ MD-ICQM27IG6 J\1YE-5;XB1/]#:R12+E$2E>++'!^.JKQ8%@RHM9%I/TRW%% M]A80$(7L^4)TNWT* NR-!OBW(0*W[M':%A?J'2[5S9_F2^FB+\5:VD;PX4;, M(?]SY3\:+L?PTDY&-(:4V,LL202G&J JS,$+4C[ ;6 M/9?U&8#?0^#O.^T."&(-J>+9U $A/K0'702-UQL/Q7EA&+-BX8?=H1A,1BCB MI/E24=YRDT%[A&O_D8(F@;HIM>C@Q^G-86DHP*%1MU\HEX"FR;UB93KLC /\ M /7&7?I_.91:J5I#&&741Y3N>T-"LYXW[ TKD$O''5R:N(/3NKB#QL:-J-+4 M[],1H\^(T33)#FCP#J6B2";KDV\;F\,#8>=CN@-O7YW)'I=;S@>*&+AER*5 MK7@A(-8CX$K=KC< @,KZ0#=&>.'-A&3ACR#:K*@4PQH"T[K72E[4[>GP7(@ M_O:_W'$K8LPW8\2_CR<=^AU6KQ4BUE;1*K\(5G#' MO<&@+0Z _ R&A\!7^DB)V@/\I=WO'XKNL /$@L)OD:;(V2**P_A^+2: 4@>3 MSN10#(=BW)V( S1KB?%$<$@N8="8%G0 G[KX\(48TLK@>Z_?H2=M;SBBM0^' M+NTHT]NW]?D0W-!JL!MZ-7=[&GH- ;U$[<+KR03@3()*;NJ'Y+\F:#_Z]Y*Y M1%]QB0G<4=WT-HYR1 7@(7#-0<( .6&31_21A@]&ID\ CQ/28CO]OACTV^:) MGX-,+.[0J-\'O.K!8+R- \ A9%,=F+X[0K"-O,$02<-0HD'36AK56-J:#<%K$ -(B$X<;[B95J+$+?KXQEIKB<^#""'&A>7.VGH%2 M_GPSPI=:S8"^DZRN(];(28"+O ;5Z5>9A&1\I:08&&HCF 5$^U*F@'B/F5BE M7\IH:0GY#0_(+ !+2XF##4C ;"-:].$J ]'I=H6)>Z=6G0G^-P"T&Y&P... M&HSL%'$I0%D<=('V''2[\,]P@O_ 5Z2._D:4:J$0 \DI?-'DLN[!_SIM,08, MS^"6H5I%T;:6OAA$1JQ1&BYV!,D&N"?(UR#.&&(V8L*%@LZ@AY>@-YA0:R;D M:5G[(9.4OT,F44D+0ZU+>[]D!5Q,ZM.&%N:5U+"E/Y?L\T$C9A+Q$':J(\:)%PT6L M:ORT:S;6\6]-:_U2]^!]OL2[%B>OA,E.0,;FC4;C0_5IT#U4;' RY(\#;S@! MAG@BHYA<+]C=R4?04:DJGXD4!].>)'8W.0&T^UG.#'[KB':B0[_M#=H=2LD# M0@_?NOTN?AOT>DIR_$ AP!P"!UA%EY?#70\ZP,$/.G1EBX\G^ZP59^R# @0S MCH"7X?PHN4Z\/O"[BJP/H*ON>'"N[5:[?[CQH==6'SKPRQ?"@@N.^$4F#'(\ M"-R= ?P[Z2%;[O>'XFKSS-A-BQ1\".H\4)P^*O<]\9.*!$:4YO]Z_8&B0C#X M! F-C.\3?[50QP-ZRSR?99CS[CNQ^9)MKE?&TE=_8=VV MG\XA)[C#AO66^..2$L=2DS:6$@=<<7,RB2.;I -M?RE :VUN8'UBGHN*<+L[ MH;]=MKMT05\;\XP/>=!#, MXU$/Y*T>L->QUQ]JF0QD?Q#;QW0]NZ@\PA_0]B9=P["Z;6U9@-$';9*]O2Z9 M@09#KPLCO98S'^1'.*SVUU4&3,Z\P-O&H:"9YFML %YD"S]< LQ2'9NI( &P M*0SY9=;$<@D[9F/,!C=)%+H/QQQH,ZAE@,Z356RB%4IV5G8L%//SFC&&"2X2 M63V.,1<,=9^0=2>,F3P_?IM2N*9.<4CD'1FO@3'CCK2:'J!;*48Z5>Y^L=%] M!MB*_75G[1I:ZD"5JB..=!HFVF_U\86(I@&=$5O^4THYRW12TA$ M2-3WQNT.H_*$=+A^S^N-R>P#V#D9"CP090KJPP]M[#(:]_#/9*!M2)NH@M0/ M]!/0;GI(W;H@LGF3SG /)+Z(I/&*><#1$K3CL]!#.89\Z3P=L:9<7-T.":-# M6)V8DF3D"EH>140:CYLS>&I&)SSY(4ZD.T\;)4F@[C89JR1=&&7DLQP;K@LG MY>V?C4M/=\]B$Y6WBM$P0!TG+ 5S&K+,8KZN)@$]5"/P] M\F V'YN #XS%"W.4FW607SGEKY15 OBI8LF!!U"TR ::V[& )E8>3N]#Z[JE M$S4//;T4=5?N(EJ,>9B@)H5>>QB129JM911122!+ ]=H@' 2DDM\\:=L2MC M];IB/!9=T-.00#F/6?SJ@'36A3T"BQX"Z0)QZCUPINK962 #EMXOK%QHMG\A M)D"Z7@ _[O1[9*Y!R_@7.IE2ACY,!BN"^8DB(H$$2: ^%1](T1@4<"*SH-QV MO.%P)"KS\<4(;?]H#1R@G0@DSKJ,?+3_=<9D?VKWQ # 8Y6ZJ$SXI#/#$^/S MXM/2:K3* 61W;DK^,_8!:R<7+*73 WBAR6LP-G#H$T9T@%\P)- _ACZ)=GO MR*MD=+*[<.C;DG5LW \B!UV@;ALV<;&,@,:G9-VGFF,S)+-P?-07V3]2./Q" M(H"* V(GR@,0%F#4^'F9FI1 =1<#/1+*,3'YJ3T3]?O@!R&)*Z:KBECFR 4] M95FB0IO1/6H,%.X'2GT)8SU'6?-@-/LWTJ9H@(K&?$44C;2"_DVYF2G&$J3Y).AN1[7WFK,295F6T\ M##$@ZYGQC0._P#$YG0?#*8&SS9!M\W8 %3&9B@;4'FX.;L(43;P 0!-ZH,?U M"9/:+9361ZUA5W1[@+6 ?\,AX!K2C6X79"*X+N?+)?3$/?RH:L M\&G*8+VP0K,[IHA-S$624-@@X*B"+X@ZE(7):4]L'B09.7Z$VX[&_"H!LY38 MBG$Y)0-0=RB&+2!Z+2"!+;B(\+G3@GW"WS;\UFN-T#VBS,ELJR3@*:C=<:R( M"F\@9*68&16[,Z^$JXIP\8$1^7 OKF>P0;1%\" JN +C6^*Y#"E69:W-8X_* MG'&DS1F^M3B,X9CK@&PK8@;QIE68&Q]BE#!T>&B"D:@IKW0!5#).2 HPC=:5 M>A$>)HOW)H+!5)VLBG0.LH@: LA_I/.L9WK0P]&U) M387@IE;.*RTP0)\QQH!M3D\1KF:-%.IE&7U:CO596V2P*_"4+\7;]8KF =)- MV-HZD.%RQ"7*H7U&(^Z$8M&#, 5YT_:ECZ-I%N2[5IH,0R 4PM3?J[$?0 M\53!=RX.^F@3.^/\%DEYG4R"X%&O/SS<'+O"\$O42 ])Y+"Z'5"C84D:LCYN MV0$:HGK 8/4>4"'K].QML)6O-V[;FP$1Y&"G+7313.'Z^>P@^?IGN[J,*]L_ M4?;M<#B0%<._:7Y0Z;/ANJ$D#I,!FS4I&LE"EXXA+((-*;H#4!AOJ$51*1A2 MZV44M!7G]PL,FD:"0/P0 \7D(\Q>5"AE/II: D:1XX*\A+@U4UF+H#)QR$SI M%B0T>92GN%#:WEU">5OE3"]%AF:D*,(%+WP;3BQA4"(WJ01)C[D2BZUSIEA% MAHLJ!F.Q%^8DU*+N "FJ+T\1=?U;8/8M8LBZLDU!DTOTW()L%-:'(AJ'8!?* MK%HR@P4$7>#-G4Z_RFNS61SPV"X.N%?CW6[<[D,\\1)VQ9%HGN0MQ2*C4DRU M):G%&[B82,6D^!PW U TZJ M,*&]W3&1MZY**'L7_)HO8O':CW[1AIR2AG ;)PD))[3B?(4(-6 ''#OC2 SK MCP8N!1TY#?NM;CF/H^TY"%W:[_5CD*85FS49]M,W'D8X2RY?BC*CJMA9G( * ML>=?KW,84(H#E=2/VT:M2-D_-WM6GT1Q$!VSNTX+Q6[0ZD!._CX'J6-D['+6 MK=I8*=:?GN<^FGF519B)O[.(.KY2]!24PP$D#1$8H0H/J#*!!,?H8Z$Z$DB^N.0Q(@[(%KUL98JP\F@21 M* :^?/K&PG):YJB9O"[YGRMN"29-H]3CS;I*M6I2#-$UJ26I*IZS$"Q28V& M4B)GD1L%-(.[HC.;2=LE/0)*[2;L'>@<(,TN"6XKF '6DI6X: M5CW'8/G4"L:A ]4:2C-8'-1O&@58I]B710&..\#,V WSVI&R)])E16D#<8D MXZK\)=PF'\KF0G6BD^:NIN9&0B(GI\N I'KI*5%(A[=#![B>Q+'3_ YU7.:Q2M@AAHZ'18?R$JM!6Z8HO!IDZD68V3)0 M@5&42T0Y*G"=J-)TV;9NY#3,SR&G!2E;)>2615*3$E&,@XMJEAAY#79,5G+$ MM#A-*:H//=F>") ^K4T5E:)>BDI#D/,RG0M03N/U6N/3TNR!<0%F2OI!5X]Q M[Y.#GC\ML"H=4R$$AQF9$GH ZU@^6R'A08$PL0X+;CI+F>:F!%@2WR/..7_ M7"O36M<89%M'PND_Y7Y6PH7.HP#*$5[O(JT)8,^G ,8I5G?"7*%QA3$+E/Z#^F.:9O MH.,O"%E1.)V3687&]K&X(A F)B-\B5'KC?&:J*0PW#T)E"3&,0V="D+5X#88SO M48*[SN0*D^V.6\CL@8< <[\*,/0= -82[V2 SL/OXP4U>1?#PN$K'@:FA(DK MX'<+#P8#24>L-454VKOJ'"^1#)]FZ"I3JK: L!=4/33 M_K!;$ )!QT)^K0@>T@>/J^Y3N2/:#!)'%/4X5UPL@Q3$*;J:5K82-&).B [2 M!&A.8JI^%*6W*HQJ?P0^CISN>@V"VM)#.R.Y(3C-=D4*=DQ7O42Q/15(@P7" M@*##@2R6)M6[0*P42U:!5+1$GL5V[B#+#6=@AR(QXD22]1T+S,$6(KFF4ML4 M%4M,&/UK+41Y)7$7&;@E3HD$%,^)T]2C.?(C?0W>Q3IW#F (IVAPF0\)@:W% M6.;>"^"X7""MT#E,B9%IB($!]]P;:!LS!D6.C0RH2 R(!4C8;Z5MCN J&+I@ M1'DC1C8E,9A4;<0H)>0$!;55%SAAB17EOB7<\,PU,>+\&(&9L.ME;=B6CW'( MY((U)69,1;H]*M'56)[X^@2I$CH00L05@U]@AXLX9C=086FPN;1G%GXK@1Q8 M1T>"'S^R,@2).[/9N1! IUKI<$U(QXM WJ&1;9830;Q@>EZ2^@R-9P:8%M8F MS7*#I%!L4M./16,[,D!EMG,YE#L=*&IYZ:C&J@J"]D#%P9]0LRM*"9/L'8=4 MN(U1%V5S4^,/VI=KF**VB2*92N($VD?98>KU% @92R[ @G$*A3@^2<4/8CJ< M0!=('%'!N")66F&,)>T7!^%X\9]>)_% ?W+*/ILQBVX>]UN+G]7?O6T?-XO: M(H25>%\FJJ9#D3'-!?A*QH5R 3XTM=E*%%GG9[J_ MKL#KZS /;4(D#*>;9@J3J%($)9H XC!F+/#9['Q*Q> K3,ICTP$-G,P+A=NJ M;V7RUE.K(B(\1Q)C4*\I2F52SIWM\L9_TD> MRE),$*U!$Y+-%5<6NV E/UP78IFR9A1![UN@4L 22S4I(^@J3]+C7^&CTZA5QV&(';+[_A8(E:F-8=X?2YQ*YY+W#Z7N'TN+YQ*W_RU+W&Y[T>VG MFV@O"8O^A*Z0S<'3?YX"N\ A,"#!]5Q?6_'2IHRN>4N[^)FZ[7\JUM3$E\D M4RK#5B$P7'>^_AA2X]D@IWB#NP#TOR,D%_P)Q:9;=K-O)(]R6 YY$^3S[:?5\#:Y=W.U=9+>41?(TG"Q-.2]-J8JSE0OBX!7%4HB%.\33FF.D9/ M!MS-PBD!(>"00&P$%4I;#Y:K.-*!DT@W6 P'W7>E5DXU:TVHLHF_MY09IUBO MZLE%>S7)IRPY@\I%U:_Q!DV*=:\#\4^O_LY8)WK>FZ7;B[V*C 2F4Y M/PWXJ7)SHBN$DV'(,E%6H.9>LVWRZ=FMYA%@]K<4'REAVZR)B2L4]^X;BW1-NR^F& M5K+*/PC%GFO?[EW[M@FE*\I$Q$K2\KWGV[9]3&WF>[[PQ-$*B+9Z@IQUN.57 KB-9%-6RV MW!;=4.&5VAKD4.V +,1OHVC^Z.00A8"QSN_3V//B1X@:7^_(3:""XSK;;]1 MJJB.%6;P5H<9U+&$FG""NN:5(01UC1O<_GO#SGFOKQ71V' 7ZCWR=2V50WX+ M/:OK;5SS=0T*#WWE#C=__+GC;.E]3 440"FATEJP;3RXO__UOV@ *I* 9;'5 M:R]2,3!O@LM(MRP3LW#;&YB;P&-O F6.4#7R\5=_:N3-[L-6NWVUWM& M(>R-2\.UN_VW9"E&Y'/=N-7T+/">^^\1[71@>]6K-C9=^]BY<[> M^\VN9*APQON\_OK=0+^#?,P5LNWN#13.10^/\W3,:W=?K[7IT+FPVT,,*A'V MI?8[XBO4V*-8_&!0V=N"VH67W1&6/[?7?,$+"=ZM1Q0ZS=WX;/',I\,'=%! M^*C%5T#"0?S/Y11OXF6?9PZO1EK19I2ZBU%C9SBXNOX R%S7RSA]ZQHT>G3W M)NZV(Q=5;#(J-QTJ^S9KI2/R:-8]+3LTFZ6@3]D^(^/.:@,-<&Y5*6O:/WGW MZA9''KWF?;G^O$_::9U T>F6[+G[C-VT>SNO-W*B %"CQGK:J\+MT^A!=EBD MY=79_47'_'9/+:NBXW#I1_D=UL6GU"-@Z[(H*VRC8$M),)1%J-YTH=^5JLHN ME-J7Z\*:3%ET%.'IZ4K^G+6Y%OJUH_!5)VWI-PJSK"DZ_-;ALG\)&[A5MDQ MSK'9KAF7$ZG%A7JSL,/,:*T MBEJJ$-,[_U2:*AKVO89U=/O[K(,WIQ"-U+O:970[50-WAI6_3BI_;5[:S6.\ MZQ'!X^/OSM]/G34V V&_&7ZXN#J=>N+J]/+#Z[?GQ^+BS-E0Y9'41P3LS5^> MY#UN5A)J.CDZ0;4S? =NS1UV;L@.^;KF]6[YNAY;3W\?]J;<\$C"Z@Y;I;;5 MJ2;;'++N96?_M!(E:IE;K8^ZKDNUG[H!3-7NZJ]?ALC4^S\UFE7>ZP@_J MJ/>CJHZ#<=6O->Y2Y\*W.A.7K+6&%;2NU>M7M>S4[V3#Z^HL7-47&NK23]V! MF/MKUZJAVHUTNTYOQW;MRG;;(=L[W$5GN9:KEG%?&4VT5:68/9_*V95Z\NRNG!6&?WJ]#Y/1VW11"8_#PHMZ><6I> M9GAFZ@**JPK:52F2O2[> GQAW@)LF5-54C^^C,.1M2HE/YLS3A:B M>!)V+;C5MEXE3G5B<:IM'=_Y'X-EOJQ?SI>!GU M194_O/[%ULQJBLR)!UU[@8.?\)*X=P_X=;N-]'3[OA^ M%2?W^8ZE?+>F]=% MQ:R!=Z \)8Y\W/Q^5W>QS4O\/H]:HJU>&%KGYK$EVIHV%[,,QE&E>'89Y_O+ M/XF#O_U?IQ$(6S!0IW&R$SEKF7?)U@TTS>]A-AZH??S=F3BX/DN<5N2H*!]A M$Z#HT85^>ZYQEE?9TK@$Q:T/R'93E#]FV],EOUP0)6^N\D15$2BXK\)_2P.) M\M2UJ$O-BO?[GO%+3]?XIC>6 UZ;5\D>^RMXZBJ4]:LO+=YFBS>@T[D6.J5Q M[;S$*XEO_"2!8.LBOP-6\8B^'2MZIR ">QU9$[3.T>TCYT5:>)7(B6^S=23$ M]W LGW&1^+)<9P[K!G;^F^_^QV6JMME:M@3B'9+ELOW7U#I MC%$#4B&5IY$K<.%;GUT#:.D]R_5V9OV*'WP[G:UT&:Q+FRS/^*IE:^J7:9I] M^_\ 4$L! A0#% @ ^8!C20 XP!'H 0 &Q\ !, ( ! M %M#;VYT96YT7U1Y<&5S72YX;6Q02P$"% ,4 " #Y@&-)2'4%[L4 M K @ "P @ $9 @ 7W)E;',O+G)E;'-02P$"% ,4 M" #Y@&-)1D'2C-T! "S'@ &@ @ $' P >&PO7W)E;',O M=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4 " #Y@&-)M,ISP!$# ;#0 M$ @ $&UL4$L! A0#% @ ^8!C22_A M53QF @ P@L T ( !"1 'AL+W-T>6QE&PO M=V]R:V)O;VLN>&UL4$L! A0#% @ ^8!C27, TK=. @ \P< !@ M ( !!Q< 'AL+W=O&PO=V]R:W-H965T&UL4$L! M A0#% @ ^8!C2=YP:S%5! I!0 !@ ( ! 2 'AL M+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ ^8!C24FK MC JA 0 L0, !@ ( !QBL 'AL+W=O&PO=V]R:W-H965T M&UL4$L! A0#% @ ^8!C28Y:W>"A 0 L0, !D M ( !2S$ 'AL+W=O&PO=V]R M:W-H965T&UL M4$L! A0#% @ ^8!C29WE;0B? 0 L0, !D ( !U#8 M 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ M^8!C28S>P?RB 0 L0, !D ( !6SP 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ ^8!C22W.>22B 0 L0, !D M ( !AT< 'AL+W=O&PO=V]R:W-H M965T&UL4$L! M A0#% @ ^8!C2?HP^RR@ 0 L0, !D ( !%$T 'AL M+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ ^8!C M2= ,ZM/6 0 104 !D ( !LU( 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ ^8!C2;O/V:4> @ YP8 M !D ( ! ED 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ ^8!C2>L*;^YI @ 3 @ !D M ( !AV 'AL+W=O&PO=V]R:W-H965T M&UL4$L! A0# M% @ ^8!C27_Z/R+2 0 B 0 !D ( !]F< 'AL+W=O M&PO=V]R:W-H965T&UL4$L! A0#% @ ^8!C245? M_XK- @ Z@H !D ( !?6\ 'AL+W=O&PO=V]R:W-H965T.QQ!G0( (0* 9 " 5-U !X;"]W;W)K&UL4$L! A0#% @ ^8!C2=;71'VW @ SPH !D M ( !)W@ 'AL+W=OP >&PO M=V]R:W-H965T&UL4$L! A0#% @ ^8!C2;8J-T_[ 0 L04 !D ( ! MNX 'AL+W=O&PO=V]R:W-H965T/9-M@0 %T: 9 M " 5^% !X;"]W;W)K&UL4$L! A0#% M @ ^8!C2<2+?ACX 0 ; 4 !D ( !3(H 'AL+W=O&PO=V]R:W-H965T XML 63 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 65 FilingSummary.xml IDEA: XBRL DOCUMENT 3.5.0.2 html 128 194 1 true 40 0 false 6 false false R1.htm 101 - Document - Document And Entity Information Sheet http://www.staar.com/role/DocumentAndEntityInformation Document And Entity Information Cover 1 false false R2.htm 102 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS Sheet http://www.staar.com/role/CondensedConsolidatedBalanceSheets CONDENSED CONSOLIDATED BALANCE SHEETS Statements 2 false false R3.htm 103 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) Sheet http://www.staar.com/role/CondensedConsolidatedBalanceSheetsParenthetical CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) Statements 3 false false R4.htm 104 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS Sheet http://www.staar.com/role/CondensedConsolidatedStatementsOfOperations CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS Statements 4 false false R5.htm 105 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS Sheet http://www.staar.com/role/CondensedConsolidatedStatementsOfComprehensiveLoss CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS Statements 5 false false R6.htm 106 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS Sheet http://www.staar.com/role/CondensedConsolidatedStatementsOfCashFlows CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS Statements 6 false false R7.htm 107 - Disclosure - Basis of Presentation and Significant Accounting Policies Sheet http://www.staar.com/role/BasisOfPresentationAndSignificantAccountingPolicies Basis of Presentation and Significant Accounting Policies Notes 7 false false R8.htm 108 - Disclosure - Inventories Sheet http://www.staar.com/role/Inventories Inventories Notes 8 false false R9.htm 109 - Disclosure - Prepayments, Deposits, and Other Current Assets Sheet http://www.staar.com/role/PrepaymentsDepositsAndOtherCurrentAssets Prepayments, Deposits, and Other Current Assets Notes 9 false false R10.htm 110 - Disclosure - Property, Plant and Equipment Sheet http://www.staar.com/role/PropertyPlantAndEquipment Property, Plant and Equipment Notes 10 false false R11.htm 111 - Disclosure - Intangible Assets Sheet http://www.staar.com/role/IntangibleAssets Intangible Assets Notes 11 false false R12.htm 112 - Disclosure - Other Current Liabilities Sheet http://www.staar.com/role/OtherCurrentLiabilities Other Current Liabilities Notes 12 false false R13.htm 113 - Disclosure - Defined Benefit Pension Plans Sheet http://www.staar.com/role/DefinedBenefitPensionPlans Defined Benefit Pension Plans Notes 13 false false R14.htm 114 - Disclosure - Basic and Diluted Loss Per Share Sheet http://www.staar.com/role/BasicAndDilutedLossPerShare Basic and Diluted Loss Per Share Notes 14 false false R15.htm 115 - Disclosure - Geographic and Product Data Sheet http://www.staar.com/role/GeographicAndProductData Geographic and Product Data Notes 15 false false R16.htm 116 - Disclosure - Stock-Based Compensation Sheet http://www.staar.com/role/StockbasedCompensation Stock-Based Compensation Notes 16 false false R17.htm 117 - Disclosure - Income Taxes Sheet http://www.staar.com/role/IncomeTaxes Income Taxes Notes 17 false false R18.htm 118 - Disclosure - Commitments and Contingencies Sheet http://www.staar.com/role/CommitmentsAndContingencies Commitments and Contingencies Notes 18 false false R19.htm 119 - Disclosure - Basis of Presentation and Significant Accounting Policies (Policies) Sheet http://www.staar.com/role/BasisOfPresentationAndSignificantAccountingPoliciesPolicies Basis of Presentation and Significant Accounting Policies (Policies) Policies http://www.staar.com/role/BasisOfPresentationAndSignificantAccountingPolicies 19 false false R20.htm 120 - Disclosure - Inventories (Tables) Sheet http://www.staar.com/role/InventoriesTables Inventories (Tables) Tables http://www.staar.com/role/Inventories 20 false false R21.htm 121 - Disclosure - Prepayments, Deposits, and Other Current Assets (Tables) Sheet http://www.staar.com/role/PrepaymentsDepositsAndOtherCurrentAssetsTables Prepayments, Deposits, and Other Current Assets (Tables) Tables http://www.staar.com/role/PrepaymentsDepositsAndOtherCurrentAssets 21 false false R22.htm 122 - Disclosure - Property, Plant and Equipment (Tables) Sheet http://www.staar.com/role/PropertyPlantAndEquipmentTables Property, Plant and Equipment (Tables) Tables http://www.staar.com/role/PropertyPlantAndEquipment 22 false false R23.htm 123 - Disclosure - Intangible Assets (Tables) Sheet http://www.staar.com/role/IntangibleAssetsTables Intangible Assets (Tables) Tables http://www.staar.com/role/IntangibleAssets 23 false false R24.htm 124 - Disclosure - Other Current Liabilities (Tables) Sheet http://www.staar.com/role/OtherCurrentLiabilitiesTables Other Current Liabilities (Tables) Tables http://www.staar.com/role/OtherCurrentLiabilities 24 false false R25.htm 125 - Disclosure - Defined Benefit Pension Plans (Tables) Sheet http://www.staar.com/role/DefinedBenefitPensionPlansTables Defined Benefit Pension Plans (Tables) Tables http://www.staar.com/role/DefinedBenefitPensionPlans 25 false false R26.htm 126 - Disclosure - Basic and Diluted Loss Per Share (Tables) Sheet http://www.staar.com/role/BasicAndDilutedLossPerShareTables Basic and Diluted Loss Per Share (Tables) Tables http://www.staar.com/role/BasicAndDilutedLossPerShare 26 false false R27.htm 127 - Disclosure - Geographic and Product Data (Tables) Sheet http://www.staar.com/role/GeographicAndProductDataTables Geographic and Product Data (Tables) Tables http://www.staar.com/role/GeographicAndProductData 27 false false R28.htm 128 - Disclosure - Stock-Based Compensation (Tables) Sheet http://www.staar.com/role/StockbasedCompensationTables Stock-Based Compensation (Tables) Tables http://www.staar.com/role/StockbasedCompensation 28 false false R29.htm 129 - Disclosure - Basis of Presentation and Significant Accounting Policies (Details Textual) Sheet http://www.staar.com/role/BasisOfPresentationAndSignificantAccountingPoliciesDetailsTextual Basis of Presentation and Significant Accounting Policies (Details Textual) Details http://www.staar.com/role/BasisOfPresentationAndSignificantAccountingPoliciesPolicies 29 false false R30.htm 130 - Disclosure - Inventories (Details) Sheet http://www.staar.com/role/InventoriesDetails Inventories (Details) Details http://www.staar.com/role/InventoriesTables 30 false false R31.htm 131 - Disclosure - Prepayments, Deposits, and Other Current Assets (Details) Sheet http://www.staar.com/role/PrepaymentsDepositsAndOtherCurrentAssetsDetails Prepayments, Deposits, and Other Current Assets (Details) Details http://www.staar.com/role/PrepaymentsDepositsAndOtherCurrentAssetsTables 31 false false R32.htm 132 - Disclosure - Property, Plant and Equipment (Details) Sheet http://www.staar.com/role/PropertyPlantAndEquipmentDetails Property, Plant and Equipment (Details) Details http://www.staar.com/role/PropertyPlantAndEquipmentTables 32 false false R33.htm 133 - Disclosure - Intangible Assets (Details) Sheet http://www.staar.com/role/IntangibleAssetsDetails Intangible Assets (Details) Details http://www.staar.com/role/IntangibleAssetsTables 33 false false R34.htm 134 - Disclosure - Other Current Liabilities (Details) Sheet http://www.staar.com/role/OtherCurrentLiabilitiesDetails Other Current Liabilities (Details) Details http://www.staar.com/role/OtherCurrentLiabilitiesTables 34 false false R35.htm 135 - Disclosure - Other Current Liabilities (Details Textual) Sheet http://www.staar.com/role/OtherCurrentLiabilitiesDetailsTextual Other Current Liabilities (Details Textual) Details http://www.staar.com/role/OtherCurrentLiabilitiesTables 35 false false R36.htm 136 - Disclosure - Defined Benefit Pension Plans (Details) Sheet http://www.staar.com/role/DefinedBenefitPensionPlansDetails Defined Benefit Pension Plans (Details) Details http://www.staar.com/role/DefinedBenefitPensionPlansTables 36 false false R37.htm 137 - Disclosure - Defined Benefit Pension Plans (Details Textual) Sheet http://www.staar.com/role/DefinedBenefitPensionPlansDetailsTextual Defined Benefit Pension Plans (Details Textual) Details http://www.staar.com/role/DefinedBenefitPensionPlansTables 37 false false R38.htm 138 - Disclosure - Basic and Diluted Loss Per Share (Details) Sheet http://www.staar.com/role/BasicAndDilutedLossPerShareDetails Basic and Diluted Loss Per Share (Details) Details http://www.staar.com/role/BasicAndDilutedLossPerShareTables 38 false false R39.htm 139 - Disclosure - Basic and Diluted Loss Per Share (Details 1) Sheet http://www.staar.com/role/BasicAndDilutedLossPerShareDetails1 Basic and Diluted Loss Per Share (Details 1) Details http://www.staar.com/role/BasicAndDilutedLossPerShareTables 39 false false R40.htm 140 - Disclosure - Geographic and Product Data (Details) Sheet http://www.staar.com/role/GeographicAndProductDataDetails Geographic and Product Data (Details) Details http://www.staar.com/role/GeographicAndProductDataTables 40 false false R41.htm 141 - Disclosure - Geographic and Product Data (Details 1) Sheet http://www.staar.com/role/GeographicAndProductDataDetails1 Geographic and Product Data (Details 1) Details http://www.staar.com/role/GeographicAndProductDataTables 41 false false R42.htm 142 - Disclosure - Geographic and Product Data (Details Textual) Sheet http://www.staar.com/role/GeographicAndProductDataDetailsTextual Geographic and Product Data (Details Textual) Details http://www.staar.com/role/GeographicAndProductDataTables 42 false false R43.htm 143 - Disclosure - Stock-Based Compensation (Details) Sheet http://www.staar.com/role/StockbasedCompensationDetails Stock-Based Compensation (Details) Details http://www.staar.com/role/StockbasedCompensationTables 43 false false R44.htm 144 - Disclosure - Stock-Based Compensation (Details 1) Sheet http://www.staar.com/role/StockbasedCompensationDetails1 Stock-Based Compensation (Details 1) Details http://www.staar.com/role/StockbasedCompensationTables 44 false false R45.htm 145 - Disclosure - Stock-Based Compensation (Details 2) Sheet http://www.staar.com/role/StockbasedCompensationDetails2 Stock-Based Compensation (Details 2) Details http://www.staar.com/role/StockbasedCompensationTables 45 false false R46.htm 146 - Disclosure - Stock-Based Compensation (Details 3) Sheet http://www.staar.com/role/StockbasedCompensationDetails3 Stock-Based Compensation (Details 3) Details http://www.staar.com/role/StockbasedCompensationTables 46 false false R47.htm 147 - Disclosure - Stock-Based Compensation (Details 4) Sheet http://www.staar.com/role/StockbasedCompensationDetails4 Stock-Based Compensation (Details 4) Details http://www.staar.com/role/StockbasedCompensationTables 47 false false R48.htm 148 - Disclosure - Stock-Based Compensation (Details Textual) Sheet http://www.staar.com/role/StockbasedCompensationDetailsTextual Stock-Based Compensation (Details Textual) Details http://www.staar.com/role/StockbasedCompensationTables 48 false false R49.htm 149 - Disclosure - Income Taxes (Details Textual) Sheet http://www.staar.com/role/IncomeTaxesDetailsTextual Income Taxes (Details Textual) Details http://www.staar.com/role/IncomeTaxes 49 false false R50.htm 150 - Disclosure - Commitments and Contingencies (Details Textual) Sheet http://www.staar.com/role/CommitmentsAndContingenciesDetailsTextual Commitments and Contingencies (Details Textual) Details http://www.staar.com/role/CommitmentsAndContingencies 50 false false All Reports Book All Reports staa-20160930.xml staa-20160930.xsd staa-20160930_cal.xml staa-20160930_def.xml staa-20160930_lab.xml staa-20160930_pre.xml true true ZIP 67 0001144204-16-131382-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001144204-16-131382-xbrl.zip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

)_[T-7\)F/)P-LCX)TBK<7AA"RU[RN)! M/I0/+^/)%'31'VNQHE;Z([R%/?OOVJ-LX7D+[[^,HR$ XLBB- Z#(9\W7/@A M__@^O3+=$4*G&BNMG4R"+!_&P4+@71E,@& BI#MN2,OOA@K&43""E\!W:3"(9SE[#] DSM_JO]JC4.GZ M[HH=9Y MD4$SU974-0H_P3##\B[1'_6G?'T,;Z[P<.9T"U1BTUSO<,&JJJHK:Y MGT$;Y16X^>)>L

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end